Tun yaushe ne waɗannan alamun suka bayyana?
Kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ga shekarunmu.
Ko da yake akwai zazzabi.
Kuma kana bukatar ka duba yawan cholesterol da kuma karfin jini.
Kuma yanzu kana da zazzabi?
Kuma yanzu zuciyarka ta yi zafi?
Kuma kuna da matsalar numfashi?
Kuma za ku iya gaya mini ko kuna da wasu alamun cutar a lokaci guda?
Kuma zafin jikinka ya tashi sosai.
Kuma ina da tari.
Kuma ina da sanyi da kuma tari.
Kuma a yau na ji zafi a kirji.
Kuma shin lokaci ne da ya dace da ku yi wa tsuntsayenku kallon sama?
Kuma hakan yana sa na ji zafi a kirji.
Kuma ina ganin ina da zazzabi.
Kuma ina so in ji daga gare ku bayanin inda ciwon kirji yake.
Kuma suna da zazzabi.
Kuma da tarihin ciwon sukari.
Kuma ina ganin kamar na yi rauni a kirji.
Kuma mutane suna tari a gabana a ko'ina.
Kuma kuna da ciwon kirji.
Kuma kun ce wannan shine matsin lamba a kirjinku.
Shin akwai wani a cikin iyalin da ke fama da cututtukan zuciya, cututtukan zuciya, cututtukan zuciya, yawan cholesterol, hauhawar jini?
Shin akwai wasu alamun cututtukan da za su iya sa ka ji zafi?
Shin akwai wani mutum a cikin iyalinku da yake da irin wannan yanayin?
Shin kana da wasu alamun cututtuka?
Kana jin kamar kana da wani abu da zai sa ka yi fushi?
Shin har yanzu kana da ciwon kirji?
Wannan lokaci ne na mura.
Amma, bai kamata mu manta da ciwon kirji da ke cikin zuciya ba.
Amma, ciwon kirji ya zama matsala mafi girma a yau.
Amma ina jin zafi sosai a numfashi.
Amma na san mutane da yawa suna tsorata da ni.
Amma, dole ne mu ɗauki kowane ciwon kirji da muhimmanci.
Amma shin numfashinka yana da kyau?
Wannan ciwon kirji ya sa na manta da kome.
Kana ganin wani yana matsa maka kirji?
Shin har yanzu kana jin kamar an yi maka laifi?
Shin sun yi zargin cewa suna fama da cututtukan da suka same su?
Shin kana da wata cuta mai tsanani kamar hawan jini ko kuma wata matsala dabam?
Shin kana da wasu cututtuka masu tsanani kamar ciwon sukari?
Shin kana jin zafi a kirjinka?
Kana da hawan jini?
Shin kana da wani abu da za ka yi da shi?
Ka san alamun da take da shi?
Kuna ganin wannan hoton?
Ka sha ruwa sosai a yau.
Duk da haka, na yi gwajin ciwon sukari.
Amma ta ji irin alamun da nake ji.
Yaya zafin zafin jikinka yake?
Yaya yawan jini kake da shi?
Idan kana da zazzabi a kullum
Idan kana da zazzabi mai zafi ko fiye da haka
Idan kana ganin kana bukatar ka duba alamun ka sosai
Na kamu da zazzabi a jiya.
Ina da zazzabi kuma.
Na yi zazzabi a jiya.
Ina jin zafi sosai a kirji a nan.
Ina samun matsala wajen numfashi.
Zan aika muku da hotuna.
Ina jin zafi a kirji a yau.
Ina jin ciwon kai da zazzabi a yau.
Ina ganin akwai mura.
A ganina, wannan wani irin kamuwa ne.
Shin kana ganin wani yana zaune a kirjinka yana da nauyi?
Ya fara ne da ciwon kai da zafin jiki.
Saboda haka, na ji ciwon ciki a tsakiyar ƙirjina.
Wannan matsin lamba yana kama da ciwon kirji.
Yana cikin ƙirjina.
Yana tsakiyar ƙirjina.
Yana tsakiyar kirji.
Ina jin zafi a ƙirjina.
Ina matukar damuwa da ciwon kirji.
Ya kamata ka yi bayani dalla-dalla game da ciwon kirji.
irin su ciwon jini ko ciwon sukari
Kamar dai a tsakiyar kirji.
Yanzu za ku iya samun tachipirina don zafi.
Yanzu Maryamu, tsawon lokacin da kake da alamun cutar?
Yanzu kun ce kuna da ciwon kirji.
A wasu lokatai, ina jin zafi a ƙirjina.
Da kyau, ban da ciwo, akwai wasu alamun da kake gani?
Ko kuwa wani yana zaune a kirjinka?
Haka kuma za a iya yin maganin zazzabi da tari da ciwon kai da kuma ciwon tsoka.
A tsakiyar ƙirjina
Ka nuna mini inda kake ji a wannan hoton.
Idan kana da zazzabi
Shin kana ganin cewa wasu daga cikin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da irin waɗannan alamun?
Ka gaya mini game da ciwon kirjinka.
A cikin dare, zafin jiki yana ƙaruwa.
Na yi zazzabi na kwanaki biyu da suka gabata.
A daren jiya, zazzabin ya soma ƙaruwa.
Ni ne Dokta Porter daga Cibiyar Kula da Matsala ta gaggawa.
Za ka iya gaya mini ƙarin game da ciwon kirjinka?
Ina jin zafi a cikin kirji na gaba.
Na yi matukar ciwo a kirji.
"Idan na ji zafi a ƙirjina,
Wane irin ciwo ne kake ji a kirji?
A wane lokaci ne ciwon kirji ya soma?
A ina ne ƙirjinka yake ciwo?
Za ka iya sanin inda zuciyarka take ciwo.
Za ka ji ƙarancin kirji.
Ka san cewa ina da ciwon sukari da sauran matsaloli.
Ka ce kana da ciwon kirji.
A cikin Tarayyar Turai/Yankin Tattalin Arziki na Turai da kuma a cikin United Kingdom, adadin cututtukan cutar COVID-19 sun karu da sauri tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Kasashen da ke cikin EU/Yankin Tattalin Arzikin Turai da na Burtaniya suna nuna irin wannan yanayin na cutar ta Coronavirus (COVID-19) wanda ya tabbatar da cewa ko da yake matakan sun bambanta daga ƙasa zuwa ƙasa, cutar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, dole ne kasashe, asibitoci da cibiyoyin kula da marasa lafiya su kara shirye-shiryen su don karuwar yawan marasa lafiya da ke fama da COVID-19, waɗanda za su bukaci kula da lafiya da musamman, magani mai inganci.
A ranar 31 ga watan Disamba na shekarar 2019, an gano jerin cututtukan cutar huhu na asibiti da ba a san su ba a Wuhan, lardin Hubei, kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar China ta ba da shawarar sabon coronavirus a matsayin matsakaiciyar hanyar cutar, wanda yanzu ake kira cutar ta hanyar numfashi mai tsanani ta SARS-CoV-2 (SARS-CoV-2).
An kira shi cutar coronavirus (COVID-19) saboda cutar ta samo asali ne daga kamuwa da cutar SARS-CoV-2.
Shaidar da aka samu ta nuna cewa kashi 80 cikin dari na mutanen da ke fama da COVID-19 suna da cututtuka masu laushi, wato, kamuwa da cutar huhu tare da ko ba tare da cutar ba, kuma yawancin sun warke.
A cikin kashi 14 cikin 100 na shari'o'in COVID-19 ya zama mafi tsanani wanda ya bukaci a kwantar da shi asibiti, yayin da sauran kashi 6 cikin 100 na shari'o'in ya zama mafi tsanani wanda ke buƙatar zurfin magani.
Yawan mutuwar da aka yi a asibiti saboda COVID-19 ya kai kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin yanayin yanayin COVID-19 a kowace ƙasa a cikin EU/EEA da kuma a cikin United Kingdom (UK) kuma muka kwatanta su da lardin Hubei na China.
Mun kuma kwatanta adadin adadin COVID-19 a cikin ƙasashen EU/EEA da UK da waɗanda suka kamu da cutar tsakanin 31 ga Janairu - 15 ga Maris, 2020 a cikin Italiya.
Kasashen EU/EEA da UK sun kamu da cutar COVID-19
Bayan China, COVID-19 ya ci gaba da yaduwa a cikin yanayin ƙasa, kuma a sauran duniya, bayanan annobar COVID-19 yanzu suna bin halin da kasar ke ciki.
A ranar 11 ga watan Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 a matsayin annoba.
A cikin wata sanarwa da aka fitar a ranar 5 ga watan Maris na EuroSurveillance 2020, Spiteri et al, an ba da rahoton farkon lamarin COVID-19 a Turai, a cewar ma'anar WHO.
A cikin EU/EEA, Faransa ta ba da sanarwar farko na mutum uku da suka dawo daga Wuhan, Hubei, China, a ranar 24 ga Janairu, 2020.
A ranar 15 ga Maris, 2020, an sami shari'o'in COVID-19 a duk ƙasashen EU/EEA 30 da United Kingdom (UK), tare da adadin shari'o'i 39,768 da mutuwar 1,727 a ranar 31 ga Disamba, 2019, tare da mutuwar 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin shari'o'in COVID-19 da kuma samun adadin shari'o'in COVID-19
Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC) tana yin rikodin shari'o'in COVID-19 na kowace ƙasa a duniya, wanda ake sabuntawa kowace rana da karfe 8:00 na safe ta amfani da ma'aikatun lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da ƙasa da na yanki da kuma WHO ta hanyar amfani da tushen hukuma.
Ana amfani da wannan bayanan ne don tantance yanayin COVID-19 a cikin EU/EEA da Burtaniya da kuma kwatanta su da shari'o'in da aka samu a Italiya.
A matsayin samfurin yawan adadin shari'o'in COVID-19 masu aiki, mun lissafa adadin shari'o'in COVID-19 na kwanaki 14 a cikin yanayin da ya dace, yana la'akari da yaduwar COVID-19 a cikin kowace EU/EEA da Burtaniya tsakanin 1 ga Janairu - 15 ga Maris, 2020.
Mun kuma gabatar da jimlar adadin wadanda aka samu a kowace kasa da misalin karfe 8:00 na safe a ranar 15 ga Maris, 2020 kuma mun kwatanta su da wadanda aka samu a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Halin da ake samu na COVID-19 a cikin EU/EEA da UK
Halin da ake ciki na yau da kullum na COVID-19 a cikin EU/EEA da UK yana kama da na lardin Hubei (China) (Figure 1).
A cikin EU/EEA gabaɗaya, da kuma a cikin Burtaniya, an fara samun karuwar adadin COVID-19 a kusan 21 ga Fabrairu, sannan ya fara karuwa cikin sauri har zuwa 28 ga Fabrairu, 2020 (ƙarin abun ciki).
Wannan ya ƙunshi yawan adadin wadanda aka samu a cikin Italiya, amma ya nuna cewa akwai karuwar adadin COVID-19 a duk sauran kasashen EU/EEA da Birtaniya (ƙarin bayani).
Hoton 2 ya nuna jimlar adadin shari'o'in COVID-19 a cikin EU/EEA da UK, idan aka kwatanta da wadanda aka samu a Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya kuma nuna cewa, a ranar 15 ga watan Maris da karfe 8 na safe, an riga an samu adadin wadanda suka kamu da cutar a Italiya, kamar yadda aka samu a sauran kasashe 15 na EU/EEA da kuma Birtaniya, makonni uku kafin wannan lokaci.
Sakamakonmu ya nuna cewa, a cikin EU/EEA da Birtaniya, adadin masu kamuwa da COVID-19 yana ƙaruwa sosai.
Halin da aka lura da shi a cikin yanayin COVID-19 ya nuna cewa cutar ta kasance tana ƙaruwa cikin sauri a duk ƙasashe.
Bugu da kari, yayin da kasashe daban-daban ke cikin matakai daban-daban, dole ne a bincika bambancin dake tsakanin amsoshin lafiyar jama'a na kasa da kuma yiwuwar tantancewar shari'o'i daban-daban a tsakanin kasashe da kuma hanyoyin daban-daban na zaɓar marasa lafiya don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10% na marasa lafiya da ke fama da COVID-19 ke bukatar maganin wuce gona da iri, kuma kafofin yada labarai sun nuna cewa asibitoci da cibiyoyin maganin wuce gona da iri a wadannan yankuna sun riga sun kai iyakar iyawarsu.
Bayanai game da shigar da marasa lafiya na COVID-19 a asibitoci da/ko cibiyoyin kula da cututtuka a halin yanzu suna samuwa ne kawai ga 6% da 1% na shari'o'in a matakin EU/EEA, bi da bi (ba a nuna bayanai ba).
Duk da haka, dole ne su tattara bayanan kulawa na yanzu ta hanyar daidaitaccen tsarin da zai mai da hankali kan yawan shari'o'in da aka gano da kuma mutuwar.
Wani bincike da aka gudanar a shekara ta 2010-11 ya nuna cewa akwai bambanci sosai tsakanin yawan gado na likita da na likita a Turai, wanda ya kai 29.2 a Jamus da 4.2 a Portugal a kowace yawan mutane 100,000.
Wannan yana nufin cewa sauran ƙasashe suna da albarkatu da yawa ko ƙasa da Italiya (da 12.5 na hypermedical da Mediummedical beds a kowace yawan mutane 100,000 a 2010-11).
Ana samun karuwar shari'o'in COVID-19 a asibitoci a kowace ƙasa ta EU/EEA da Burtaniya. Wannan yanayin samfurin da ke tattare da saturatedness na iyawar HealthNigation yana da alaƙa da haɗarin wucewa > 90% na ƙarfin kwanciyar hankali na ICTs, wanda aka bayar a cikin sabuntawa ta shida na ECDC Rapid Risk Assessment na COVID-19.
Tun da har yanzu ana iyakance shari'o'i ga wasu ƙasashen EU/EEA da wasu yankuna na Burtaniya, kuma asibitoci da cibiyoyin zurfin lafiya suna ba da magani ga wasu yankuna na yanki, ya kamata a samar da bayanan shari'o'i da bayanan cibiyoyin zurfin lafiya a matsayin ma'anar cibiyoyin yanki don matakin NUTS-2 (Fituna 2).
Kwarewar Italiya da yanayin yanzu a wasu ƙasashe sun nuna cewa COVID-19 cutar tana yaduwa cikin sauri a cikin EU/EEA da Burtaniya.
Saboda haka, dole ne kasashe, asibitoci da cibiyoyin kula da cututtuka su shirya kansu don ci gaba da kamuwa da cutar ta SARS-CoV-2 da kuma karuwar yawan marasa lafiya da ke fama da COVID-19, waɗanda za su bukaci kula da lafiya da kuma musamman, kula da cututtuka masu tsanani, kamar yadda yanayin ya faru a yankunan da ke fama da cutar a Italiya.
Ana buƙatar hanzari, aiki, da kuma cikakkiyar hanyar yin amfani da nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
An kuma jera matakan kiwon lafiya na jama'a a cikin saurin kimanta hadarin don kawar da tasirin cutar.
Akwai ɗan gajeren lokaci na dama a cikinsa da ƙasashe za su iya ƙara ƙoƙari don rage yaduwar SARS-CoV-2 da kuma rage matsin lamba akan kiwon lafiya.
Idan hakan bai yi nasara ba, akwai yiwuwar cewa sauran tsarin kula da lafiya na EU/EEA za su fuskanci yawan marasa lafiya da ke bukatar karin magani a cikin 'yan kwanaki ko makonni masu zuwa.
Cutar Corona Virus Disease 2019 (COVID-19) ta barke ne saboda cutar ta Coronavirus (SARS) mai tsanani ta Coronavirus (SARS-CoV-2) wanda ya haifar da mutuwar mutane sama da 3,000 a China da sauran wurare a duniya, kuma ya kamu da mutane sama da 80,000, wanda ya zama bala'i ga bil'adama.
Kamar SARS-CoV-2 wanda ya haifar da cutar SARS-CoV, wanda ya haifar da dubban mutane a shekara ta 2003, SARS-CoV-2 na iya kamuwa da cutar ta hanyar cututtukan fata kuma yana nuna alamun bayyanar cututtuka ta hanyar fasaha iri ɗaya.
Ko da yake, cutar COVID-19 tana da ƙarancin tsanani da mutuwa fiye da SARS, amma ana samun karuwar kamuwa da ita a cikin tsofaffi fiye da matasa da kuma a cikin maza fiye da mata.
A cikin amsa ga yawan wallafe-wallafen da ke faruwa game da cutar, wannan labarin yana ƙoƙarin samar da cikakken bayani game da batun bincike da ke faruwa a cikin lokaci mai dacewa.
Mun yi amfani da ilimin cututtuka, ilimin halayyar mutum, ilimin cutar, bincike, magani, annobar cutar, da kuma rigakafin cutar.
Ko da yake har yanzu akwai amsoshin tambayoyi da yawa, muna fatan wannan bita zai taimaka mana mu fahimci wannan mummunar cuta kuma mu magance ta.
Ranar 25 ga Janairu, 2020 ta kasance abin tunawa ga dukan mutanen kasar Sin da aka ce su zauna a gida a lokacin hutu da kuma makonni masu zuwa saboda barkewar sabuwar cuta.
Wannan cutar ta kasance mai kama da cutar coronavirus (CoV), wanda ya haifar da cutar ta SARS mai tsanani a shekara ta 2003, saboda haka a ranar 11 ga Fabrairu, 2020, WHO ta sake suna da SARS-CoV-2 da kuma cutar da ta danganci shi da sunan COVID-19.
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma nan da nan ta bazu zuwa dukan kasar da kuma sauran kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta shafi 80,000 tabbataccen shari'o'in COVID-19, wanda ya sami sama da 40,000 marasa lafiya da aka sallami kuma ya kashe marasa lafiya 3,000.
WHO ta yi gargadin cewa COVID-19 "maƙiyi na mutane na farko" ne kuma yana iya zama mafi iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin watanni biyu, an buga fiye da 200 na binciken kan COVID-19 wanda ya haɗa da ilimin kwayoyin halitta, cututtukan cututtuka, etiology, ganewar asali da magani, wanda ya ƙayyade yadda cutar ta kasance, ban da marasa lafiya daban-daban, tun lokacin da aka fara samun labarin farko a ranar 7 ga Janairu 2020.
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a cikin sababbin batutuwa masu tasowa.
Idan za ta yiwu, za mu gwada cutar ta SARS da sauran COVID-19 da cutar ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki ta tsokoki.
Za mu kuma tattauna abin da muka koya game da rigakafin cututtuka da kuma yadda za mu magance su, da kuma wasu tambayoyi masu muhimmanci da za a iya yi a yanzu.
An yi la'akari da cewa CoVs ba su da lahani ga mutane, suna haifar da kusan 15% na cututtukan sanyi.
Amma a wannan karni, mun sha wahala sau biyu daga cutar ta musamman ta mutum, wato SARS-CoV da MERS-CoV, wanda ya haifar da barkewar cutar a China a 2003 da Saudi Arabia a 2012 kuma nan da nan ya yada zuwa wasu ƙasashe tare da cututtukan da suka fi muni da yawan mutuwar.
Saboda haka, COVID-19 na yanzu shine fashewar COVID-19 ta uku a tarihin ɗan adam na kwanan nan.
Kamar yadda aka nuna a Figure 1.1, Hukumar Lafiya ta Kasa ta kasar Sin ta fara yin rajistar rukuni na cutar ta huhu da asalinsa ba a sani ba a Wuhan a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an ba da umarnin CoV.
An samu mutum na farko da ya mutu a Wuhan a ranar 15 ga Janairu, 2020.
A lokacin, cutar ta bazu cikin sauri zuwa garuruwan da ke makwabtaka da shi, da yankuna da ƙasashe.
A ranar 20 ga Janairu, an samu rahoton kamuwa da cutar ga masu ba da sabis na kiwon lafiya wanda ya nuna cewa cutar tana iya kamuwa da mutane daga mutum zuwa mutum.
A ranar 23 ga Janairu, an kulle dokar hana fita a birnin Wuhan, kuma an dakatar da duk hanyoyin sufuri na jama'a a can.
A ranar 24 ga watan Janairu, binciken farko na asibiti kan cutar ya nuna cewa, daga cikin mutane 41 da aka tabbatar da cutar, 21 ne kawai suka yi tuntuɓe kai tsaye da kasuwar abincin teku ta Wuhan, wadda aka yi la'akari da ita cibiyar kamuwa da cutar ta farko daga asalin dabbobi da ba a sani ba.
A ranar 30 ga watan Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa na kiwon lafiya a duniya.
A lokacin da aka wallafa wannan rahoton, cutar ta riga ta bazu a duk faɗin ƙasar Sin da kuma ƙasashe 50 a duniya (adadi 2.2).
Yayin da yanayi ke canzawa cikin sauri, har yanzu ba a san ainihin yanayin da kuma yadda za a yi fashewar ba.
Wani bincike na cibiyar da ta yi nazari a kan mutane 8,866 da suka kamu da cutar COVID-19 a ranar 11 ga Fabrairu, 2020, wanda ya hada da mutane 4,021 da aka tabbatar da cutar COVID-19 (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA) ya ba da cikakken hoto na annobar kamar haka:
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma ya fi dacewa da mutanen da ke tsakanin shekaru 30 zuwa 65.
Rabin (47.7%) na wadanda suka kamu da cutar sun kasance shekaru 50, kuma aƙalla 20 ne, kuma 14 ne kawai suka kamu da cutar a ƙarƙashin shekaru 10.
SARS-CoV-2 ya sami maza da yawa (0.27/1,00,000) fiye da mata (0.31/1,00,000).
COVID-19 ya bazu ne a cikin biranen Hubei da kewaye.
Ana ɗaukar matsakaicin kwanaki 5 (2-9) daga kamuwa da COVID-19 zuwa ganewar asali.
Matsakaicin lokacin riƙewa ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin da aka yi amfani da shi daga haihuwa zuwa mutuwa ya kai kwanaki 9.5 (4.8-13).
Matsayin da aka tsara na asali (R0) shi ne 3.77 (95% CI: 3.51-4.05) kuma daidaitaccen R0 shi ne 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, wanda ya dace da yaduwar da ta gabata a kasar Sin.
A cikin marasa lafiya da suka kamu da cutar, yawan mutuwar da aka samu ya kasance 1.44% (95% CI: 1.10-1.86%) da kuma adadi na mutuwar marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Babban manyan abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (>60) da matsanancin cutar huhu.
CoV wani nau'in kwayar cuta ne mai girma da kuma haɗuwa wanda ya ƙunshi zaren RNA guda ɗaya.
Ana iya rarraba su zuwa kwayoyin halittar guda hudu, wato alpha, beta, gamma, da delta, wanda aka sani cewa alpha- da beta-CoVs suna shafar mutane.
Wannan spike na (S) glycoprotein yana ɗaure ƙwayoyinsa masu karɓar angiotensin-transforming enzyme 2 (ACE2) da dipeptidyl peptides 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan kuma haɗuwa da fata.
Ana sakin RNA mai cutarwa a cikin ƙwayoyin cuta; bayan kwayar cutar ta yi kwayar cutar, RNA mai ƙwayoyin cuta ta gina wani vascular mai ƙunshe da virion tare da glycoprotein da nucleocapside sun haɗu da ƙwayoyin cuta, wanda aka haɗa tare da ƙwayar plasma don sakin ƙwayoyin cuta.
An samu rahoton farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV wanda aka gano 99.98% na kwayoyin halitta a cikin samfurin 10 na jerin da aka ɗauka daga cibiyar asalin cutar a Hunan Seafood Market, Hunan.
SARS-CoV-2 ya fi kama da MERS-CoV fiye da SARS-CoV.
Ta hanyar daukar hoto na lantarki, an gano kwayoyin SARS-CoV-2 a cikin ƙananan ƙananan sassan jikin mutum.
An gano cewa ACE2 na mutum shine mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, sunadarai na SARS-CoV-2 suna ɗaure mutum zuwa ACE2 fiye da sunadarai na SARS-CoV, wanda ke haifar da ƙananan cututtukan SARS-CoV-2 fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabon ƙaramin furotin, wanda aka yi wa lambar ta orf3b, kuma an yi wa lambar ta orf8.
Orf3b na SARS-CoV-2 na iya taka rawa a cikin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cut
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun nuna cewa tsarin cryo-EM na cikakken-tsawon mutum ACE2 a ƙuduri na 2.9 Å ya haɗu da amino acid mai ɗaukar hoto B0AT1.
Sun gano cewa tsarin da ke buɗe da rufe na gland ya haɗu a matsayin dimers kuma glandin ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da shaida na ganowa da kamuwa da cutar CoV.
B0AT1 na iya zama manufa ta magani don gwajin magani don magance kamuwa da cutar SARS-CoV-2.
Mai watsa shiri na asali da na matsakaici
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga kwayoyin halitta, kuma sun isa ga mutane daga cats da raƙuma masu cin abinci, bi da bi.
A lokacin da aka kwatanta SARS-CoV-2 da sauran CoVs, an gano cewa SARS-CoV-2 ne mai karɓar bakuncin gida saboda sabon kwayar cutar ya yi daidai da kashi 96% na SARS-like CoVs, wanda ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san wane matsakaici ne ya taimaka wa cutar ta tsallaka shingen jinsuna don kamuwa da mutane ba, kuma hanyar kamuwa da cutar ba ta bayyana ba.
Ji, et al., sun ba da shawarar cewa macizai su zama masu ɗaukar hoto don isa ga mutane daga ƙwayoyin cuta, wanda ya kamata ya haifar da sake haɗuwa tsakanin masu jima'i tsakanin S-protein.
Wani bincike da aka gudanar daga Guangzhou, China, ya nuna cewa dogon hanci, cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat cat
Duk da haka, kashi 1% na bambancin da ke tsakanin jinsunan biyu har yanzu yana da nisa, don haka akwai tabbaci mai ƙarfi don yanke shawara (adadi na 33).
Har yanzu ba a san yawancin halaye na jiki na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa har zuwa awanni 48 a yanayin bushe kuma suna iya rayuwa har zuwa kwanaki 5 a 20 ° C da 40%-50% zafi.
SARS-CoV-2 yana da irin wannan fasalin.
An nuna cewa SARS-CoV-2 ba zai iya tsayayya da hasken ultraviolet ba bayan minti 30 a cikin radiation da kuma a zafin jiki na 56 ° C, kuma mai narkewa mai narkewa ba tare da ether, 75% ethanol, chlorinated disinfectant, paracetic acid, chloroform, da chlorhexidine ba zai iya yin amfani da shi sosai.
A cikin al'ada, ɗan adam gaba ɗaya ba zai iya magance SARS-CoV-2 ba, saboda haka yana da rauni ga wannan sabon kwayar cutar.
A halin yanzu, babu wani cikakken bincike game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ga wasu nazarin CoVs, musamman: SARS-CoV da MERS-CoV (Figure 4).
A yadda aka saba, lokacin da cutar ta kai hari ga mai masaukin baki, ana gano tsarin farko ta hanyar ganewa (PRR), wanda ya haɗa da C-type lactine-like receptors, Toll-like receptors (TLRs), NOD-like receptors (NLRs), da RIG-i-like receptors (RLRs).
Ta hanyar hanyoyi daban-daban, ƙwayoyin cuta suna haifar da bayyanar ƙwayoyin cuta, ƙwayoyin dendritic da kuma irin tsangwama na I (INN), wanda ke iyakance yaduwar ƙwayoyin cuta da kuma saurin fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar fashewar
Duk da haka, ƙwayoyin cuta na SARS-CoV na iya taimakawa ƙwayoyin cuta su hana su amsa rigakafi.
Ba da daɗewa ba, tsarin rigakafi mai kyau zai shiga cikin yaki da cutar.
T lymphocytes, ciki har da CD4+ da CD8+ T cells, suna taka muhimmiyar rawa wajen karewa.
CD4+ T yana sa Cells B su yi amfani da su wajen samar da maganin rigakafi na musamman, kuma CD8+ T yana kashe Cells da ke da nasaba da cutar kai tsaye.
T-helper cells suna samar da cytokines masu yaduwa don taimakawa kwayoyin ceto.
Amma, ta hanyar haɗa ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta ta hanyar ƙuntata ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta ta hanyar ƙuntatawa.
Hakanan, tsarin rigakafin mutum wanda ya ƙunshi abubuwa da rigakafi kamar C3A da C5A yana da mahimmanci don yaƙar kamuwa da cutar.
Alal misali, an gano cewa an riga an yi amfani da kwayoyin cutar da aka samo daga wasu cututtuka don a iya maye gurbin cutar MERS-CoV.
A gefe guda kuma, tsarin rigakafi na jiki yana haifar da tarin kwayoyin halitta masu kyauta a cikin gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma a cikin mummunan yanayi, zai iya haifar da lalacewar gabobin jiki da mutuwa.
Ana iya samun kamuwa da cutar SARS-CoV-2 a cikin tsofaffi da mata masu ciki waɗanda ke da cutar tare da cutar.
Waɗanda suke da wasu cututtuka ko kuma waɗanda ke da tsarin rigakafi na rashin ƙarfi suna da mafi yawan haɗarin kamuwa da cutar fiye da wasu.
An kiyasta matsakaicin lokacin warming na SARS-CoV-2 na kwanaki 1 zuwa 14, a mafi yawan lokuta kwanaki 3-7, kamar yadda aka samu a farkon shari'o'in 425 a Wuhan.
Koyaya, binciken da aka yi a kan mutane 1,099 ya nuna cewa matsakaicin lokacin warming ya kasance kwanaki 3 kuma ya kasance tsakanin kwanaki 0 zuwa 24.
Kamar yadda aka bayyana a sama, wani sabon bincike ya nuna cewa a cikin mutane 8,866 da aka kamu da cutar, lokacin warming ya kai kwanaki 4.8.
Yana da mahimmanci ga hukumomin kiwon lafiya su daidaita lokacin keɓewa mai inganci bisa ga mafi kyawun lokacin warming, don hana mutane masu kamuwa da cutar amma ba su da alamun cutar daga kamuwa da cutar.
A matsayin magani na yau da kullum, ana bukatar a ware mutanen da suka kamu da cutar ko kuma waɗanda suka kamu da ita har tsawon kwanaki 14.
Shin wajibi ne a yi kwanaki 24 a lokacin da ake ware mutane?
Cutar zazzabi ita ce babbar alama da kuma farkon bayyanar COVID-19, tare da rashin bayyanar cututtuka ko wasu alamomi kamar tari, ciwon hanci, tsokoki, ciwon kai, ciwon hanci, rhinorrhea, ciwon kirji, diarrhea, kumburi da kuma kumburi.
Wasu marasa lafiya za su iya samun dyspnia da/ko hypoxia bayan mako guda bayan sun kamu da cutar.
A cikin matsanancin yanayi, marasa lafiya suna fuskantar ciwon numfashi mai tsanani, saurin shan wahala, ƙwayar cuta, da kuma coagulopathy.
Idan mutum yana da zazzabi da kuma/ko kuma alamun numfashi da kuma zazzabi mai tsanani, dole ne a fara gwada shi da cutar don gano ko yana da wani abu da ya sa ba a san shi ba.
Wani bincike na binciken da aka yi a watan Disamba na 2019 ya nuna cewa kashi 98 cikin 100 na marasa lafiya da ke fama da zazzabi, 76 cikin 100 na masu fama da tari, 55 cikin 100 na masu fama da dyspepnia, da kuma 3 cikin 100 na masu fama da cutar, kuma kashi 8 cikin 100 na marasa lafiya suna bukatar taimakon numfashi.
Wasu bincike guda biyu da aka yi a kwanan nan da suka shafi mutanen da ba su da alamun cutar da kuma waɗanda suke da iyali sun nuna hakan.
A matsayin kwatankwacin, binciken binciken mutane na 2012 ya nuna cewa masu cutar MERS-CoV sun kamu da zazzabi (98%), tari mai zafi (47%) da dyspnea (55%) a matsayin manyan alamun bayyanar cututtuka.
Amma, kashi 80 cikin dari na wadanda ke bukatar taimakon iska, wanda ya fi na marasa lafiya da ke fama da COVID-19 yawa kuma ya fi na MERS hadari.
An kuma gano ciwon ciki (26%) da kuma ciwon hanci (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, an lura cewa zazzabi (99%-100%), tari (29%-75%), dyspnea (40%-42%), diarrhea (20-25%) da kuma ciwon hanci (13-25%) sune manyan alamun bayyanar cututtuka, kuma kusan 14%-20% na marasa lafiya suna buƙatar taimakon iska.
A ranar 14 ga Fabrairu, lokacin da aka samu mutane 66,576 a duniya, adadin mutuwar COVID-19 ya kai kashi 2 cikin 100.
Idan aka kwatanta, a watan Nuwamba na shekara ta 2002, yawan mutuwar SARS ya kai kashi 10 cikin 100 na adadin mutane 8,096.
A cikin binciken da aka gudanar a watan Yuni na shekarar 2012, an samu kashi 37 cikin 100 na mutane 2494 da suka mutu.
Wani binciken da aka yi a baya ya nuna cewa SARS-CoV-2 yana da RO 6.47 da kashi 95% na lokaci na amincewa (CI) na 5.71 zuwa 7.23, yayin da SARS-CoV ke da RO tsakanin 2 zuwa 4.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamomi, mutuwar, da RO a cikin Table 1.1.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 na da damar yadawa fiye da MERS-CoV da SARS-CoV, amma sun fi muni.
Saboda haka, yana da matukar kalubale a sarrafa cutar ta SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Ƙungiyoyin da aka fara da su suna farawa ne a cikin iyali ɗaya ko kuma a cikin bikin guda ɗaya ko a cikin jirgin ruwa guda ɗaya, kamar jirgin ruwa.
Masu cutar suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da aka shafa ko kuma sun yi hulɗa da mutane masu kamuwa da cutar ko kuma sun kasance a cikin makonni biyu da suka gabata kafin fara cutar.
Koyaya, an nuna cewa mutane na iya riƙe da cutar ba tare da alamun bayyanar cututtuka ba har tsawon makonni biyu, kuma marasa lafiya da suka warke daga asibiti na iya sake ɗaukar cutar wanda ya ba da gargadi don ƙara tsawon lokacin keɓewa.
A farkon lokaci, yawan marasa lafiya na yau da kullum ko raguwa suna da ƙwayoyin jini na farfajiyar (musamman: lymphocytes).
Alal misali, an gano cewa mutane 1,099 da ke fama da cutar COVID-19 suna da lymphocytes < 4×109/L, wanda ya haɗa da lymphocyte < 1×109/L, da kuma ci gaba da aminotransferase da viarremia.
A wasu marasa lafiya, an samu karuwa a cikin jini na hanta da na tsoka da kuma matakan mitochondria, kuma an samu karuwa a cikin jini na yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, ƙwayoyin jini na fibrin da aka rage sun ƙaru da matakin D-dimer kuma ƙididdigar lymphocytes ta ragu da sauri.
Yawancin marasa lafiya da ke fama da cutar COVID-19 sun sami rashin daidaito a cikin radiography na kirji, kuma an gano shi ne a cikin huhu, shadows na bilateral patch, ko kuma ƙarancin gilashin ƙasa.
A yawancin lokuta, marasa lafiya suna fama da cutar pneumonia, ciwon huhu mai tsanani, da kuma ciwon hankula na numfashi (ARDS).
Lokacin da ARDS ta faru, kumburi mara kyau, ajiyar ruwa da kuma ci gaba da tasiri mai tsanani akan musayar iska.
Rashin ƙwayar cuta na nau'in 1 da nau'in 2 yana rage matakin farfajiya da kuma ƙara ƙarfin farfajiya, yana rage ƙarfin ƙwayar huhu da kuma haɗarin cutar huhu.
Saboda haka, mafi munin sakamakon radiography yana iya zama mafi munin cutar.
A ranar 18 ga Fabrairu, 2020, an gudanar da bincike na farko na gano cutar COVID-19 wanda ya nuna cewa ƙwayar ƙwayar ƙwayar cuta ta ƙonewa, samar da ƙwayar cuta, da kuma shiga cikin lymphocytes na tsakiya, da kuma ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na mutum wanda ya mutu daga cutar, sun dace da gano cutar ta ARDS da kuma cutar SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar juyawa-transcriptase polymerase chain reaction (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Amma, saboda yawan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddaddadd
Wannan ya faru ne bayan an gano cutar SARS.
Saboda haka, hada tarihin cutar, bayyanar cututtuka, gwaje-gwajen dakin gwaje-gwaje da binciken radiological suna da mahimmanci kuma suna da mahimmanci don yin ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ta bayyana wata yarjejeniya ta amfani da fasaha ta SHERLOCK na CRISPR don gano SARS-CoV-2, wanda ke gano SARS-CoV-2 RNA mai amfani da 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 na microllitre na shigarwa) a cikin sa'a daya ba tare da buƙatar kayan aiki mai yawa ba.
Muna fatan cewa idan aka tabbatar da shi a cikin samfurin magani, sabon fasaha zai iya ƙara haɓaka da kuma saukakawa a cikin ban mamaki.
Saboda rashin kwarewa game da sabon COVID, likitoci na iya ba da kulawa ta goyan baya ga marasa lafiya na COVID-19 kuma su gwada wasu hanyoyin magani da aka yi amfani da su ko kuma aka ba da shawarar a baya akan sauran CoVs kamar SARS-CoV da MERS-CoV da kuma sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Wadannan hanyoyin magani sun hada da maganin riga-kafi, magungunan rigakafi, steroids, plasma na marasa lafiya, magani na kasar Sin da kuma maganin tunani.
Ba wai kawai haka ba, an kuma yi shawarar yin amfani da kwayoyin da aka samu daga marasa lafiya da yawa don yin magani.
Kamfanonin kera magunguna suna kokarin samar da rigakafi da alluran rigakafi da sauri don cutar.
SARS-CoV-2 yana fara kai hari ga huhu, kuma yana iya kai hari ga sauran gabobin da ke nuna ACE2, kamar su gastrointestinal system da koda.
Saboda haka, rashin ƙarfi da kuma rashin ƙarfi na tsarin numfashi yana haifar da haɗarin haɗari ga marasa lafiya kuma yana haifar da babban dalilin mutuwa.
Saboda haka, don samun taimako daga bayyanar cututtuka da kuma ceton rayuka, tsarin numfashi yana bukatar taimako, wanda ya hada da maganin oxygen na yau da kullum, oxygen mai yawa, iska mai iska mai iska da iska mai iska mai iska, dangane da yanayin rashin lafiya.
Masu fama da cututtukan numfashi masu tsanani ya kamata su tallafawa Oxygenation of Extracorporeal Membrane (ECMO), ingantaccen fasahar kardio-palmonic bypass da ake amfani da ita don magance cututtukan zuciya ko kuma rashin lafiyar numfashi.
Bugu da ƙari, kula da daidaiton electrolyte, hana kamuwa da cuta ta biyu da kuma bugun jini, da kuma kula da aiki na manyan gabobin jiki yana da mahimmanci ga marasa lafiya na SARS-CoV-2.
An gano cewa karin maganin rigakafi a cikin marasa lafiya na SARS da MERS yana haifar da tashin cytocin.
Cytocin storm wani nau'i ne na tsarin amsa mai karɓa wanda ke nuna fitowar jerin cytokines wanda ya haɗa da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan kwayoyin suna sa ƙwayoyin rigakafi su saki ƙwayoyin da ke cikin jiki da yawa waɗanda ke haifar da ARDS da kuma cututtukan jiki daban-daban.
Maganin rigakafi yana da mahimmanci wajen magance hadari na cytokine, musamman ga marasa lafiya masu tsanani.
Ana amfani da maganin anti-IL6 monoclonal antibody na cortisteroids da tocillizumab don magance cytocin storm.
Sauran magungunan immunosuppression na Cytocin Storm sun hada da maganin rigakafin da ke tattare da kwayoyin T, hana IFN-Y, IL-1 da TNF, hana JAK, Blinetumomab, suppressor na siginar Cytocin 4 da kuma masu hana HDAC.
Ana amfani da steroids a matsayin magungunan rigakafi don rage cutar ta kumburi a cikin maganin SARS.
Amma, a cikin SARS da COVID-19, yawan steroid ba shi da amfani ga cututtukan huhu masu tsanani.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman: Osteoanecrosis na jijiya, wanda zai iya shafar ganewar asali.
Duk da haka, ana ba da shawarar yin amfani da ƙananan maganin corticosteroids a cikin ƙananan zuwa matsakaiciyar sashi don yin tunani ga marasa lafiya masu cutar COVID-19.
A lokacin da muke rubutu, babu wata maganin riga-kafi da aka tabbatar da inganci.
Amma, an gano cewa Remdesivir ya yi tasiri sosai lokacin da aka ba shi jijiya ga wani mara lafiya a Amurka wanda ke fama da COVID-19.
Remdesivir magani ne mai ban mamaki wanda Gilled ta haɓaka don magance cututtukan da suka faru da cutar Ebola da Marlburg.
Daga baya, Remdesivir ya nuna yiwuwar hana wasu kwayoyin RNA guda ɗaya, ciki har da MERS da SARS.
A cewarsa, Zilled ta ba da wannan sinadarin ga kasar Sin don yin gwaji a kan marasa lafiya da ke fama da SARS-CoV-2, kuma sakamakon ya kasance mai ban sha'awa.
Bugu da kari, an ba da shawarar baricTNB, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin magani mai yiwuwa ga marasa lafiya da ke fama da cututtukan numfashi masu tsanani.
Yin amfani da maganin Ritonovirus na iya haifar da cutar sankara, kumburi, cuta, cutar hanta da sauran abubuwa masu illa.
Ana bukatar a lura da yadda wadannan magunguna suke shafar sauran magunguna da ake amfani da su a cikin marasa lafiya.
A cikin marasa lafiya da yawa, ana samar da jini da kuma rigakafi.
Akwai tarihi mai tsawo na tattara jinin marasa lafiya da yawa da suka kamu da cututtuka masu yaduwa don magance cututtukan marasa lafiya ko kuma hana mutane lafiya kamuwa da cutar.
Gaskiya ne cewa a yawancin marasa lafiya, akwai ƙwayoyin cuta da yawa a cikin jinin fiye da waɗanda suke da cutar.
Maganin da ke hana kamuwa da cuta da kuma wasu abubuwa na waje shine immunoglobulin (IG), wanda kwayoyin B suke samarwa kuma suna gano kwayoyin da ke cikin masu cutar kuma suna lalata su kai tsaye.
A bisa wannan, an tattara kwayoyin daga jinin marasa lafiya da yawa na COVID-19 kuma an yi wa marasa lafiya 10 da ke da mummunan rauni.
A cikin sa'o'i 24 da suka gabata, an samu ci gaba a cikin bayyanar cututtukan, an rage ciwon kumburi da kuma cutar ta jini, an kuma samu ingantaccen iskar oxygen a cikin jini.
Duk da haka, har sai an ci gaba da inganta hanyoyin magance cutar, ana buƙatar tabbatarwa da bayani don amfani da su a kan yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yadu.
Bugu da ƙari, don samun sakamako mai kyau, dole ne a yi la'akari da wasu lahani na ƙwayoyin halitta.
Alal misali, ƙwayoyin cuta suna iya saurin motsa jiki kuma su haifar da ciwon fitowar cytokine, wanda zai iya zama mai guba.
A cikin jini, yawan kwayoyin halitta yana da ƙasa kuma yana da babban bukatar kwayoyin don magance marasa lafiya masu ciwo.
Yana da wuya a ci gaba da samar da wasu kwayoyin cutar da sauri don magance cutar ta duniya.
Saboda haka, yana da muhimmanci kuma a yi amfani da shi wajen rarrabe kwayoyin B daga cikin marasa lafiya da yawa da kuma gano lambobin kwayoyin da ke ba da lambar ƙwayoyin da ke aiki ko kuma gwada ƙwayoyin da ke aiki da ƙwayoyin da ke da tasiri a kan ƙwayoyin da ke da muhimmanci ga cutar.
Ta haka ne za mu iya ƙara yawan kwayoyin halitta da sauri.
TCM an yi amfani da ita wajen magance cututtuka daban-daban a kasar Sin na shekaru dubbai.
Amma, tasirinsa ya dogara ne sosai da haɗuwa da abubuwa daban-daban a cikin tsarin, bisa ga ka'idar TCM.
Yawancin abubuwan da ke tasiri ba a sani ba ko kuma ba a sani ba saboda yana da wuya a zana da kuma tabbatar da irin waɗannan abubuwan ko kuma babban haɗin su.
Saboda rashin ingantaccen magani na musamman ga COVID-19, TCM ya zama zaɓi na zaɓi ga marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda suka sami ci gaba mai tsanani.
Misali, an gano cewa shan Shu Feng Ji Do capsules da Lian Hua King Wen capsules suna da tasiri ga marasa lafiya na COVID-19.
A lardin Sin da ke amfani da TCM don magance COVID-19, kashi 87% na marasa lafiya sun sami mafi yawan farfadowa a cikin lardunan da ke amfani da TCM a cikin Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei inda kashi 30% na marasa lafiya da ke amfani da TCM suka sami mafi ƙarancin farfadowa (13%) a cikin COVID-19.
Amma, wannan kwatancen yana da ɗan taushi saboda dole ne a haɗa wasu abubuwan tasiri kamar yawan marasa lafiya da kuma tsanani a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boly Zhang da abokan aiki sun buga wani binciken da ya kwatanta Magungunan Yammacin Turai (WM) kawai da magungunan WM da TCM.
Sun gano cewa lokacin da za a iya dawo da zafin jiki, a kawar da alamun cutar, da kuma shiga asibiti ya yi ƙasa da na WM + TCM fiye da na WM kawai.
Mafi mahimmanci, ƙimar haɓakar bayyanar cututtuka (mai sauƙi zuwa mai tsanani) ya kasance ƙasa da ƙasa a cikin WM+TCM (7.4% vs. 46.2%) fiye da na WM kawai, kuma mutuwar a cikin WM+TCM (8.8% vs. 39%) fiye da na WM kawai.
Duk da haka, don tabbatar da inganci da aminci na TCM, ana buƙatar gudanar da gwaji mai ƙarfi a ƙarin cibiyoyi.
Yana da ban mamaki a bayyana fasahar aiki da kuma bayyana abubuwan da ke cikin maganin TCM ko kuma haɗuwa da su idan zai yiwu.
Yawancin marasa lafiya da ake zargi ko kuma waɗanda ke da tabbataccen COVID-19 suna fuskantar cututtukan cututtuka masu cutarwa ko na mutuwa, kuma waɗanda ke keɓewa suna fuskantar rashin tausayi, kadaici da fushi.
Hakanan, rashin barci da ke tattare da cututtuka kamar zazzabi, hypoxia da tari da kuma sakamako masu illa na magani kamar su corticosteroids na iya haifar da damuwa da damuwa.
A farkon barkewar cutar, an samu cututtukan motsin rai kamar su damuwa, damuwa, firgici, tashin hankali, alamun rashin hankali, rikici da tunanin kashe kansa.
Dole ne a bi da lamba da keɓewa a matsayin ɓangare na amsawar lafiyar jama'a ga barkewar COVID-19 na iya sa mutane su ƙara damuwa game da kamuwa da cuta, keɓewa da kuma yin laifi a cikin dangi da abokai.
Saboda haka, dole ne a ba da kulawar lafiyar hankali ga marasa lafiya da masu cutar COVID-19, da waɗanda ake zargi da cutar da kuma waɗanda suka haɗu da su, da kuma talakawa da ke cikin bukata.
A cikin tunanin mutum, an haɗa da kafa ƙungiyoyin kula da lafiyar hankali na zamani, tattaunawa ta yau da kullun da kuma bayyanawa game da ingantaccen labarai da shirye-shiryen magani game da barkewar SARS-CoV-2, amfani da na'urorin lantarki na kasuwanci da kuma amfani da aikace-aikacen hana kusanci da wasu.
Ana buƙatar samun allurar rigakafi mai tasiri don karya sarkar yaduwar cutar daga ajiyar kwayar cutar a cikin dabbobi da kuma mai saurin kamuwa da cutar ga mutum, kuma ana iya amfani da allurar rigakafin cutar don sarrafa cutar da ke haifar da cutar ta fitowa.
Ana kokarin samar da allurar rigakafi mai gina jiki don samar da rigakafi mai inganci da kare lafiya na dogon lokaci da kuma/ko rigakafi na kare kariya daga SARS-CoV.
An yi nazarin samfurin samfurin SARS a kan dabba.
Duk da haka, har yanzu ba a gano wani samfurin motsa jiki da ƙalubalen kisa a cikin manya da kuma abubuwan kariya daga kamuwa da kwayar cutar da aka yada ta dabba a cikin waɗanda aka yi wa allurar rigakafi kafin a fara binciken likita ba.
Dalilin shi ne, cutar ta SARS ta ƙare shekaru 17 da suka gabata kuma ba a sami sabbin cututtuka ba.
A akasin haka, an samu wasu cututtuka na cutar ta MERS a Gabas ta Gabas da kuma ci gaba da yaduwa zuwa wasu yankuna, wanda ya nuna cewa akwai albarkatun da ke yada dabbobi a yankin.
An tsara manufofin rigakafin MERS ta amfani da ƙwayoyin cuta marasa inganci, plasmids na DNA, vectors na kwayar cuta, ƙwayoyin cuta, ƙwayoyin cuta, da kuma sake haɗuwa da su, kamar su ƙwayoyin cuta, da kuma kimanta wasu daga cikin samfurori na dabba.
Samar da rigakafi mai lafiya da inganci ga SARS-CoV-2 ga mutanen da ba su da kariya ga cutar yana da gaggawa da kuma muhimmiyar mahimmanci ga annobar yanzu.
Duk da haka, shawo kan matsalar yana da ƙalubale saboda yana buƙatar dogon lokaci (ma'ana watanni 18) don haɓaka allurar rigakafi da haɓaka nau'ikan CoV masu motsi.
Saboda sabon cuta, COVID-19 ya fara nuna cikakkiyar hanyar warkarwa a cikin dubban marasa lafiya a kowane wuri.
A yawancin lokuta, mai haƙuri zai iya warkewa a hankali ba tare da maimaitawa ba.
Amma, kamar SARS da MERS, COVID-19 yana da alaƙa da yawan rashin lafiya da mutuwa a cikin manyan lokuta.
Saboda haka, dole ne cibiyoyin kiwon lafiya su kafa tsarin bincike na cutar a cikin wuraren da ba su da albarkatu, musamman don fifita ayyukan su.
Bisa ga binciken likitanci da aka bayar har zuwa yanzu, abubuwan da ke biyo baya na iya kasancewa da alaƙa da ko kuma tasiri ga binciken marasa lafiya na COVID-19 (tebur 33):
Shekara: Shekara ita ce muhimmiyar mahimmanci wajen gano cutar SARS, kamar yadda yake a COVID-19.
A cikin binciken da aka yi a kan shari'o'i 8,866 da aka bayyana a sama, kashi 47.7% na marasa lafiya da suka wuce shekaru 50 da haihuwa da suka kamu da COVID-19 sun kasance tsakanin shekaru 30 zuwa 65.
Marasa lafiya da ke bukatar kulawa mai zurfi sun fi fuskantar cututtukan da suka shafi cututtukan da ke tattare da su, kuma sun fi tsufa fiye da waɗanda ba su da (tsufa na matsakaici na 66 a kan 51), wanda ya nuna cewa shekaru shine tushen ganewar asali ga marasa lafiya na COVID-19.
jinsi: Kamar yadda aka bayyana a sama, SARS-CoV-2 ya fi kamuwa da maza fiye da mata (0.31/1,00,000 vs. 0.27/1,00,000).
Coherence and complications: Mai cutar COVID-19 wanda ke buƙatar maganin hypertension yana iya fuskantar matsaloli kamar ciwon zuciya mai tsanani da rashin saurin aiki.
Cutar zuciya ta kasance daya daga cikin manyan dalilan mutuwar marasa lafiya da ke fama da cutar SARS.
An kuma nuna cewa SARS-CoV-2 yana ɗaure ACE-2 mai kyau colangiocytes, wanda zai iya haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Yana da mahimmanci a lura cewa alaƙar shekaru da cututtukan yanzu suna da mahimmanci kuma suna iya shafar juna.
Binciken Lab na Musamman: Matsayin jini na C-reactive protein (CRP) yana nuna tsanani na kumburi ko rauni na ƙwayoyin cuta, kuma yana da mahimmanci ga dogon lokaci na ganewar asali don cutar, amsa ga magani, da kuma murmurewa.
An kuma nuna alaƙar matakin CRP da tsanani da kuma ganewar asali na COVID-19.
Bugu da ƙari, ƙarin lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alenin aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana samun wannan hormone a cikin gabobin jiki da yawa, musamman a zuciya da hanta da kuma cututtukan da suka lalace.
Saboda haka, suna kallon cututtukan zuciya ko hanta.
Babban alamun magani: Radiography na kirji da kuma karuwar bayyanar cututtuka na magani ya kamata a yi la'akari da su tare da sauran matsaloli don yin binciken COVID-19 da kuma hasashen rikitarwa.
Amfani da Steroids: Kamar yadda aka bayyana a sama, steroids suna da ƙwayoyin rigakafi waɗanda ake amfani da su a matsayin magani na taimako don cututtukan cututtuka don rage yawan cutar ta kumburi.
Saboda amfani da kwayoyin cuta na corticosteroids a cikin marasa lafiya masu tsanani na SARS, yawancin masu tsira sun sha wahala daga rashin lafiyan da ke tattare da nakasa da rashin lafiyan rayuwa.
Saboda haka, a cikin marasa lafiya na COVID-19, ana amfani da steroids a ƙananan allurai da gajeren lokaci idan ya cancanta.
Rashin hankali: Kamar yadda aka bayyana a sama, yawancin marasa lafiya sun sha wahala daga ƙarin damuwa yayin barkewar COVID-19 saboda sun kasance cikin keɓewa na dogon lokaci da yanayin rashin tabbas da kuma ganin mutuwar dangi da abokan hulɗa.
Yana da mahimmanci a ba da shawara ta tunani da taimako na dogon lokaci don dawo da su daga damuwa da kuma komawa rayuwa ta yau da kullun.
A cewar binciken da aka yi na ilimin kididdiga, cutar COVID-19 ta bambanta da SARS.
SARS-CoV-2 na iya sake faruwa a cikin iska fiye da na sama fiye da na kasa, kuma ba zai iya haifar da sauƙi ko alamun bayyanar cututtuka a farkon lokacin kamuwa da cutar ba, kamar sauran CoVs da ke iya haifar da sanyi.
Saboda haka, masu kamuwa da cutar a farkon matakin ko lokacin riƙewa na iya samar da ƙwayoyin cuta masu yawa a cikin ayyukan yau da kullun, wanda zai iya sa ya zama da wahala a sarrafa cutar.
Koyaya, idan marasa lafiya suna da mummunan rauni, ana iya ɗauka cewa cutar SARS-CoV tana yaduwa, amma yawancin kamuwa da cutar ba ta fara faruwa ba.
Saboda haka, cutar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wuyar sarrafawa.
A halin yanzu, ana yin ƙoƙari sosai a China, wanda ya haɗa da kulle-kulle a Wuhan da garuruwan da ke kusa da shi da kuma sanya kusan dukkanin jama'a cikin keɓewa na yau da kullun, don hana yaduwar SARS-CoV-2.
Duk da cewa wadannan ayyukan suna haifar da mummunan lahani ga tattalin arziki da sauran sassan kasar, duk da haka, adadin sabbin cututtuka yana raguwa kuma hakan na nuna cewa cutar tana raguwa.
Mafi kyawun hasashen shine cewa fashewar za ta ƙare a watan Maris kuma za a ci gaba da raguwa har tsawon watanni 3-4.
Amma, wasu masana ba su da irin wannan tabbacin.
Paul Hunter ya yi hasashen cewa COVID-19 wanda ya fi SARS kamuwa da cuta ba zai ƙare ba a shekarar 2020.
Ira Langini ta kafa wani tsari don hango sakamakon cutar, kuma ta nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wani rukuni na Kanada ya nuna cewa an gano SARS-CoV-2 a cikin wani samfurin na mid-turbinate da throat swab na marasa lafiya da aka bar asibiti makonni 2 da suka gabata bayan sun warke daga cutar, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zuwa cikin jerin juyin halitta kamar mura.
Duk da haka, a cikin ƙarancin adadin sabbin shari'o'i, akwai alamun da ke nuna kyakkyawan sakamako daga China, wanda ke nuna tasirin manufofin da ake ciki.
Da farko an yi hasashen cewa cutar Ebola za ta kai mutum miliyan daya kuma mutane miliyan biyar za su mutu.
Amma, saboda tsananin keɓewa, cutar ta kasance a ƙarshe.
Kamar SARS-CoV, yana yiwuwa SARS-CoV-2 ya zama mara ƙarfi har sai ya zama mara tasiri kuma a ƙarshe ya lalace ko ya zama ƙarancin cutarwa wanda ke rayuwa tare da mutane.
A ƙasa akwai kwatancen annobar COVID-19 da annobar SARS da MERS (Figure 55).
SARS-CoV-2 yana da matukar yaduwa ta hanyar tari ko kuma ta hanyar tari, kuma yana iya faruwa ta hanyar kai tsaye ta hanyar tuntuɓar gurɓataccen abu ta hanyar cutar.
An gano cutar a cikin ƙwayar cuta, wanda ya ba da damar samun sabon kamuwa da cutar daga ƙwayar cuta zuwa baki.
Wani binciken da aka yi kan mutane 138 ya nuna cewa kashi 41 cikin 100 na wadanda suka kamu da cutar sun kasance masu kamuwa da cutar ta asibiti, inda mutane 17 ke da wasu cututtukan da suka gabata kuma masu ba da sabis na kiwon lafiya 40 ke da su.
Saboda haka, dole ne a yi hankali sosai wajen kare mutane, musamman: masu ba da kiwon lafiya, masu aikin zamantakewa, 'yan uwa, abokan aiki da kuma wadanda ba marasa lafiya ba, har ma da wadanda ke cikin hulɗa da marasa lafiya ko masu kamuwa da cutar.
Mataki na farko na tsaro don rage haɗarin kamuwa da cuta shine amfani da abin rufe fuska; Masks na tiyata da N95 respirator masks (series #1860s) dukansu masks suna taimakawa wajen hana yaduwar kwayar cutar.
Masks na fuska na tiyata suna hana ruwan daga masu kamuwa da cutar daga iska zuwa saman kayan don haka ba za su iya kamuwa da wasu ba.
Duk da haka, N95 (serial # 1860) kawai zai iya hana ƙwayar cuta ta numfashi daga 10 zuwa 80 nm, wanda kawai kashi 5 cikin 100 na ƙwayoyin cuta za su iya shiga cikin jiki; SARS-CoV-2 yana da girman kama da SARS-CoV, kuma duka suna da girman kusan 85 nm.
Domin kwayoyin suna iya shiga cikin masks biyar na tiyata na mutum-mutumin, masu ba da sabis na kiwon lafiya da ke da alaƙa kai tsaye da marasa lafiya suna buƙatar saka N95 (serial # 1860) ba tare da yin amfani da masks na tiyata ba.
Baya ga abin rufe fuska, dole ne masu ba da sabis na kiwon lafiya su sa rigar rigakafi mai kyau don guje wa haɗuwa da cutar.
Kwayar cutar tana iya kamuwa da mutane ta idanunsu.
A ranar 20 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya saka abin rufe fuska na N95, kuma ana iya ganin cewa cutar ta shiga jikinsa ta idanunsa masu kumburi.
Saboda haka, masu ba da sabis na kiwon lafiya suna buƙatar yin amfani da fuska mai tsabta ko kuma tabarau yayin aiki tare da marasa lafiya.
Ana kuma ba da shawara ga jama'a a yankunan da aka shafa ko kuma waɗanda za su iya kamuwa da cutar su wanke hannayensu da sabulu mai kashe kwayoyin halitta fiye da yadda aka saba, su zauna a gida don su yi zaman kansu, kuma su rage hulɗa da waɗanda za su iya kamuwa da cutar.
An yi amfani da ƙafa uku don kiyaye mutane daga cutar.
An bayyana cewa wadannan ayyuka suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo duniya a matsayin sabon kwayar cutar, saboda an ruwaito shi a ranar 7 ga Janairu, 2020, cewa shi ɗan luwaɗi ne na SARS-CoV, tun da yake tunawar barkewar cutar SARS ta 2003 ya sa an yi ta busa kararrawa a China.
Ko da yake, har zuwa 19 ga Janairu, 2020, daraktan Cibiyar Kula da Cututtuka ta Wuhan yana gaya wa mutane cewa sabon kwayar cutar ba ta da ƙarancin kamuwa da cuta kuma ba ta da ƙarancin haifuwa daga mutum zuwa mutum, kuma ba shi da wuya a hana cutar da kuma sarrafa ta.
Wannan sakon ya rage hankalin jama'a musamman a lokacin da duk kasar ke shirin bikin bazara kuma lokacin da za a rage cutar a Wuhan ya ɓace.
Hukumar kula da cututtuka a kasar Sin za ta iya koyon darasi daga wannan darasi mai wuya kuma ta yi gagarumin gyara a nan gaba.
Alal misali, waɗannan cibiyoyin suna bukatar su yi hankali sosai (1) wajen yin sanarwa ga jama'a saboda kowane kalma da aka faɗa yana da mahimmanci ga jama'a kuma hakan na iya canza ra'ayinsu da shawarwarin su; (2) su kasance masu hankali da kuma amsawa ga bayanan da ba a saba gani ba a asibitoci ba, ba tare da jiran rahotanni na likita ko ma'aikaci ba; (3) su sanya ƙarin takunkumi don hana yiwuwar cutar a farkon matakin ba; da kuma (4) su ba da takunkumi da ingantattun darussan lokaci-lokaci don haɓaka wayar da kan jama'a game da cutar ta cututtuka da kuma gwadawa da kuma inganta tsarin amsawar jama'a.
An yi annobar COVID-19 ne saboda sabon kwayar cutar SARS-CoV-2 da ta fara a ƙarshen Disamba 2019.
A cikin watanni biyu da na rubuta wannan labarin, an samu shi a duk faɗin China da kuma ƙasashe 50 a duniya.
Tun da yake cutar ta yi kama da SARS-CoV, kuma alamun sun kasance iri ɗaya a lokacin COVID-19 da SARS, barkewar COVID-19 ta haifar da jin kamar SARS ta dawo.
Duk da haka, akwai bambanci tsakanin COVID-19 da SARS, wanda ke da mahimmanci don sarrafa cutar ta ta'addanci da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa, kuma ya fi rinjayar maza fiye da mata, kuma yana da haɗari da yawan mutuwa a cikin tsofaffi fiye da matasa.
Wannan ya fi na COVID-19 girma (kashi 10.91 bisa 1.44%).
Idan mutum yana da cutar ta COVID-19 ba tare da alamun bayyanar cututtuka ba, zai iya kamuwa da cutar, yayin da SARS ke kamuwa da cutar ne kawai idan ya kamu da cutar, saboda haka yana da matukar wahala a hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ke yaduwa da sauri da kuma yaduwa fiye da SARS-CoV.
Wasu marasa lafiya na COVID-19 na iya samun mummunan gwajin RNA na SARS-CoV-2 a cikin yau da kullun.
A gefe guda kuma, waɗanda suka warke za su iya samun cutar ta koma.
Wannan binciken ya kara hadarin yaduwar cutar.
Wannan ci gaba mai sauri a cikin bincike kan COVID-19 bai magance wasu muhimman batutuwa ba, kamar su:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano kashi 96 cikin 100 na jima'i tsakanin SARS-CoV-2 da SARS-like COV guda biyu, ba za mu iya kammala cewa SARS-CoV-2 ya fito ne daga kwayar cutar ba.
Wane dabba ne ya zama matsakaiciyar hanyar kamuwa da cutar daga mahaifar asali, dabba ko mutum?
Ba za mu iya hana kamuwa da cuta ba idan ba mu san amsoshin # 1 da # 2 ba, kuma cutar ba za ta sake dawowa ba.
Ko da yake samfurin kwayoyin halitta da kimantaccen halittu sun nuna cewa SARS-CoV-2 yana ɗaure ACE2, ta yaya cutar ta shiga cikin ƙwayoyin cuta na iska kuma daga baya ta canza ganewar asali?
Shin kwayar cutar tana ɗaure ƙwayoyin cuta na ACE-2 a wasu gabobin jiki?
Idan ba mu sami amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya samun ganewar asali da magani mai sauri ba.
Yaya tsawon lokacin da cututtukan cututtuka za su ci gaba?
Ta yaya kwayoyin cuta ke samo asali a cikin mutane yayin da suke kamuwa da cutar?
Shin zai zama annoba ta duniya, ko kuma zai mutu kamar SARS, ko kuma zai ci gaba da zuwa kamar mura?
Yana da muhimmanci mu bincika waɗannan tambayoyin da kuma wasu, amma hakan zai ɗauki lokaci.
Amma duk da haka, ba mu da wani zaɓi sai dai mu kawar da cutar ta AIDS da wuri-wuri kuma mu daidaita rayuwarmu.
An gano asalin cutar ta dabbobi da ke haifar da cutar korona ta mutum.
Tun shekaru dubbai, canjin da kuma daidaitawa na kwayar cutar coronavirus (CoV) da kuma yanayin rayuwar mutum yana haifar da juyin halitta tare da su.
Kafin 2003, an gano cewa mutum biyu masu cutar korona (HCoV) suna haifar da wani abu mai tsanani kamar sanyi.
Cutar cutar ta HCV ta nuna yadda cutar ta HCoV ke da lahani da kuma kisa.
A ƙarshen 2019, cutar ta sake bayyanawa a tsakiyar China tare da barkewar cutar SARS-CoV-2 kuma mun yi mamakin yadda take da babban kamuwa da cutar, amma ta kasance ƙasa da cutar ta SARS-CoV.
HCV cuta cuta ce ta dabbobi, saboda haka yana da kyau mu fahimci asalin cutar dabbobi ta HCV.
Yawancin cututtukan HCV sun samo asali ne daga cututtukan da ba su da cutar.
An san wasu kwayoyin halittar da ke da alaƙa da HCV.
Idan aka gano abincin dabba, za a iya samun sakamako na kai tsaye don hana cututtukan mutum.
Binciken yadda dabbobi ke hulɗa da masu cutar ta COVID zai iya kawo haske game da muhimman bayanai game da cutar ta COVID a cikin mutane.
A cikin wannan bita, muna ba da nazarin bayanan da ke akwai game da HCV bakwai, wanda ya danganta da tarihin binciken su da kuma asalin cututtukan dabbobi da kuma cututtukan cututtukan su.
Abu mafi muhimmanci shi ne, muna kwatanta HCOVs daban-daban daga ci gaban kwayar cutar da kuma sake tsara kwayoyin halitta.
A cikin wannan labarin, an tattauna game da cutar COVID-19 ta yanzu.
Bugu da kari, an kuma jaddada bukatar samun nasarar sauya kayan abinci da kuma tasirin juyin halittar kwayar cutar akan cutar.
Coronavirus (COV) yana cikin iyalin coronaviruses, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta.
Ana kiran waɗannan ƙwayoyin cuta "COVs" domin suna kama da rawani a cikin microscope na lantarki, wanda ke ɗauke da mafi girma daga cikin kwayoyin cuta na 26 zuwa 32 kilobes.
A tsarin gine-gine, COVs suna da nau'ikan kwayoyin halitta marasa rarrabuwa waɗanda suke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na genomes suna da manyan manyan manyan bayanan buɗewa (ORF1a da ORF1b), waɗanda aka canza zuwa pp1a da pp1ab replicas polyproteins.
Ana ci gaba da sarrafa polyproteins don samar da sunadarai 16 da ba na tsari ba, waɗanda aka tsara su da NSP1 zuwa 16.
Sauran kwayoyin halitta na cikin kwayoyin halitta sun ƙunshi ORFs don gina jiki, wanda ya haɗa da spike (S), envelope (E), membrane (M), da nucleoproteins (N).
Ana kuma haɗa wasu furotin masu taimakawa da yawa ta hanyar tsarin zuriyar COVID daban-daban.
An rarraba COVs zuwa ƙarni huɗu bisa ga jerin sunadarai daban-daban na furotin (alpha-COV, isotope-COV, gamma-COV, da Delta-COV), daga cikinsu, ƙarni na beta-COV ya ƙunshi mafi yawan HCOVs kuma an rarraba su zuwa ƙarni huɗu (A, B, C, da D).
Shaidar phylogenetic ta nuna cewa warts da beraye suna aiki a matsayin tushen kwayoyin halitta ga yawancin alpha-CoV da beta-CoV, yayin da tsuntsaye sune babban abin rufewa ga gamma-CoV da Delta-CoV.
A cikin shekaru dubbai, COVID ya ci gaba da ƙetare ƙuntatawa na jinsuna kuma ya zama babban cuta ga mutane.
A yau, an san mutum bakwai da ke dauke da cutar COV.
Daga cikin su, akwai HCoV-229E da HCoV-NL63 wato Alpha-CoV.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, matsanancin cututtukan numfashi mai tsanani coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), da kuma SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da bayyanar cututtuka masu sauƙi kamar sanyi da/ko ciwon sukari.
A akasin haka, SARS-CoV, MERS-CoV da kuma sabon SARS-CoV-2 suna da matukar cutarwa, wanda ke haifar da mummunan kamuwa da ƙananan huhu a cikin marasa lafiya da ke da haɗarin kamuwa da cutar ta matsananciyar cutar ta numfashi (ARDS) da bayyanar cututtukan extraspalmonary.
A shekara ta 1960, an gano cutar HCV-229E ta farko, wato B814, daga cikin nasal discharge na marasa lafiya da suke da sanyi.
Tun daga wannan lokacin, an samu ƙarin ilimi ta hanyar nazarin zurfi game da HCoV-229E da HCoV-OC43, wanda ke haifar da alamun da ke iyakance kansa.
A lokacin da SARS ta fara, mutane da yawa sun yi imani cewa cutar HCoV ba ta da lahani.
Cutar SARS ta 2003 ta kasance daya daga cikin cututtukan da suka fi halakarwa a tarihin zamani, inda ta kamu da mutane fiye da 8,000, tare da mutuwar kusan kashi 10 cikin dari na yawan cututtukan.
Shekaru goma bayan haka, cutar ta cutar MERS ta gabatowa ta haifar da ci gaba da kamuwa da cutar a yankin Larabawa wanda ya bazu cikin sauri zuwa sauran duniya.
Sabon HCoV na 2019 (COVID-19) wanda aka sake suna da shi SARS-CoV-2 shi ne babban abin da ya haifar da cutar ta COVID-19, wanda ya haifar da mutuwar 3,120 da kamuwa da cutar ta COVID-19, wanda ya kai fiye da 91,000 a ranar 3 ga Maris, 2020.
Ana kiran kararrawar barazana a koyaushe kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa ta duniya.
Dukan cututtukan da ke tattare da cutar ta dabbobi guda bakwai suna faruwa ne a cikin dabbobi masu launin fata, da beraye, da kuma dabbobi masu dabbobin gida.
Akwai hujjoji da yawa da suka tabbatar da cewa kwayoyin sun samo asali ne daga kwayar cuta, inda kwayoyin suka karɓi yanayin kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta mai ban mamaki.
Cutar COVID-19 ta kawo manyan kalubalen kiwon lafiya, kimiyya, zamantakewa da kuma dabi'a ga kasar Sin da kuma duniya.
Idan aka gano asalin cutar ta dabbobi ta ACV, za a iya gano tarihin halitta, ƙarfin motsawa da kuma tsarin ƙuntatawa na tsalle-tsalle na jinsuna.
Wannan zai taimaka wajen jagorantar ko kuma taimakawa wajen gano wuraren da SARS-CoV-2 ke zama, matsakaici da kuma karuwa (V) wanda zai iya yin aiki mai mahimmanci don hana shi yadawa a nan gaba.
A cikin wannan bita, muna ba da bita game da asalin cututtukan dabbobi, cututtukan da ke tsakanin jinsuna da kuma cutar HCV.
Musamman: Mun jaddada wasu jigogi na yau da kullum kuma muna tattauna cewa kwayar cutar HCV mai haifacciyar cutar ba ta da cutarwa a cikin abincin ta na halitta, amma tana da cutarwa yayin da ta kamu da nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Mun kuma yi nazarin yadda HCV ta samo asali, inda idan kamuwa da cutar ta karu, cutar ta rage.
A cikin wannan mahallin, an tattauna game da tasirin barkewar cutar SARS-CoV-2 da ke gudana.
An san dabbobi da cutar ta COVID tun daga ƙarshen shekarun 1930.
Kafin a fara gano cutar HCoV-229E daga cikin hancin mai cutar sanyi, an gano nau'ikan COVID-19 daga dabbobi masu kamuwa da cutar daban-daban, ciki har da turkey, beraye, shanu, alade, cats da karnuka.
A cikin shekaru da suka gabata, an gano HCOV guda bakwai.
Ga taƙaitaccen bayani game da gano cutar HCoV (Table 1) a cikin jerin abubuwan da suka faru, zai zama mai bayani da kuma bayani.
An gano cutar HCoV-229E ta farko a cikin 1966 daga marasa lafiya da ke fama da cutar ta hanyar huhu, kuma daga baya an samu karuwar WI-38 a cikin ƙwayoyin cuta na huhu.
A cikin marasa lafiya da ke dauke da cutar HCoV-229E, an nuna alamun sanyi, ciki har da ciwon kai, ciwon kai, ciwon kumburi da kuma ciwon hanci, da kuma yawan zazzabi da tari a cikin kashi 10-20 cikin dari na lokuta.
Daga baya a shekara ta 1967, an cire HCoV-OC43 daga kwayoyin halitta na ƙananan beraye, sannan kuma daga tsarin da ke cikin kwakwalwa.
HCV-OC43 na da halaye na asibiti kamar HCV-229E, wanda ba a iya rarrabe shi da sauran cututtukan huhu kamar su Influenza A da Rhinoviruses ba.
HCoV-229E da HCoV-OC43 sun bazu a duniya, kuma suna kamuwa da cutar a lokacin hunturu a yanayin zafi mai ƙarancin zafi.
A yawancin lokaci, lokacin da waɗannan ƙwayoyin cuta biyu suka kamu da cutar bai kai mako ɗaya ba, sai kuma bayan kusan mako biyu, sai su kamu da cutar.
Wani bincike da aka yi a kan mutane masu aikin sa kai ya nuna cewa masu lafiya da ke dauke da cutar HCoV-229E sun kamu da sanyi mai laushi.
Wasu marasa lafiya da ke da rashin ƙarfi ne kawai suke da cututtukan da ke sa su kamu da cutar ta kasa.
SARS da ake kira "antipical pneumonia" shi ne HCoV na farko da aka rubuta a duniya a tarihin ɗan adam, kuma shi ne HCoV na uku da aka gano wanda ya haifar da cutar SARS-CoV.
An fara gano SARS a ƙarshen shekara ta 2002 a lardin Guangdong na kasar Sin.
SARS ya haifar da mutuwar 774 da suka shafi mutum 8,096 da suka kamu da cutar a kasashe da nahiyoyi da dama.
Ba tare da cututtukan da ke da yawa ba, an kiyasta cewa kowane hali zai iya haifar da cututtukan biyu na biyu, wanda ke da lokacin wanka na kwanaki 4 zuwa 7, kuma ana iya ganin tasirin cutar a rana ta goma ta cutar.
Masu kamuwa da SARS-CoV suna iya samun ciwon tsoka, ciwon kai, zazzabi, kumburi da sanyi, sannan kuma shan numfashi, tari, da kuma numfashi.
Abubuwan da ke faruwa a cikin dakin gwaje-gwaje na SARS sune lalacewar ƙwayoyin halitta, gwajin aikin hanta da kuma karuwar ƙwayar halitta.
An kuma gano cutar ta alveolar da ta lalace, da karuwar kwayoyin halitta da kuma karuwar ƙwayar cuta a cikin marasa lafiya na SARS.
Kimanin kashi 20 zuwa 30 cikin 100 na marasa lafiya suna bukatar kulawa mai kyau da kuma iska mai iska.
Ƙananan hanyoyin numfashi da kuma na hanji, hanta da koda suna iya kamuwa da wannan mummunar cuta, mai yiwuwa ta hanyar hadarin cytokine, wanda zai iya zama mai haɗari ga marasa lafiya da ke fama da rashin ƙarfi.
A karon farko, an gano cutar ne daga wani bincike na wani dangin da ya zo Hong Kong daga birnin Guangzhou.
Tun daga lokacin, an yi ƙoƙari sosai don yin bincike kan HCoVs.
A cikin marigayi na shekara ta 2004, an cire cutar HCoV-NL63 daga jariri mai wata bakwai a Netherlands.
An fara gano shi a cikin yara, tsofaffi, da kuma marasa lafiya da ke fama da rashin lafiyar numfashi.
Cutar da ake samu daga cutar HCV-NL63 ta ƙunshi sanyi, rashin gani, zazzabi, da kuma rashin numfashi.
Wani bincike na dabam ya nuna cewa an cire wannan kwayar daga hancin wani jariri mai watanni takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an samo shi a Netherlands, an yi amfani da shi a dukan duniya.
An kiyasta cewa cutar HCoV-NL63 tana da alhakin kashi 4.7% na cututtukan numfashi na yau da kullun, kuma mafi yawan cututtukan suna faruwa a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da cututtukan ƙwayoyin cuta na ƙwayoyin cuta, wanda ake kira croup.
A wannan shekarar, an ware HCV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti a Hong Kong don cutar huhu da kumburi.
HCV-HKU1 yana da alaƙa da rashin ƙarfi na rashin ƙarfi, ciki har da cutar pneumonia da rashin ƙarfi na numfashi.
HCV-NKU1 kamar HCoV-NL63, HCoV-229E, da HCoV-OC43 suna da yawa a duniya, suna haifar da cututtukan numfashi masu laushi.
Dukkanin waɗannan nau'ikan HCV guda huɗu da aka samo daga al'umma sun samu karbuwa sosai a cikin mutane kuma ba su da wataƙila su zama cututtuka masu cutarwa sosai, amma har ma da wasu dalilai da ba a sani ba, suna iya haifar da haɗari kamar yadda suka faru a cikin ƙarin nau'ikan kwayar cutar HCV-NL63, wanda kwanan nan aka ruwaito yana haifar da mummunan kamuwa da cutar ta kasa a China.
A kullum, idan wadannan cututtukan suna da ikon kamuwa da cutar ta hanyar da ta dace kuma suna iya kasancewa a cikin mutane, za su zama marasa guba ko kuma masu cutarwa.
An fara cire cutar MERS-CoV daga huhu a Saudiyya a shekarar 2012 daga wani mutum mai shekaru 60 da haihuwa wanda ke fama da cutar huhu mai tsanani da kuma matsalar cututtukan koda.
Ko da yake mafi yawan shari'o'in da aka tabbatar sun fito ne daga Gabas ta Tsakiya, an yi rahoton wasu lokuta a cikin ƙasashen Turai da Tunisia, saboda kusanci da aka yi da su.
Na biyu ya faru ne a Koriya ta Kudu a shekarar 2015 inda aka samu mutane 186 da suka kamu da cutar.
Alamun cutar ta cutar ta Mars sun yi kama da cutar SARS, wanda ake gani ta hanyar ci gaba da cutar huhu.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar ta MERS sun kamu da mummunan rauni na koda, wanda ba shi da kyau ga MERS a cikin cututtukan da ke haifar da HCV.
Yawan marasa lafiya da suka kamu da cututtukan narkewa kamar tari da kuma zagi sun wuce kashi 30.
A ranar 14 ga Fabrairu, 2020, an samu karin karin karin karin mutum 2,500 da suka kamu da cutar, inda adadin mutuwar da suka samu ya kai kashi 34.4 cikin dari, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi hallaka da aka sani ga bil'adama.
A tsakiyar watan Disamba na shekarar 2019, an samu wasu cututtukan cutar huhu da ke da alaƙa da cutar SARS-CoV-2 da aka sani a Wuhan, lardin Hubei, China.
Hukumar lafiya ta duniya ta bayyana barkewar cutar ta hanyar huhu ta hanyar SARS-CoV-2 a matsayin gagarumin gagarumin gaggawa na lafiyar jama'a na damuwa ta duniya, kuma ta sanya sunan cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duniya, wanda ya kai kashi 3.4 cikin dari na mutuwar cutar.
Abin lura, a kasar Sin, adadin mutuwar mutane a Hubei ya kai kashi 4.2 cikin dari, amma a waje ya kai kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV wanda ke nuna zazzabi, tari da kumburi.
Wasu marasa lafiya ma sun kamu da cutar ta maniyyi.
Rashin numfashi yana cikin alamun da suka fi tsanani kuma yana iya saurin karuwa a cikin alamun ciwon numfashi.
Ko da yake suna da kamanceceniya sosai saboda tsararren nucleotide na homogenization, SARS-CoV da SARS-CoV-2 suna cikin rassan daban-daban a cikin tsarin phylogenetic.
A wannan yanayin, SARS-CoV-2 ba shi da cutarwa sosai, amma ya fi SARS-CoV da MERS-CoV kamuwa da cutar.
An samu marasa lafiya marasa alamun cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs shida, akwai wasu kamanceceniya da bambance-bambance.
Na farko, lokacin da aka yi maniyyi da lokacin da aka yi maniyyi na cutar HCV suna da yawa.
A wannan yanayin, SARS-CoV-2 ya bi al'amuran sauran HCoVs shida.
Na biyu, cutar ta COVID-19 tana da tsanani tsakanin SARS-CoV da HCoVs (watau HCoV-229E, HCoV-OC43, HCoV-HQ1, da HCoV-NL63) da aka samo daga ƙungiyoyi hudu.
A gefe guda, SARS-CoV-2 yana nuna halaye da ake gani a lokacin kamuwa da cutar HCoV na kowa, wanda ya haɗa da rashin bayyanar cututtuka, marasa ƙarfi, ko rashin bayyanar cututtuka.
A gefe guda kuma, duk da cewa adadin ya rage, akwai karamin adadin cututtukan COVID-19 a cikin SARS-CoV.
Na uku, SARS-CoV-2 ya nuna wasu abubuwa masu ban sha'awa game da HCoV da SARS-CoV, wanda ke faruwa a cikin al'umma.
A gefe guda, SARS-CoV-2 yana da karfin kamuwa da cutar kamar HCoV da aka samu daga al'umma.
A gefe guda kuma, kamar yadda SARS-CoV da MERS-CoV suka rage yawan kamuwa da cutar a cikin mutane, haka ma SARS-CoV-2 ya rage yawan kamuwa da cutar.
A ƙarshe, kamar sauran HCoVs, SARS-CoV-2 na iya bayyana a cikin samfurori na ƙwayoyin cuta.
Za a yi bincike a nan gaba don ganin ko cutar ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta hanyar magana ta da ta da ta da ta da ta da ta da ta daɗi.
Kamar yadda ake samun cutar HCoV daga al'umma, zai zama mai ban sha'awa ganin ko SARS-CoV-2 na nuna yanayi.
Koyaya, bayan yaduwar cutar cikin mutane, halaye na SARS-CoV-2 wanda ya haɗa da kamuwa da cuta, kamuwa da cuta da kuma ci gaba da yaduwar cutar cikin mutane zai zama tasiri ga makomar ƙarshen barkewar COVID-19.
HCOVins, wanda aka samo daga dukkanin al'ummomin da ke haifar da bayyanar cututtuka masu laushi, sun dace da mutane sosai.
A wani bangare kuma, zai iya zama gaskiya cewa mutane sun daidaita da wadannan HCOVs hudu.
A wasu kalmomi, dukansu sun tsira daga cutar HCV ta dā.
Dole ne a kawar da cutar HCoV da ke haifar da cututtuka masu tsanani a cikin mutane da kuma cututtukan HCoV da ke haifar da cututtuka masu tsanani.
Don haka, dole ne a bar HCoVs su zama masu kwafi a cikin mutane har sai an sami wadataccen adadi na masu canji masu kyau wanda zai iya lalata abubuwan hana abinci.
A wannan ma'anar, SARS-CoV-2 zai iya zama cikakke ga mutane idan ya daɗe yana kamuwa da mutane da yawa.
Idan aka daidaita shi da kyau, zai yi wuya a hana shi yaduwa tsakanin mutane ta hanyar warewa ko wasu hanyoyin hana kamuwa da cuta.
A cikin shekaru da yawa, mutane suna samun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Waɗannan ƙwayoyin ba sa bukatar mafaka.
A akasin haka, SARS-CoV da MERS-CoV masu cutarwa ba su daidaita da mutane ba kuma ba za su ci gaba da kamuwa da cutar ba.
Dole ne su ci gaba da yada su a wuraren da suke kare dabbobi kuma su yada su ta hanyar matsakaici ko fiye da matsakaici da kuma ingantaccen abinci don cimma burin mutum mai hankali.
Halin SARS-CoV-2 ya yi daidai da na SARS-CoV/MERS-CoV da kuma HCoVs hudu da aka samo daga al'umma.
Aƙalla a yanzu, yana da matukar yaduwa kamar cutar HCV da ake samu daga al'umma.
Duk da haka, yana da matukar cutarwa fiye da HCV da aka samo daga al'umma, kuma yana da ƙananan cutarwa fiye da SARS-CoV ko MERS-CoV.
Ba tare da wani gida ko kuma wani dabba mai matsakaici ba, zai zama cikakke ga mutane, kuma za a ga ko zai iya yaduwa cikin mutane.
Kafin mu tattauna game da asalin dabbobi na HCoV, zai dace mu tattauna ma'anar da kuma halaye na HCoV na juyin halitta, halitta, mafaka, matsakaici da kuma haɓaka.
Dabba za ta iya zama gurɓataccen gurɓataccen halittar HCV idan ta yi amfani da gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓataccen gurɓata.
A cikin wannan kayan, ƙwayoyin cuta na asali suna da yawa kuma ba su da cutar.
Hakazalika, abincin da ke cikin kwayoyin halitta yana ba da mafaka ga cutar HCV a kai a kai.
A lokuta biyu, cutar ta kamu da cutar ta halitta, kuma ta kamu da cutar ta HCV ko kuma ta iyaye.
A akasin haka, idan an saka HCV a cikin wani matsakaici kafin ko a lokacin da aka gabatar da shi a cikin mutane, ba zai dace da sabon kayan ba kuma zai iya zama mai cutarwa.
Wadannan kayan aikin na iya zama kayan aikin dabbobi na mutum, kuma suna iya zama kayan aikin haɓaka, suna ba da damar kwayar cutar ta ɗan lokaci ta hanyar samar da kwayar cutar ta ɗan lokaci, sannan kuma suna iya ɗaukar cutar zuwa mutane don faɗaɗa yaduwar cutar.
HCV zai iya zama sanadiyyar kamuwa da cutar idan ba ya iya riƙe cutar a cikin matsakaiciyar sutura.
A akasin haka, HCVs na iya karɓar abinci mai matsakaici kuma ba kawai su iya kafa rashin lafiyar na dogon lokaci ba.
A wannan yanayin, matsakaiciyar abincin ta zama abincin aljanu na halitta.
Bayanai na cututtuka sun nuna cewa an gano tarihin farautar SARS da farautar dabbobin daji.
Binciken da aka yi a baya na CeroPrivavelance ya nuna cewa ana samun karuwar cutar ta anti-SARS-CoV-IGG a cikin masu sayar da dabbobi fiye da talakawa.
A cikin kasuwar dabbobi masu rai, an gano cewa masked palm seats (Pugma larvae) da raccoon karnuka sun fara ɗaukar ƙwayoyin cuta kamar SARS-CoV, wanda yayi kama da SARS-CoV.
Wannan ya karfafa shi ne saboda babu wani SARS da aka samu bayan an kashe dukan 'yan kasuwa a kasuwa.
Duk da haka, an kuma lura cewa masked palm seeds a cikin gandun daji ko gonaki waɗanda ba su da alaƙa da kasuwar rayayyun dabbobi suna da mummunan sakamako ga SARS-CoV, yana nuna cewa masked palm seeds na iya zama matsakaiciyar haɓakar haɓakawa amma ba zai zama wurin shakatawa na SARS-CoV ba.
Abin lura, kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da maganin rigakafin SARS-CoV, saboda haka ba za a iya ƙaryata cewa wasu nau'ikan ƙananan dabbobi masu shayarwa suna aiki a matsayin matsakaici don haɓaka SARS-CoV ba.
Dukkanin wadannan sun bayyana a matsayin makomar SARS-CoV.
Binciken da aka yi na samar da abinci ga dabbobi na SARS-CoV ya haifar da gano wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Wadannan kwayoyin sun kasance masu kyau ga anti-SARS-CoV antibodies da kuma SARS R-RH-BATCOV-HKU3 genomic sequence.
Wannan da sauran kwayoyin halitta suna da kashi 88 zuwa 92% na jituwa tsakanin kwayoyin halitta da SARS-CoV.
Wannan binciken ya kafa wani sabon ra'ayi cewa dabbobi masu tsufa suna ciyar da masu cutarwa na mutum.
An gano wasu cututtukan SARS-like (SL-CoV) daga kwayar cutar, amma ba a gano kowa ba a matsayin mai rai sai WIV1.
An kira shi anjin mai canzawa na mutum (ACE2) mai karɓar SARS-CoV.
WIV1 an samo shi ne daga samfurin ƙwayoyin cuta na ƙwayoyin cuta wanda aka nuna don amfani dashi azaman ƙwayoyin cuta, ƙwayoyin cuta da ƙwayoyin cuta na mutum don shigar da ƙwayoyin cuta na ACE2.
Abin sha'awa, an gano cewa jini na SARS mai cutar ya iya hana cutar ta HIV1.
Saboda haka, WIV1 yana wakiltar SARS-CoV a matsayin mafi kusantar nasaba a cikin kwayoyin halitta, wanda ke da kashi 95% na haɗin kai na nucleotide.
Ko da yake akwai babban daidaituwa tsakanin waɗannan ƙwayoyin, ana fahimtar cewa WIV1 ba shine matsakaiciyar mahaifa na SARS-CoV ba, kuma ƙwayoyin cuta ba su da ainihin ɓoyewar cutar SARS-CoV.
Nazarin tarihin ya hada MERS-CoV zuwa cikin rukuni guda daya kamar yadda yake da COV-HKU4 da BAT COV-HKU5.
A cikin kwayoyin halitta, ana amfani da dipeptidyl peptidase 4 (DPP4) don shigar da kwayar cutar.
Tsarin RNA-dogon RNA polymers na MERS-CoV yana da alaƙa da tsarin da aka samu a cikin bat beta-CoVs a Turai da Afirka.
Har yanzu, ba a samu wani cutar MERS-CoV mai rai a cikin daji ba.
A cikin MERS-CoV da bat-CoV-HQ25, an gano kashi 87 cikin 100 na nucleotide-sort homogenization.
Saboda haka, zai yiwu cewa tsuntsaye ba su da wata hanya ta kai tsaye ta kamuwa da cutar MERS-CoV.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa dromedary camels suna da cutar cutar sankarar cutar MERS-CoV, kamar yadda camels na tseren Gabas ta Tsakiya suke a kasashen Afirka da dama.
An gano cewa cutar MERS-CoV mai rai tana kama da cutar da ake samu a cikin mutane, wanda aka bambanta shi da na dromedary camel ta hanci, kuma ya nuna cewa camels suna aiki a matsayin masu amfana daga MERS-CoV.
Yana da kyau a lura cewa an gano cewa a cikin gwaji mai yawa na kwayoyin cuta, wanda yawanci yana da sauƙi, an gano cewa MERS-CoV ya yi amfani da su a cikin raƙuman da ke da cutar.
Abin lura, rakumi masu cutar ba wai kawai suna ba da mafaka ta hanyar numfashi ba, har ma da hanyar da ke cikin bakunansu, wanda kuma shine babban hanyar da za a iya samun mafaka daga cutar.
Koyaya, tambayar ta kasance cewa yawancin shari'o'in da aka tabbatar da cutar ta Mars ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, hanyar kamuwa da cutar ta mutum-zuwa-mutum ko hanyar kamuwa da cutar da ba a sani ba wanda ke iya haifar da nau'ikan dabbobi da ba a san su ba waɗanda ke ba da mafaka ga cutar ta MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na nucleotide homogeneity tare da bat COV RATG13 wanda aka raba daga Rhinolavus related albasa.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RATG-13 yana da kyau sosai wajen tantance alaƙar iyaye.
Wannan yana nufin cewa, akwai yiwuwar cewa, ba za a iya ganin cewa dabbobi masu kama da dabbobi masu kama da SARS-CoV-2 ba, sai dai idan an gano irin wannan cutar a nan gaba.
Yawancin SARS-CoV-2 na iya kasancewa daga cikin jinsunan da aka sayar da su a kasuwar sayar da abinci ta teku ta Hunan, wanda ya haɗa da wasu daga cikin farkon shari'o'in da suka shafi COVID-19, wanda ke nuna yiwuwar yaduwar cutar daga dabba zuwa mutum.
Yawancin bincike na kwanan nan dangane da tsarin metagenomic sun nuna cewa ƙungiyar ƙananan dabbobi masu shayarwa masu haɗari da ake kira pangolins (Manis Jovanica - Cats da aka ci) na iya zama mafaka ga tsohuwar SARS-CoV-2 mai alaƙa da beta-CoV.
Waɗannan sabbin jinsunan na Cove na Pangolin suna da daidaituwa tsakanin kashi 85 zuwa 92% na nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaƙa da RATG13 a kusan 90% na daidaito a matakin jerin nucleotides.
Sun rarraba kwayoyin halitta kamar SARS-CoV-2 zuwa sassan biyu a cikin tsire-tsire na tarihi, daya daga cikinsu wanda ya ba da kashi 97.4% na amino acid da aka gano, wanda ya fi kama da sars-CoV-2 zuwa wani yanki mai kama da sars-CoV-2.
A cikin rashin daidaito na gaskiya, SARS-CoV-2 da RATG13 suna da bambancin RBD, duk da haka suna da babban rabo daga tsarin homogeneity a cikin genomes.
Wani bincike na kwanan nan kan cutar Pangolin ya kuma nuna cewa an gano wani nau'i na kwayar cutar a cikin samfurin huhu, wanda ya kasance da alaƙa da SARS-CoV-2.
Wannan bincike ya yi amfani da tsarin taro daban-daban da kuma maganin jiki don samar da wani sashi na kashi 86.3% na jimlar kwayoyin cuta na cikakken tsawon.
Ba za mu iya ƙyale yiwuwar cewa ɗayan dabbobi masu tsaka-tsaki na SARS-CoV-2 sune pangolin ba.
Duk da haka, saboda bambancin tsari tsakanin SARS-CoV-2 da panoglycine SARS-CoV-2-related beta-CoVs, babu wani tabbacin da ake da shi a halin yanzu don tallafawa asalin panoglycine kai tsaye na SARS-CoV-2.
Bugu da kari, tazara tsakanin SARS-CoV-2 da RATG13 ta yi ƙasa da tazara tsakanin SARS-CoV-2 da kuma beta-CoVs na SARS-CoV-2 da ke tattare da Pangolin.
Ana bukatar a daidaita hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi masu rai, da pangolins da sauran dabbobi masu shayarwa.
A cikin RBDs, an gano mafi yawan daidaituwa tsakanin SARS-CoV-2 da Pangolin, yayin da beta-CoVs na SARS-CoV-2 da SARS-CoV-2 da RATG13 suka raba mafi yawan daidaituwa tsakanin tsarin genomic.
Akwai wasu dabaru da ke nuna cewa akwai babban kamance tsakanin cutar ta SARS-CoV-2 da ke da alaƙa da beta-CoV-2 da kuma SARS-CoV-2 da ke da alaƙa da kwayoyi masu amfani da kwayoyi masu amfani da kwayoyi masu amfani da kwayoyi.
Panogolin yana da wani zaɓi a cikin amfanin sake haɗuwa tsakanin SARS-CoV-2 da ke da alaƙa da beta-CoV da kuma RATG13 a cikin nau'in dabba na uku.
A matsayin mai motsawa a juyin halitta, sake haɗuwa yana da yawa a cikin beta-CoV.
Jury har yanzu suna bincike kan asalin dabbobi na SARS-CoV-2.
Ko da yake akwai cutar HCoV mai yawa, an kuma yi nazarin asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar tarihi ta nuna cewa HCoV-NL63 da HCoV-229E sun fito ne daga cutar ta COV ta biyu, yayin da aka gano HCoV-OC43 HCoV-HKU1 a cikin dabbobi masu shayarwa.
An ruwaito cewa an gano cutar ta COV a cikin cutar ta ARCOV.2 (Apalatian Ridge COV) a cikin cutar ta Triangular North American, yana nuna alaƙar kusa da HCoV-NL63.
A gefe guda kuma, HCoV-229E yana da alaƙa da chromosomal a cikin wani nau'in cutar ta COV, mai suna Hipposiderosis/Ghanaquam/19/2008, wanda aka gano a Ghana, a lokacin da aka gano camels a matsayin masu amfani da su.
Don bayyanawa, ana ba da taƙaitaccen bayanin ilimin halin yanzu game da asalin dabba na cutar HCV da aka sani a cikin Figure 1 da Table 2.
Tarihi ya nuna cewa an yi nazarin halittu ta hanyar nazarin halittu don tabbatar da cewa cutar ta kamuwa da cutar ta HCV.
A shekara ta 1890, an yi rahoton cewa cutar ta kamuwa da cutar ta hanyar numfashi ta kamuwa da cutar ta hanyar HCoV-OC43 daga dabbobi na gida zuwa ga mutane.
Tarihin kamuwa da cutar HCoV-229E tsakanin jinsuna bai bayyana ba.
An gano wani abu mai kama da HCoV-229E, wato bat alpha-CoV.
Akwai Alpha-COV a cikin su.
Akwai shaidu da yawa da ke tallafawa kai tsaye ga kamuwa da cutar daga lokacin da aka yi lalata zuwa mutane.
Na farko, akwai yiwuwar cewa mutane ba alpacas ba ne suka haɗu da albasa a cikin yanayin da aka raba.
Maimakon haka, mutane suna da dangantaka mai kyau da alpacas.
Na biyu, cutar ta HCoV-229E ta bambanta da cutar ta Alpha-CoV, yayin da Alpacas Alpha-CoV ta haifar da cutar ta hanyar numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a gano Alpha-CoV a cikin daji ba.
Saboda haka, ba za a iya ƙyale yiwuwar cewa Alpha-CoV da ke da alaƙa da HCoV-229E ya samo asali daga mutum ba.
A gaskiya ma, dabbobi masu fashi suna da kai tsaye tushen cututtukan mutum, ciki har da kwayar cutar rabies, Ebola, Nipah, da kuma cutar Hendra.
Saboda haka, ba abin mamaki ba ne cewa warts suna iya kamuwa da cutar HCoV-229E kai tsaye zuwa ga mutane.
A madadin haka, bat alpha-CoV shine asalin HCoV-229E, alpacas da dromedary camels na iya zama matsakaici masu ɗaukar hoto waɗanda zasu iya ɗaukar kwayar cutar a cikin mutane, kamar yadda ya faru a cikin yanayin MERS-CoV.
MERS-CoV ya zama misali mafi kyau na yaduwar jinsuna daga kamaye zuwa kamaye da kuma daga kamaye zuwa mutum.
An san asalin juyin halitta na Mars-CoV tun daga lokacin da aka fara shi kuma an ƙarfafa shi ta hanyar binciken da aka yi a baya.
A bayyane yake cewa, dabbobi masu kama da daji suna ba da wadataccen adadi na nau'ikan ƙwayoyin cuta don musayar nau'ikan kwayoyin halitta da kuma cututtuka tsakanin jinsuna.
Rayuwa mai tsawo, zama a cikin yankunan da ke cike da mutane, da kuma kusanci da zamantakewar jama'a da kuma iyawar tashi, duk sun sa 'yan tsiraru su zama masu watsa kwayar cutar.
A gefe guda kuma, MERS-CoVs sun shiga cikin raƙuman raƙuman ruwa na shekaru da yawa.
Wadannan raƙuman sun karɓe su sosai wanda ya sa suka zama abinci mai ɗorewa daga matsakaici zuwa abinci mai ɗorewa na aljanu.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana da ƙananan canji a cikin waɗannan dabbobi.
A cikin ƙananan mutane, kamuwa da cutar ta zama hatsari ne, kuma mutane suna rayuwa ne a ƙarƙashin cutar MERS-CoV saboda ba za ta dawwama ba.
Matsayin raƙumi a cikin kamuwa da cutar MERS-CoV, a cikin haɗuwa da SARS-CoV-2, ya bambanta da na panoglycine, idan akwai, idan akwai.
Musamman, cutar beta-CoV tana da matukar cutarwa ga panogulins.
Suna iya zama matakai na gaba don beta-CoVs da ke da alaƙa da SARS-CoV-2, kamar yadda suke a cikin SARS-CoVs.
A nan gaba, ana iya yin la'akari da yiwuwar karuwar SARS-CoV-2 daga dabba zuwa mutum a cikin bincike.
Na farko, dabbobi masu fashi suna iya zama masu karɓar kwayoyin cutar SARS-CoV-2, wanda ke da kusan kama da SARS-CoV-2.
Mutane za su iya raba muhalli tare da cin amanarsu ta hanyar yanka da kuma yin amfani da ma'adinai.
Na biyu, panoglycine na iya kasancewa cikin abincin da ke ba da abinci mai gina jiki wanda aka gano kwanan nan game da cutar SARS-CoV-2.
Ana samun kwayar cutar ta hanyar cin naman da aka kashe da kuma cin naman da aka kashe.
Yana yiwuwa cewa dabbobi masu shayarwa da yawa, har da dabbobi masu gida, suna da ƙarancin cutar SARS-CoV-2.
Ana bukatar a yi bincike a kan dabbobi da kuma namun daji don gano kwayoyin.
Na uku, kamar yadda aka ambata a sama, ana iya samun sake haɗuwa da karɓar SARS-CoV-2 a cikin jinsuna na uku waɗanda ke cikin haɗuwa da warts da pangolins.
Har yanzu ana bincike kan asalin dabba na SARS-CoV-2.
Ban da nau'ikan kayan abinci na dabbobi, akwai manyan abubuwa uku da ke taimakawa wajen kawar da cutar COVID don sauƙaƙe ƙuntatawa na nau'ikan dabbobi na biyu.
Na farko, suna da ƙimar canji mai yawa a cikin kwayar RNA.
Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, ana iya la'akari da ƙimar canjin COVID a matsayin "mai laushi" zuwa "mai girma" yayin da sabon abinci ke ɗaukar matakin maye gurbin COVID, tare da sauyawa -10-4 a kowace shekara a kowane rukunin yanar gizo.
COV yana da ƙwayar exoribonuclease mai karanta shaida, wanda cirewa yana haifar da wucewa da kuma lalatawa ko ma rayuwa mai kyau.
Abin mamaki, an san Remdesivir mai amfani da ƙwayar cuta ta nucleotide don hana kwayar cutar ta COV ta ƙone ƙwayoyin cuta na exoribonuclease da RNA-daidaitaccen RNA polymers.
Remdesivir yana daya daga cikin mafi kyawun wakilai masu karewa na SARS-CoV-2 da ake gwadawa a cikin gwaji na asibiti.
Duk da haka, yawan canjin da ke faruwa a cikin cutar ta COVID ya ninka na abinci sau miliyan ɗaya.
Bugu da ƙari, idan ba a karɓi COVs da kyau ta hanyar abinci ba, yawan canjin canji yana da yawa.
Idan aka kwatanta da SARS-CoV da ke da yawan canji, SARS-CoV-2 yana da ƙananan canji, yana nuna karbuwa ga mutane.
Wataƙila wasu mutane sun riga sun karɓi wannan.
Wannan ya shafi MERS-CoV, wanda ya dace da DroneDry Unta, a matsayin ƙari ga SARS-CoV-2.
A ka'idar, ba zai yiwu ba cewa daukar kwayar cutar ta hanyar haihuwa ta sa rashin tasiri a kan SARS-CoV-2 ya zama na gaggawa da kuma na rashin ƙarfi.
Na biyu, manyan kwayoyin RNA a cikin C.O.V.s suna jan ƙarin sassauci a cikin gyaran kwayoyin halitta don juyawa da sake haɗuwa, wanda ke ƙara yiwuwar juyin halitta tsakanin jinsuna, wanda ke da fa'ida ga bayyanar sabon C.O.V.s lokacin da yanayin ya dace.
Wannan yana da nasaba da wasu manyan tsarin da za a iya karantawa da kuma ayyukan furotin da ke ƙunshe da 3' a ƙarshen jini.
Na uku, COVs suna sauya samfuran tsakanin kwafin RNA a bazuwar kuma a kai a kai ta hanyar tsarin "sawu-zaɓar" na daban.
A cikin tufafi suna aiki a matsayin tukwane don haɗuwa, sau da yawa sauya sharuɗɗa yana faruwa yayin da aka fassara COV RNA.
Ana iya sake haɗa RNA mai girma da kuma na gaba da sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin sinadarin
An gano shaidar halitta ta hanyar HCoV-HKQ1 da HCoV-OC43 da kuma CVD na dabba kamar su UL-CoV da CVD-HKQ9.
Hadin kai tsakanin kwayoyin cuta da kwayoyin cuta a lokacin da ake kamuwa da cutar
Baya ga abubuwan da aka ambata a sama, wani muhimmin abu kuma da ke taimakawa wajen kamuwa da cutar shi ne hulɗar da ke tsakanin kwayoyin cuta da masu karɓar kwayoyin cuta.
A nan, an dauki sake haɗuwa da SARS-CoV a matsayin misali, wanda kuma ya nuna hujja na zaɓi mai kyau a tsakanin yanayin yaduwar nau'in.
Bisa ga bincike na kwatancen tsakanin bambance-bambancen SARS-CoV tsakanin mutane da na mutum, SARS-CoV ya bayyana cewa an karɓi SARS-CoV cikin sauri a cikin abinci daban-daban, musamman ma tare da canji a cikin RBD na furotin S.
A cikin RBD na S, COV yana hulɗa da mai karɓa na ƙwayoyin halitta kuma ana zaɓar shi ta hanyar amsawar ƙwayar cuta ta jiki.
A cikin SARS-CoV, RBDs suna cikin kashi 318 zuwa 510 na amino acid a cikin S1, wanda ke ɗaure masu karɓa tare da su don shigar da kwayar cutar, kamar yadda yake da ACE2.
RBD na SARS-CoV yana ba da damar kamuwa da kwayar cutar ta hanyar nau'ikan da ke iya gano masu karɓar ACE2 na dabbobi daban-daban, gami da warts, bats, beraye da karnuka na raccoon.
A zahiri, an gano cewa amino acid guda shida ne kawai suka bambanta a cikin RBD na mai raba kwayar cutar mutum da na mutum, kuma hudu daga cikinsu suna cikin hoto na mai karɓa-mai ɗaure don hulɗa da mai karɓa ACE2.
A cikin SARS-CoV na ciwon daji, masu canzawa K489N da S487T suna cikin RBDs, wanda zai iya ƙarfafa sha'awar hulɗa da furotin mai ƙyama tare da masu karɓar ACE2 na mutum.
A wasu kalmomi, maye gurbin amino acid biyu na iya zama muhimmiyar mahimmanci ga karɓar kwayar cutar a cikin mutane.
Yana da mahimmanci a lura cewa SARS-CoV-2 yana da karɓar kwayoyin halitta iri ɗaya da SARS-CoV.
Bambanci na kashi 30 cikin 100 tsakanin SARS-CoV-2 da SARS-CoV-2 a cikin s1 na S sun nuna cewa ana iya canza sha'awar ɗaukar S tare da ACE2 na mutum.
Hakika, wani bincike na Cryo-EM ya nuna cewa ana son wadannan abubuwa sau 10 zuwa 20 fiye da yadda ake so a tsakanin kwayoyin ACE2 da SARS-CoV-2 a cikin mutane.
Zai kuma zama da sha'awa a tantance ko akwai wasu masu karɓar karɓar karɓar karɓar karɓar SARS-CoV-2.
HCoV-NL63 ma ya kamata ya kasance yana da alaƙa da ACE2, amma tare da wani ɓangare na S.
Akwai wasu nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau
Hakanan zasu iya zama masu alhakin nasarar kamuwa da wannan cutar a cikin mutane bayan an kamu da ita daga abincin dabbobi.
A cikin ƙwayoyin halitta, an yi amfani da ƙarin ƙwayoyin halitta don sarrafa tasirin watsawar HCV ta hanyar nau'in kwayoyin halitta da kuma wasu abubuwan hanawa.
Wannan furotin na iya hana kamuwa da cutar tsakanin jinsuna biyu tsakanin mutane da kuma wasu abubuwan da ke tattare da HCV, kamar su ƙwai, raƙuma da kuma beraye.
Don samun nasarar kamuwa da cutar HCV, dole ne a karfafa abubuwan da ke tattare da abinci mai gina jiki kuma a juya abubuwan da ke hana abinci mai gina jiki.
A wannan yanayin, ana bukatar a gano abubuwa masu ƙayyadewa na kwayoyin halitta da kuma gano halayensu a cikin wannan muhimmin ɓangaren hulɗar ƙwayoyin cuta da ƙwayoyin cuta.
Ana iya amfani da fasahar CRISPR ta zamani don amfani da SARS-CoV-2 don yin bincike ba tare da nuna bambanci ba game da abubuwan da ke tattare da ƙwayoyin cuta da kuma abubuwan da ke hana su.
Tashin sabon HCV: Komawa zuwa Zero
Bambancin CVO na CIV yana ba da dama ga sabon HCOV.
Saboda haka, cutar ta COV ta zama tushen tushen HCV.
Bugu da ƙari, saurin canji da kuma sake tsara kwayoyin halitta suna haifar da juyin halitta na HCoVs kuma suna aiki a matsayin matakai biyu masu muhimmanci a cikin wannan tsari.
Alal misali, samun ko kuma lalacewar sababbin kwayoyin da ke ba da lambar sunadarai na iya canja yanayin hoto na hoto.
A cikin sunadarai masu taimakawa SARS-CoV, ORF8 ana ganin yana da mahimmanci don karɓa a cikin mutane, saboda ana samun ƙwayoyin cuta masu alaƙa da SARS-CoV yayin da aka ware su, amma ana samun su a cikin ɓoye don yin encoding na ORF8 proteins.
An gano cewa SARS-CoV-2 ya kawar da nucleotide 29 daga cikin jinsunan da aka rarraba a farkon cutar ta cututtukan mutum.
Bayan an cire shi, ORF8 ya raba ORF8a da ORAP8B kuma an dauke shi wani canjin da zai iya taimakawa wajen karfafa hijirar abinci mai gina jiki.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa da zuriyar alpha- da gamma-CoVs, wanda ke nuna ƙananan ƙananan sassan RNA.
An gano wuraren da aka sake haɗuwa a cikin NSP9, da yawa a cikin NSP10, da kuma wasu sassan NSP14.
Hakazalika, an nuna cewa cutar MERS-CoV ta sami abubuwan da suka faru na sake haɗuwa a cikin zuriya daban-daban, kamar yadda aka lura a cikin raƙuman dromedary a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an gano abubuwan da ke faruwa a cikin HCoVs, wanda ke haifar da sake haɗuwa da HCoVs tare da COVs na wasu dabbobi a cikin al'adun su na rashin tsari.
Zaɓin mutum na iya taimakawa wajen canza jinsin kwayar cuta, wanda sau da yawa yakan kawar da kwayar daga matsin lamba na zaɓin da tsarin rigakafin ƙwayar cuta ke amfani da shi.
Wani misali na wannan sakamako shine lalata cikakken tsawon ORF4 a cikin HCoV-229E prototype lineage wanda ya haifar da kawar da nucleotides biyu.
Ana iya samun ORF4 a cikin kwayar cutar HCOC-229E da ke tattare da kwayar cutar kwayar cutar da ke nuna alpha-CoV guda ɗaya, wanda ke haifar da frame shift.
A ƙarshe amma ba duka ba, sabon HCoVs na iya samo asali ne ta hanyar matsin lamba a cikin abincin da suke so.
A bayyane yake cewa, idan an gano bayyanar cututtuka a lokacin da mutum ya kamu da cutar, ko kuma a lokacin da ya kamu da cutar, hakan zai nuna cewa an yarda da juna tsakanin cutar da kuma cutar.
A cewar wasu, masu karɓar cutar ta COVID sun yi nasara wajen yin aiki da kuma motsa jiki.
Alal misali, rashin inganci a cikin kunnawa na amsawar pre-mutuation a cikin ƙwayar cuta yana rage ingancin maganin cututtuka da aka yi ta hanyar COVID.
Bugu da ƙari, an hana aikin kwayoyin halitta na halitta na NKG2/CD94 da kuma ƙananan matakan bayyanawa na manyan kwayoyin halitta na Tissue Compound Class I.
Bugu da kari, yawan adadin kwayoyin oxygen (ROS) masu aiki da yawa da suka samo asali daga aikin maye gurbin kwayoyin cuta suna hana aikin kwayar cutar COV kuma suna haifar da rigakafin ta hanyar exoribonuclease, don haka lokacin da aka shiga cikin sabon abinci mai gina jiki, asalin asalin kwayar cutar yana ba da matsin lamba don zama mai cutarwa.
Ƙari ga haka, zuriyar da ke da cutar ta COVID ta samo asali ne daga sake haɗuwa, wanda ke haifar da sabon furotin ko kuma sabon fasalin furotin don karɓar abinci mai gina jiki.
Saboda haka, ba a samu sababbin cututtukan HCV guda uku ba a cikin shekaru biyu da suka gabata.
Covids suna haifar da rashin lafiya ko bayyanar cututtuka a cikin parasites kamar su wolves ko camels.
Waɗannan riguna masu ƙarfi suna yin kwayar cutar ba tare da kawar da amsa ba.
Dalilin da ya sa aka gano masu dauke da cutar a nan da kuma abin da ke haifar da matsala mai tsanani a cikin kamuwa da cutar ta mutum ba a sani ba.
Alamun cututtuka masu tsanani suna faruwa ne saboda yawan ƙwayar cuta da kuma ƙwayar cytokine, yayin da a inda ƙwayar cuta ta fi ƙarfi, cutar ta fi muni.
A maimakon haka, a cikin masu karɓar kwayar cutar, an cire amsawar rigakafi daga kwayar cutar COVID.
Wannan shi ne hanya mafi kyau na magance cutar ta SARS-CoV-2 don hana kamuwa da cutar.
Interferon yana da tasiri sosai a cikin ƙwayar cuta.
Saboda haka, a kalla a farkon farkon kamuwa da cutar SARS-CoV-2 a cikin mutane, gudanar da Interferon Type-I ya kamata ya kasance mai amfani.
Bugu da ƙari, an gano cewa activation na NLRP3 mai ƙyama a cikin furen yana da lahani.
Saboda haka, MCC950 co-sandaman na NLRP3 mai yaduwa zai iya zama da amfani wajen magance COVID-19.
Wannan ya haifar da SARS-CoV-2 wanda ya biyo bayan tsarin da aka saba amfani da shi, wanda ya haifar da SARS-CoV da MERS-CoV.
A wani bangare kuma, an gano cewa kashi 95 cikin 100 na beta-CoVs na Cloves suna da haɗin kai tsakanin su da SARS-CoVs, yayin da kashi 96 cikin 100 na Cloves suna da haɗin kai tsakanin su da SARS-CoV-2.
Amma, duk da cewa an gano cewa dabbobi masu kama da SARS-CoV suna da kyau a kasuwa, ba a gano kayan aikin da ke tsakanin SARS-CoV-2 ba.
Ana iya gano cewa akwai wani abu mai ban mamaki game da SARS-CoV-2 a cikin pangolin beta-CoV, wanda ya nuna cewa pangolin na iya zama ɗayan masu tsaka-tsaki ko kuma cewa pangolin beta-CoV ya ba da gudummawa ga rigakafin kwayoyin halitta a cikin sigar ƙarshe ta SARS-CoV-2.
Amma, tambayar ita ce, babu wata hujja da ta nuna cewa SARS-CoV-2 ta kasance ko dai ta sani ko ta hanyar hadari.
A sakamakon barkewar cutar SARS-CoV-2 da ta faru kwanan nan, an sake samun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun sanannun
Nazarin da aka yi a cikin dabbobi da kuma wasu dabbobi ya canza fahimtarmu game da muhimmancin kwayar cutar HCoV a cikin dabbobi da kuma mutum.
Shaidar yaduwar ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
An fara kamuwa da cutar ta SARS-CoV ta hanyar hulɗa tsakanin mutane da cats a cikin kasuwa, rufe kasuwar abincin teku da kashe cats a can, wanda ya kawo ƙarshen cutar ta SARS-CoV.
Saboda wannan dalili, dole ne a cire panoglycine daga kasuwar abincin teku don hana yaduwar dabbobi, saboda gano cewa akwai alaƙa da SARS-CoV-2 tsakanin jinsunan da yawa na panoglycine beta-CoV.
Koyaya, bincike na gaba ya kamata ya bayyana ko kuma yadda SARS-CoV-2 ya kamu da mutum daga pangolins da sauran dabbobi masu tasowa.
A gefe guda kuma, MERS-CoV ya kasance a cikin raƙuman dromedary na dogon lokaci.
Yana da muhimmanci a cikin sufuri na raƙumi, kuma yana da mahimmanci a cikin nama, madara, fata da kuma kayan ulu ga mazauna yankin.
Sun yi yawa a Gabas ta Tsakiya da Afirka.
Kamar yadda aka yi a kasuwar namun daji ta kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2, ba zai yiwu a yi hadaya da dukkan raƙuman don sarrafa cutar ba.
Don hana barkewar cutar, dole ne a dauki cikakken tsarin samar da allurar rigakafi mai tasiri don kamara, tare da hada-hadar sauran matakan hana kamuwa da cutar.
Domin ba za mu iya kawar da waɗannan ƙwayoyin ba, za mu iya haifar da sabon nau'in cutar da zai iya haifar da barkewar cutar.
Akwai wasu dabbobi da ke yawo a cikin daji.
Musamman, akwai bambancin dabbobi da yawa a cikin cutar COVID.
Akwai dama da dama ga wadannan cututtukan dabbobi na iya tasowa da kuma sake haɗuwa, wanda zai haifar da sabon nau'in cututtukan da ke da yawa da kuma/ko kuma na mutuwa a cikin mutane a nan gaba.
Don rage hulɗa tsakanin mutane da dabbobi, a wasu wurare a China, al'adun cin dabbobi na daji dole ne a bar su.
A cikin tsarin SARS, MERS da COVID-19, dole ne a shirya da kuma shirya shirin amsawa.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniya.
Suna rayuwa har sai sun sami damar yin yawo a cikin gidajensu na halitta.
Ko da yake dabbobi masu fashi suna da halaye masu yawa na yaduwar ƙwayoyin cuta, idan aka horar da mutane su guji dabbobi masu fashi da sauran jinsunan namun daji, za a iya rage hulɗarsu da mutane.
Don samun kyakkyawar fahimtar rayuwar COVID da kuma yanayin rayuwarsu, ana buƙatar ci gaba da lura da dabbobi masu shayarwa, wanda zai iya taimakawa wajen hana kamuwa da cutar daga dabbobi zuwa mutane da kuma barkewar cutar a nan gaba.
A ƙarshe, kasancewa a nesa da yanayin yanayin yanayin da kwayoyin halitta ke ciki shine hanya mafi inganci don hana ƙwayoyin cuta.
Har yanzu akwai wasu abubuwa da ba a gano ba game da cutar SARS-CoV-2 da aka samo daga dabbobi.
Da farko, idan cutar SARS-CoV-2 ta kamu da cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta ta ta hanyar cutar ta ta ta ta ta hanyar cutar ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta
Na biyu, idan dabbobi masu rarrafe sun taka rawa kai tsaye wajen yaduwar mutum, dole ne mutane su yanke shawarar yadda suka shiga cikin hanyar da ta sa su kamu da cutar.
Na uku, idan dabbobi masu shayarwa na uku sun kasance masu matsakaici, dole ne a bayyana yadda suka yi hulɗa da jinsuna daban-daban, kamar mutane, da dabbobi masu fashi da kuma pangolins.
A ƙarshe, ana buƙatar a bincika da kuma gwada wasu dabbobi masu shayarwa, ciki har da dabbobi masu shayarwa, don yiwuwar su zama masu saurin kamuwa da SARS-CoV-2.
Idan dabba ce mai kama da dabba, ko kuma dabba ce mai kama da dabba, ko kuma dabba ce mai kama da dabba mai kama da SARS-CoV-2 ko kuma ƙwayar cutar da ta riga ta haifa, za a iya gano ta a cikin abincin da suke da shi a nan gaba.
Ci gaba da bincike a wannan yanki zai kawo ci gaba da ingantacciyar hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, da kuma muhimman bayanai game da rigakafi da kuma sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idodin bincike na "masu sharhi" da "masu tabbatar da" COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagororin saurin shawara don ganewar asali na cutar Coronavirus (2019-nCoV) ta 2019, kuma waɗannan jagororin sun sanya mu zama tushen tushen tushen mu da kuma kyakkyawan tsari don yaƙar cutar a duniya.
Koyaya, cutar Coronavirus 2019 (COVID-19) sabuwar cuta ce. Saninmu da iliminmu suna ƙaruwa a hankali dangane da binciken bincike da ƙwarewar aikin asibiti a halin yanzu, saboda haka, ana sabunta dabarun ganewa da magani akai-akai.
A cikin wannan wasikar, an ba da wata sanarwa game da jagorarmu kuma an ba da sabuwar hanyar ganewar asali ta COVID-19 (salla na bakwai) "Masu Amfani da Magana" da "Masu Amincewa" ta hanyar sabuwar ganewar asali da magani ta hanyar Kwamitin Lafiya na Jama'ar Sin.
A watan Disamba na shekarar 2019, an samu barkewar cutar Coronavirus ta 2019 (2019-nCoV), wacce aka sake suna da ita da cutar Coronavirus Disease 2019 (COVID-19), kuma an sake suna da cutar da ake kira Civiary Acute Syndrome Coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin cutar cututtuka.
Don yaki da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawara mai sauri kuma an buga su akan layi a cikin Military Medical Research a ranar 06 ga Fabrairu, 2020.
Tun lokacin da aka wallafa shi, ya samu karbuwa sosai.
Ka lura cewa ko da yake COVID-19 sabon cuta ne, ilimin da muke da shi na wayar da kan jama'a yana ƙaruwa a hankali dangane da binciken da ake samu da kuma ayyukan asibiti; saboda haka, ana sabunta dabarun ganewa da magani.
Misali, an buga duka fito na jagororin bincike da magani na COVID-19 da aka buga ta kwamitin kula da lafiyar jama'ar kasar Sin (NCHR) tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020 tare da wasu canje-canje a cikin mahallin.
Yanzu, ka'idodinmu sun samu bayani daga Zhou et al. sun gabatar da shawarwari masu sauki bisa ga kwarewarsu ta asibiti.
Ayyukansa sun kara sabbin hujjoji ga ka'idodinmu kuma sun ba da muhimmiyar ma'ana ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Muna godiya da kuma yaba wa aikinsa mai girma.
Duk da haka, aikinsa yana buƙatar sabuntawa daidai da COVID-19 (Test 7th Edition) da kuma sabon binciken bincike da jagororin magani.
A cewar Fassarar ta bakwai (3 ga Maris, 2020), don tabbatar da shari'ar da ake zargi, ana buƙatar haɗa kowane ɗayan abubuwa na tarihin cututtukan cututtuka tare da abubuwa biyu na binciken cututtuka, ko kuma idan babu wani tarihin cututtuka na asali, ana buƙatar kammala abubuwa uku na binciken cututtuka.
Tarihin kamuwa da cuta: (1) Tarihin tafiya ko zama a birnin Wuhan da kewaye da shi, ko a cikin kwanaki 14 kafin bayyanar cututtuka, ko a yankin da aka samu rahoton kamuwa da cutar COVID-19; (2) Tarihin tuntuɓar mutane da ke dauke da cutar SARS-CoV-2 (ciki har da gwajin kwayar cutar nucleic acid); (3) Tarihin tuntuɓar mutane da ke dauke da cutar (kamar su, ofishin, aji a makaranta, da sauransu); ko kuma daga birnin Wuhan da kewaye da shi, ko kuma daga wasu al'ummomin da suka samu kamuwa da cutar COVID-19 a cikin kwanaki 14 da suka gabata, ko kuma daga wasu al'ummomin da suka fara samun cututtuka, ko kuma daga wasu al'ummomin da suka samu kamuwa da cutar, kamar su zazzabi ko kuma daga wuraren da ake samun cututtuka na numfashi; (4) Tarihin tuntuɓar mutane da suka kamuwa da cutar (kamar a gida, ofishi, aji, da sauransu, da kuma daga cikin kananan al'ummomin da suka kamuwa da cutar da cutar da suka kamuwa da cutar da cutar, ko kuma daga cikin kananan cututtuka da suka kamuwa da cutar da cutar da suka kamuwa da cutar da cutar da cutar da ake fama da cutar da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cuta da cutar ta kamuwa da cuta da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamuwa da cutar ta kamu da cutar ta kamu da cutar ta kamuwa da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da cutar ta kamu da ta kamu da ta kamu da ta kamu da cutar ta kamu da ta kamu da ta kamu da ta kamu da ta kamu da ta kamu da ta
Abubuwan da aka gano a asibiti: (1) zazzabi da/ko alamun numfashi; (2) bayyanar hoto na kamuwa da COVID-19; (3) nuna yawan adadin ƙwayoyin fari a cikin farkon matakin da ya rage, ko kuma ya rage yawan lymphocytes.
Ana buƙatar gano shari'ar da aka tabbatar bisa ga wata sanarwa ko kuma wata sanarwa ta hanyar tabbatar da cewa akwai wata sanarwa ko kuma wata sanarwa ta hanyar tabbatar da cewa: (1) gwajin PCR na ainihi don SARS-CoV-2 ya zama mai kyau; (2) cikakken tsarin kwayoyin cuta na kwayar cutar da aka sani don nuna babban jinsin kwayar cutar; (3) SARS-CoV-2 ya zama mai kyau ga takamaiman IgM antibodies da IgG antibodies a cikin gwajin magani; ko kuma sauyawa daga mummunan zuwa tabbataccen kwayar cutar IgG na SARS-CoV-2, ko kuma ninkawa ≥4 a cikin matakan warkewa a cikin wani mataki na tsanani.
Za mu ga cewa an kara gwajin PCR na ainihi na nucleic acid a cikin numfashi ko a cikin jini a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An kara da cewa an gano cututtukan jini a cikin na hudu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan an kara da cewa an kara da tabbacin cutar a cikin na bakwai.
Waɗannan canje-canjen sun dogara ne akan aikin yau da kullun na masu bincike, waɗanda suka haɓaka wadatar samfurori daban-daban, kuma sun goyi bayan samun sakamako mai kyau na ƙwayoyin cuta na musamman a cikin ka'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin hujjoji da suka tuna mana mu yi hankali da marasa lafiya masu alamun bayyanar cututtuka da kuma rashin lafiya.
Saboda haka, Zhou et al. ya kamata su sabunta jadawalin su, domin suna rarraba mutum ba tare da alamun asibiti ba a matsayin "ƙarancin haɗari".
Ana buƙatar tabbatar da tsarin ƙididdiga a cikin ƙarin aikin asibiti da nazarin.
Don kammala, muna fatan cewa akwai karin hujjoji masu kai tsaye da za su iya ba da ra'ayoyin masu karatu.
Don gano shari'ar da ake zargi da kuma tabbatar da shari'ar, dole ne mu bi kuma mu bi sabon jagororin kasarsa.
Ƙungiyarmu za ta sabunta jagororinmu a kan lokaci don taimakawa.
Bangladesh ta samu sabbin mutane biyar da suka mutu sakamakon COVID-19, wanda ya kai matsakaicin adadin a cikin rana guda.
Jiya, Bangladesh ta tabbatar da sabbin mutum biyar da suka mutu a rana daya sakamakon COVID-19.
Wannan kwayar cuta ce ta fi yawan mutuwar mutane a rana.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa, akwai mutane 114 da suka kamu da cutar da suka kamu da cutar, da kuma mutane 33 da suka warke daga cutar da suka kamu da cutar da ke zaune a gida.
An samu mutuwar mutane 17 a total.
A wani rahoto na kan layi, Daraktan IEDCR, Dakta Mirzaje Sabrina Flora, ya ce, cikin wadanda suka mutu akwai maza hudu da mace daya.
A cewar Dr. Mirzade, akwai wasu mutane biyu da suka kai shekaru 60, wasu daga cikin su 51 zuwa 60, kuma wani daga cikinsu yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu sun kasance 'yan garin Dhaka.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta bayyana COVID-19 a matsayin cuta.
Jami'an asibitin sun shaida wa wani kamfanin dillancin labarai na gida, Adolu Agency cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ake jinya a asibitin Amitra dake Kuwait.
A cikin wani sanarwar bidiyo ta yanar gizo a ranar Asabar, Ministan Sufuri da Rukunin Ruwa na Bangladesh, Obaidul Kwadar ya ce, za a rufe zirga-zirgar jama'a har zuwa ranar Asabar mai zuwa, fiye da yadda aka shirya a baya.
An shirya rufe zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya rufe shi a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyakin da ake bukata, kamar su magani, man fetur da kuma kayayyakin da ake bukata.
A ranar 8 ga watan Maris, Bangladesh ta fara samun kamuwa da cutar COVID-19, wanda ya shafi mutane biyu da suka dawo daga Italiya da matar wani daga cikinsu.
A ranar 19 ga Maris, dukansu sun warke.
SARS-CoV-2 ya kai kamuwa da cutar miliyan daya a duniya.
Bayanai daga Jami'ar John Hopkins sun nuna cewa a ranar Alhamis, jimlar adadin mutane da suka kamu da cutar SARS-CoV-2 ta wuce miliyan daya a duniya.
Akalla mutuwar 52,000 an danganta su da COVID-19, cutar da ke haifar da cutar coronavirus.
Wannan muhimmin batu ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar ta farko da kuma mutuwar da ta shafi cutar ta korona a Zambia.
Koriya ta Arewa ta ce a ranar Alhamis ta kasance daya daga cikin kasashe da suka tsira daga kamuwa da cutar.
Har zuwa jiya, WHO ta tabbatar da cewa akwai mutane 1,051,635 da suka kamu da cutar, gami da mutum 79,332 a cikin sa'o'i 24 kafin karfe 10.00 na safe na Central European Time (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu karin mutane 244,000 da suka kamu da cutar, wanda ya hada da mutuwar 5,900.
Labarin CBS News, yana mai da hankali ga bayanan jami'ar John Hopkins, ya ce, an kashe mutane fiye da 1,000 a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duniya, an sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow, Sergei Sobyanin, ya dage dokar kulle har zuwa 1 ga Mayu.
A matakin kasa, Shugaban kasar Vladimir Putin ya bayyana cewa har zuwa ranar 30 ga watan Afrilu, Rasha za ta ci gaba da samun albashi har ma da ba ta tafi aiki ba.
Majalisar dokokin Portugal ta kara da cewa an yi dokar ta baci ta kasa da ta kasa har kwana 15, ta amince da ƙuduri 215 da aka kada, 10 sun yi watsi da shi, kuma ɗaya ya yi adawa da shi.
Saudiyya ta yi amfani da dokar hana fita ta yini a cikin biranen Makka da Madina: a baya, dokar hana fita ta kasance daga karfe 3 na rana zuwa 6 na safe.
Thailand ta shirya yin dokar hana fita daga 10 na dare zuwa 4 na safe.
Gwamnan jihar Ohio, Mike Devine, ya kara dokar hana fita zuwa ranar 1 ga watan Mayu.
Duka shaguna a Ostiraliya sun rage yawan kayan wanka a kowace ma'amala.
A ranar Lahadi da Asabar da yamma, wani kamfanin sayar da kayayyaki na Australiya, Woolworths & Coles, ya rage takunkumin sayen takardar wanka zuwa kashi biyu a jere da kuma a kasa da kasa a matsayin tanadi daya a kowace ma'amala.
ALDI ta kuma fara aiwatar da iyakar fakitin guda a ranar Litinin.
An sanya waɗannan iyakokin a matsayin saƙo a cikin rajistar rajista da kuma shafin Facebook na sarkar.
Idan mutane suna bukatar su keɓe kansu, masu siye suna ajiye su saboda tsoron COVID-19 suna sake ajiye su.
A ranar Laraba, kamfanin Woolworths ya kuma iyakance farashin kaya zuwa fakiti daya a kowane tsari.
Wannan canjin ya biyo bayan dokar hana karbar kudade ta hudu da Woolworths da Coles suka gabatar a ranar 4 da 5 ga watan Maris, bi da bi.
Coles, a cikin sanarwar da ya yi a ranar 8 ga Maris, ya ruwaito cewa za a hana duk wani kaya guda hudu, "ma'aikata da yawa suna sayar da kayayyaki a cikin sa'a daya bayan bayarwa", kuma ya ce bukatar "ba ta da iyaka", yayin da ALDI, a shafinsa na Facebook a ranar Talata, ya kira shi "ba zato ba tsammani".
Wani mai magana da yawun kamfanin Woolworths ya ce, "an samu karuwar tallace-tallace a makon da ya gabata".
Costco's store a Canberra ta kuma rage adadin kaya biyu a makon da ya gabata.
Don rage rashi, Coles ta ba da umarni ga manyan fakitoci daga masu samarwa kuma ta ƙara yawan isar da sako. Woolworths ta ba da umarni don ƙarin ajiya, yayin da ALDI ta ba da isasshen isasshen isasshen isasshen isasshen isasshen ranar da aka shirya.
Shugaban kungiyar sayar da kayayyaki ta Australiya, Russell Zimmerman, ya ce, 'yan kasuwa sun yi kokarin kara yawan kayayyakin, amma an hana su zuwa gida saboda takunkumin da majalisar dokokin kasar ta kafa a kan lokacin da za a kawo kaya.
Sun yi tsammanin cewa farashin samarwa zai karu, saboda masu samarwa suna bukatar su biya bukatar, kuma a cikin ƙananan adadin, suna bukatar su biya bukatun.
A ranar Talata, ADLI ta sanar da cewa saboda saurin jigilar kaya, wasu shaguna ba za su iya gudanar da wani abu na musamman a ranar Laraba ba.
A wani rahoto da News.com.au ta fitar, Dr. Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce, shaguna suna cike kayayyaki a kowace rana.
Sun ce takardar gidan wanka abu ne mai girma, wanda ke kawo karancin ajiya a cikin adadi, kuma, lokacin da aka sayar, yana zubar da babban adadin sararin aljihun.
Coles da Woolworths sun nuna cewa idan akwai abubuwa da yawa a kan kai, kamar kayan wanka da kuma kayan wanka, kuma akwai su da yawa, za ka rage yiwuwar tashin hankali, Russell Zimmerman ya ce, a cewar ABC News.
Wani mai kera takardar gidan wanka mai sake amfani da ita mai suna Who Gives a Crap ya ce ya rasa kayayyakin da yake da su.
Rahotanni daga News.com.au sun ce Kimberly-Clark, wanda ke kera Kleenex Toilet Tissue, da Solaris Paper, wanda ke kera Sorbent, sun tabbatar da cewa suna aiki 24/7 don kiyaye wadatarsu.
Domain.com, wani shafin intanet na gidaje, ya ruwaito cewa wasu masu sayar da dukiya a Melbourne suna ba da takardar wanka kyauta ga mai yin hayar da ya fara yin hayar a lokacin da ake yin hayar, lokacin da aka yi wani hayar da ba a yi ba saboda masu sayen suna da lokaci a lokacin babban ranar ma'aikata.
A cikin labaran da aka buga a ranar Alhamis na NT News, Darwin ya haɗa da shigar ruwa guda takwas don a buga su a kowace rana, a yanke su kuma a yi amfani da su a matsayin takarda ta gidan wanka.
A cewar wani rahoto na ABC Australia na 3 ga watan Maris, shagunan sun kasance da farko suna adawa da sanya takunkumi, inda suka ce ba su da wani shiri na sanya takunkumi kan sayayya.
Russell Zimmerman ya ce akwai bukatar kayayyaki masu yawa da suka hada da masks, sanitizers, dryware, handwashes da kuma flour.
Hakazalika, a waje da Australia, a ranar Lahadi da yammacin, babban kanti na yanar gizo na Burtaniya Ocado ya iyakance sayen takardar bayan gida ta Andres zuwa fakitin 12-roll guda biyu.
Hukumar lafiya ta duniya ta bayyana COVID-19 a matsayin annoba ta duniya
Hukumar lafiya ta duniya ta duniya (WHO) ta bayyana barkewar cutar COVID-19 a ranar Laraba a matsayin cuta mai rikitarwa da cutar coronavirus, SARS-CoV-2.
Ko da yake kalmar "matsananci" ba ta nufin yadda za a iya gano yawan cutar ba, amma ta nuna cewa gwamnatoci suna bukatar su ɗauki mataki mai kyau.
Dukkanin kasashe na iya canza kudin wannan annoba ta duniya.
Idan al'ummai suka gane wannan, za su yi gwaji, su warke, su ware, su ja da baya, su kuma haɗa kan al'ummarsu a wannan yaki, in ji Daraktan WHO, Tedros Adhanom Gebraussus.
Muna matukar damuwa da yadda ake yadawa da kuma yadda ake yin amfani da shi sosai da kuma yadda ake yin amfani da shi sosai.
A cewar Dr. Tom Freedden, tsohon shugaban cibiyoyin kula da cututtuka na Amurka, wannan annoba ce ta duniya da ba a taɓa gani ba.
A cikin wata sanarwa da ya wallafa a cikin CNN a watan Fabrairu, ya ce, "Ba a gano wani kwayar cutar da ta shafi numfashi ba, banda cutar mura, tun daga farkonta har zuwa yaduwar ta duniya".
Gabreyesus ya bayyana wannan ra'ayi, yana cewa, "Ba mu taɓa ganin annobar korona ta haifar da mummunan yanayi a duniya ba".
Ya kara da cewa, "Ba mu taba ganin wata cuta ta duniya da za a iya sarrafawa a lokaci guda ba".
Yanayin annobar ta duniya ya biyo bayan shawarar WHO ta bayyana barkewar cutar a matsayin gaggawa ga lafiyar jama'a a watan Janairu.
Darakta Anthony Fosse, shugaban cibiyar kula da cututtuka masu yaduwa da cututtuka na kasa a Amurka, ya ce game da annobar, "Tabbas, yanayin zai kara muni".
A ranar Alhamis, Associated Press ta ruwaito cewa a duniya akwai akalla shari'o'i 126,000 na COVID-19 wanda ya haifar da mutuwar sama da 4,600.
Cutar COVID-19 ta kasance sanadiyyar cutar COVID-19 ta duniya ta 2019-20 wanda ya haifar da cutar ta SARS-CoV-2 wanda ke haifar da mummunan cutar ta numfashi.
An gano barkewar cutar a Wuhan, China a watan Disambar 2019, an bayyana ta a matsayin gagarumin gaggawa na lafiyar jama'a na duniya a ranar 30 ga Janairu, 2020, kuma an san ta da cutar ta duniya daga 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a cikin kasashe da yankuna 210 da suka haifar da kusan mutuwar 97,000.
Kusan mutane 3,64,000 ne suka warke.
A duniya, an kiyasta cewa China tana da kashi 4 cikin dari na mutuwar, daga Aljeriya zuwa 13.04 cikin dari zuwa New Zealand zuwa 0.08 cikin dari.
Abubuwan da ake gani a yau sun ƙunshi zazzabi, tari, da kuma ciwon daji.
A cikin cututtukan da suka shafi cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Lokaci daga kamuwa da cuta zuwa bayyanar cututtuka yana da kusan kwanaki biyar, amma zai iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko maganin rigakafi na musamman da aka sani.
Maganin farko shine maganin alamun bayyanar cututtuka da kuma na asali. Maganin rigakafin da aka ba da shawarar ya haɗa da wanke hannu, rufe baki yayin tari, nisantar da kai, kula da kai da keɓe kai daga mutanen da ake zargin suna da cutar.
Jami'ai a duk faɗin duniya sun amsa ta hanyar hana tafiya, killacewa, kulle-kulle, sarrafa haɗari a wuraren aiki da rufe ayyukan sabis.
Wannan annobar ta haifar da matsanancin warewar zamantakewa da tattalin arziki a duniya. Wasanni, ayyukan addini, siyasa da al'adu sun jinkirta ko kuma an soke su, kuma akwai babbar karancin kayayyaki da aka samu saboda cinikin da ake yi.
Makarantu da jami'o'i a kasashe 193 sun rufe a matakin ƙasa ko na gida, kuma hakan ya shafi kusan kashi 99.4% na yawan ɗaliban duniya.
An samu karuwar rashin gaskiya game da cutar ta hanyar yanar gizo, kuma akwai wasu lokuta da ake jin tsoro ko nuna bambanci da kuma nuna bambanci ga mutanen kasar Sin, da sauran mutanen Gabas da kudu maso gabashin kasar, da kuma mutanen da suke kama da su, da kuma yankunan da ke da alamun cutar.
Rage yawan tafiye-tafiye da kuma rufe manyan masana'antu ya rage yawan gurɓataccen iska da kuma fitar da iskar carbon.
Jami'an lafiya a Wuhan, China (babban birnin lardin Hubei) sun bayar da rahoton wani lamari na cutar huhu da aka samu daga wani dalili da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an fara binciken a farkon watan Janairu, 2020.
Yawancin cututtukan sun kasance a cikin kasuwancin sayar da abincin teku na Hunan, saboda haka ana ganin cewa kwayar cutar ta samo asali ne daga dabbobi.
Wannan sabon kwayar cutar da aka gano da ke haifar da cutar ta SARS-CoV-2 tana da alaƙa da cutar Corona na fuka-fuki, cutar Corona ta cats da aka ci da SARS-CoV. An gano cewa mutumin da aka sani da farko da ya fara samun alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba shi da alaƙa kai tsaye da rukunin kasuwar taro na baya.
A cikin rukunin farkon shari'o'in da aka samu a shekarar 2019, kashi biyu bisa uku na shari'o'in da aka samu sun danganta ga kasuwa.
Rahoton da ba a tabbatar ba na Morning Post na Kudancin China a ranar 13 ga Maris, 2020 ya nuna cewa wannan na iya zama farkon shari'ar mutum mai shekaru 55 a lardin Hubei wanda aka lura da shi zuwa 17 ga Nuwamba, 2019. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa yayin da sabbin shari'o'in suka ragu a China amma suka karu a Italiya da Koriya ta Kudu, adadin sabbin shari'o'in da aka samu a waje da China ya karu fiye da na kasar Sin a karon farko.
Ana iya samun rahotanni da yawa a cikin ƙananan bayanai, musamman ma a cikin waɗanda suka nuna alamun rashin lafiya.
A ranar 26 ga Fabrairu, an samu karamin adadin shari'o'i a tsakanin matasa, wadanda shekarunsu 19 ko ƙasa da haka sun kai kashi 2.4% na shari'o'in a duniya. Patrick Valance, babban mai ba da shawara kan likitancin Burtaniya, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya suna bukatar kamuwa da cutar kafin su sami rigakafin gaba daya.
Maganganun suna nufin yawan mutanen da aka gwada su da COVID-19 kuma waɗanda aka tabbatar sun tabbata sun kasance masu kyau a ƙarƙashin ƙa'idodin hukuma.
Har zuwa 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawanta, kuma yawancin ƙasashe kamar Italiya, Netherlands, Spain da Switzerland sun yi amfani da manufofin hukuma na kada a gwada waɗanda ke da alamun cutar.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa, a kasar Sin, kimanin kashi 86 cikin dari na wadanda suka kamu da cutar COVID-19 ba a gano su ba har zuwa 23 ga watan Janairu, kuma wadanda ba su da rubutu ba ne suka zama tushen kamuwa da cutar a kashi 79 cikin dari na wadanda suka kamu da cutar.
Wani bincike na kididdiga da aka fitar a ranar 30 ga watan Maris ya nuna cewa adadin kamuwa da cutar a Italiya ya fi yawan wadanda aka samu.
Matsayin farko na yawan haihuwa game da COVID-19 (R0) ya kasance 1.4 zuwa 2.4.
Wani bincike da cibiyar kula da cututtuka ta Amurka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da suka kamu da COVID-19 sun warke.
Kuma a cikin wadanda ba su da bayyanar cututtuka, tsawon lokacin da suka fara zuwa mutuwa ya kai daga kwanaki 6 zuwa 41, kuma mafi yawan kwanaki 14 ne.
Kusan mutane 97,000 ne suka mutu sakamakon COVID-19 a ranar 10 ga Afrilu, 2020.
Kashi 80% na mutuwar da aka samu a kasar Sin a ranar 5 ga Fabrairu sun kasance a cikin shekaru 60, kuma kashi 75% na waɗanda suka kamu da cututtukan zuciya da suka hada da ciwon sukari tare da matsalolin kiwon lafiya na baya.
A gaskiya, mutuwar COVID-19 na iya zama mafi girma, saboda ba za ta iya haɗa da waɗanda ba a gwada su ba, misali, waɗanda ke mutuwa a gida, a cikin asibiti, da sauransu.
Ƙananan bayanai a Italiya sun nuna cewa adadin mutuwar da aka samu a lokacin annobar ta duniya ya ninka adadin mutuwar COVID sau 4-5 fiye da na hukuma.
Wata mai magana da yawun cibiyar kula da cututtuka ta Amurka (CDC) ta yarda cewa, "Mun san cewa [ƙididdigar mutuwar da aka haɗa] ba ta da kyau", sanarwa ne da ba a tabbatar da ta ba da rahoton raguwar ƙididdigar a Amurka. Irin wannan ƙididdigar ƙididdigar ta faru sau da yawa a cikin annobar, kamar yadda ta faru a lokacin cutar H1N1 Swine Flu ta 2009.
Wannan shi ne karo na farko da aka samu mutuwar a waje da kasar Sin a ranar 1 ga watan Fabrairu a Philippines, kuma a Faransa ne aka samu mutuwar farko a waje da Asiya a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da 12 a Iran da Koriya ta Kudu da kuma Italiya.
A duk nahiyoyin da suka rage sai Antarctica, an samu mutuwar fiye da 40 a cikin kasashe da yankuna fiye da 13 ga watan Maris.
Waɗannan kididdigar sun bambanta ta hanyar yankuna da lokatai, kuma suna shafar yawan gwaje -gwajen da aka yi, yanayin tsarin kiwon lafiya, zaɓin magani, tsawon lokacin da ya barke da kuma yanayin yawan jama'a; misali, shekaru, jinsi da kuma lafiyar gaba ɗaya.
A cewar bayanan da Jami'ar Johns Hopkins ta bayar, a ranar 10 ga Afrilu, 2020, yawan mutuwar da kamuwa da cutar a duniya ya kai kashi 6.0% (97,039/1,617,204).
Wannan yawan ya bambanta da yankuna.
A kasar Sin, adadin mutuwar ya ragu daga kashi 17.3% (daga 1 zuwa 10 ga Janairu 2020 ga wadanda ke da alamun cutar) zuwa kashi 0.7% (daga 1 ga Fabrairu 2020 ga wadanda ke da alamun cutar). Sauran hanyoyin sun hada da CFR, wanda ke nuna yawan wadanda suka kamu da cutar (masu kamuwa da cutar da ba a gano su ba) da suka kamu da cutar.
Wannan adadi ba shi da iyaka a lokaci kuma yana bin wani yanki na al'umma har sai an warware cutar.
Yawancin cibiyoyin ilimi sun yi ƙoƙari su lissafa waɗannan kididdigar don wasu alƙaluma.
Bisa ga bayanan da aka samu daga Jami'ar Oxford, Cibiyar Nazarin Magunguna ta kiyasta cewa yawan mutuwar da ke tattare da kamuwa da cutar ta duniya ya kai kashi 0.1% zuwa 0.39%.
Wannan babban darajar ta dace da gwajin farko na COVID-19 a cikin bazuwar a Jamus da kuma nazarin kididdiga wanda ke nazarin tasirin gwajin akan CFR.
WHO ta tabbata cewa za a iya sarrafa cutar ta duniya.
Mafi girman matakin da kuma matsakaicin lokacin fashewar ba a sani ba kuma zai iya bambanta da wurin.
Macije Boney na Jami'ar Jihar Penn ya ce, "Idan ba a bincika ba, cutar za ta daina tashi zuwa wani matakin kuma za ta rage idan an rage yawan masu karɓar cutar.
Amma a yanzu ba za mu iya yin hasashen lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhang Nanshang, ya yi jayayya cewa idan duk ƙasashe suka fara bin shawarar WHO na hana yaduwar cutar, "za a kammala wannan a watan Yuni".
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Lafiya da Lafiya ta Tropical ya bayyana cewa ana iya ganin SARS-CoV2 zai yi yaduwa cikin shekara guda zuwa biyu".
Wani bincike da Neil Ferguson na Imperial College ya gudanar ya nuna cewa, kula da nesa da sauran matakan "zai dauki watanni 18 ko fiye kafin a samu allurar rigakafi".
William Shaffner na Jami'ar Vanderbilt ya ce, "Yana da wuya a kawar da cutar gaba ɗaya, domin tana da saukin kamuwa da cutar", saboda haka "za ta zama wata cuta ta yanayi kuma mai yiwuwa za ta dawo kowace shekara".
Rashin guba ko kuma tsanani na dawowa ya dogara da ƙarfin jimiri da kuma yadda za a canza shi.
Alamomin COVID-19 ba su da mahimmanci kuma ba za a iya ganin alamun a cikin mutanen da suka kamu da cutar ba.
Abubuwa biyu da suka fi kama da juna sune zazzabi (88%) da kuma tari (68%).
Alamomin da ba a lura da su ba sun haɗa da gajiya, kumburi a cikin numfashi, rashin wari, ciwon jijiya, ciwon jijiya da jijiya, ciwon hanci, ciwon kai, sanyi, kumburi, zubar da jini, ciwon kumburi ko rashin iskar oxygen. WHO ta ce mutum ɗaya cikin shida a cikin waɗannan ya kamu da rashin lafiya mai tsanani kuma yana fama da matsalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa; misali, wahalar numfashi, ciwon kirji ko ciwon hankula, rikicewar zuciya, tashin hankali da kuma fuska ko lebe mai launin shuɗi; idan akwai alamun, ana ba da shawarar samun magani na gaggawa. Idan cutar ta ci gaba, zai iya haifar da mummunan cutar huhu, rashin jin daɗin numfashi, rauni, raunin jiki, da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar ba za su iya nuna alamun cutar ba, ba za su iya samun alamun likita ba amma sakamakon gwajin zai tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda suka yi hulɗa da mutanen da suka tabbata cewa suna da kamuwa da cutar su kamata a lura da su sosai kuma a bincika su don kawar da yiwuwar kamuwa da cutar.
Masana kasar Sin sun kiyasta cewa yawan marasa bayyanar cututtuka zai iya kaiwa kashi 44 cikin dari.
A cikin yanayin yau da kullun, lokacin da kwayar cutar ta shiga jiki (lokacin fara cutar daga kamuwa da cuta zuwa bayyanar cututtuka) yana daga kwana 1 zuwa 14, yawanci yana da kwanaki biyar. Misali na rashin tabbas shine cewa yawan mutanen da suka rasa ƙanshi a cikin COVID-19 an kiyasta cewa da farko sun kasance 30% kuma daga baya sun ragu zuwa 15%.
Har yanzu ana neman wasu bayanai game da yadda cutar ta yadu.
Ana ganin cewa cutar tana yaduwa ne saboda kusanci da ƙananan saukad da ke faruwa yayin tari, taɓawa ko magana, yayin da kusanci ke tsakanin mita 1 zuwa 2 (ƙaffi 3 zuwa 6).
A lokacin binciken, an gano cewa saukad da za su iya tafiya daga mita 4.5 (15 ft) zuwa mita 8.2 (27 ft) saboda tari ba tare da rufe bakinsu ba.
Wasu sun ce, ƙananan saukad da da suke fitowa daga bakin lokacin magana za su iya kamuwa da cutar ta hanyar ƙananan saukad da da ke cikin iska na dogon lokaci. Ko da yake ba a samar da wannan kwayar a cikin iska ba, saukad da ke cikin numfashi na iya zama lokacin da muke numfashi, ko kuma lokacin da muke magana.
Za a iya shigar da waɗannan saukad da a cikin bakinsu ko hancin mutane ko kuma a cikin huhu ta hanyar numfashi.
Aikin likita kamar intubation ko kardio-pulmonary rescitation zai iya yin amfani da iskar da aka samu a cikin numfashi don yadawa ta iska.
Idan mutum ya taɓa wani gurɓataccen wuri, har da fata, kuma ya taɓa idanunsa, hanci ko bakinsa, zai iya yaduwa.
Ko da yake ana ganin cewa zai iya yaduwa ta hanyar ƙwayoyin cuta, ana ganin cewa yana da ƙananan haɗari.
Gwamnatin kasar Sin ta yi watsi da yiwuwar kamuwa da SARS-CoV-2 ta hanyar hanci ko ta hanyar baki. Ko da yake akwai yiwuwar yaduwar cutar kafin bayyanar cututtuka da kuma a cikin matakan da suka biyo baya, ana iya samun kamuwa da cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka.
Mutane sun samu sakamako mai kyau kwanaki uku kafin bayyanar cututtuka, kuma hakan ya nuna cewa ana iya kamuwa da cutar kafin bayyanar cututtuka da yawa.
Akwai rahotanni kaɗan na marasa bayyanar cututtuka da aka tabbatar a cikin dakin gwaje-gwaje, amma yayin da ake bincika hulɗa, wasu ƙasashe sun gano cewa an kamu da cutar ba tare da bayyanar cututtuka ba.
Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kula da Cututtuka ta ce, ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yana iya kamuwa da mutane biyu zuwa uku.
An gano cewa cutar tana iya samuwa a kan filastik (polypropylene) da kuma karfe mai laushi 304, har zuwa kwana uku, a kan takarda kwana daya, da kuma a kan tagulla har tsawon sa'o'i hudu.
Amma wannan zai iya bambanta da yanayin zafi da zafin jiki. Gwajin COVID-19 a cikin dabbobi da sauran dabbobi ya tabbata.
Ko da yake jami'an Burtaniya sun ba da shawarar wanke hannuwanku bayan sun zo wurin dabbobi, kamar yadda suka ba da shawarar wanke hannuwanku bayan sun zo wurin wasu farfajiyar da mutane masu kamuwa da cutar suka taɓa, babu wata hujja cewa dabbobi za su iya kamuwa da cutar a cikin mutane.
Cutar cutar sankarar numfashi mai tsanani, coronavirus 2 (SARS-CoV-2), wani kwayar cutar da ba a taɓa gani ba, an fara ware ta daga mutane uku da ke fama da cutar huhu a Wuhan, wanda ya shafi rukunin cututtukan da ke tattare da cutar sankarar numfashi.
Ana samun dukkan halaye na sabon SARS-CoV-2 a cikin dukkanin ƙwayoyin cuta masu alaƙa da coronavirus a cikin yanayi. Wannan ƙwayoyin cuta yana mutuwa a waje da jikin mutum saboda sabulu na gida ya warware ƙwayar cutar. SARS-CoV-2 yana da alaƙa da SARS CoV.
An yi imani da cewa an samo shi ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar Corona tana da nau'ikan kwayoyin halitta biyu tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta tare da nau'ikan kwayoyin halitta.
A cikin dukkanin kwayoyin halitta, yana da daidaituwa 96% da samfurori na Corona Virus (BatCov RaTG13) da ke da alaƙa da sauran kwayoyin cuta.
A watan Fabrairun shekarar 2020, masu binciken kasar Sin sun gano cewa akwai bambanci tsakanin amino acid guda daya tsakanin kwayoyin cuta na cuta da kuma wasu sassan kwayoyin halitta na kwayoyin cuta na mutum.
A yau, an gano kashi 92% na abubuwan da ke cikin kwayar cuta da SARS-CoV-2 ke da su a cikin dukkanin tsarin kwayoyin halitta, wanda bai isa ya tabbatar da cewa masu kula da abinci sune masu tsakiya ba.
Ana iya gano cutar ta wucin gadi ta hanyar bayyanar cututtuka, amma ana iya tabbatar da ta ta ta hanyar juyawa na kwayar cutar ta hanyar yin amfani da rRT-PCR ko CT Imaging.
Wani bincike na PCR da CT da aka gudanar a Wuhan ya nuna cewa CT, ko da yake ba ta da cikakkiyar daidaito, tana da matukar damuwa fiye da PCR, kuma yawancin halayen hotunan ta suna da alaƙa da sauran cututtukan huhu da cututtuka.
A watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta ba da shawarar kada a yi amfani da CT don gano COVID-19 ko a yi amfani da shi azaman gwajin farko.
WHO ta fitar da dokoki da dama na gwajin RNA akan SARS-CoV-2, na farko daga cikinsu a ranar 17 ga Janairu.
Wannan gwajin yana amfani da ainihin lokacin fassarar fassarar polymerase chain reaction (rRT-PCR).
Ana iya gwada shi a kan jini ko kuma a kan numfashi.
A wasu lokatai, sakamakon zai iya samuwa a cikin 'yan sa'o'i ko kwanaki.
Ana yin wannan gwajin ne a kan samfurin jini daga saman hanci, amma ana iya amfani da samfurin jini daga cikin hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna ci gaba da gwajin jini.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan gwaje-gwajen da suka tabbatar da cewa sun isa su zama daidai don karɓar amfani da yawa.
A Amurka, gwajin jini da aka yi da sailaxoni ya amince da shi ne kawai don gaggawa daga gwaje-gwaje masu inganci.
Wasu siffofin hoto na mutane da ba su da alamun bayyanar cututtuka a kan radiograph da computed tomography (CT) suna da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Kungiyar Radiological Italiyanci ta tattara bayanan kan layi na duniya game da binciken hotunan da aka tabbatar da lokuta.
Ana amfani da hotunan hoto don gano COVID-19 ba tare da tabbacin PCR ba saboda haɗuwa da kamuwa da cuta kamar adenoviruses.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa daukar hoto, ko da yake ba shi da cikakken bayani game da gano kamuwa da cuta, yana da sauri kuma yana da mahimmanci, kuma ya ba da shawarar cewa a yi la'akari da amfani da shi azaman kayan bincike a yankunan da cutar ta yadu.
An kirkiro cibiyoyin sadarwa na neuronal tare da radiographs da CTs na tushen wucin gadi don gano sifofin hoto na cutar.
Tsarin hana kamuwa da cutar ya hada da kula da lafiyar mutum gaba daya, wanke hannu, hana shan hannu idan ba a wanke shi ba, hana shan hanci ko hanci, hana shan hanji ko kuma shan iska, da kuma sanya kayan jikin mutum kai tsaye a cikin shara.
An shawarci waɗanda suka riga sun kamu da cutar su sa abin rufe fuska a wuraren jama'a.
An kuma ba da shawarar matakan kiyaye nesa ta jiki don hana kamuwa da cuta. Gwamnatoci da yawa sun ƙuntata tafiya daga wuraren da cutar ta barke zuwa wasu wurare ko kuma sun ba da shawarar kada ku yi tafiya.
Amma, cutar ta riga ta kai ga yaduwar zamantakewa a manyan sassan duniya.
Wannan yana nufin cewa cutar ta fara yaduwa a cikin al'umma kuma wasu mutane a cikin al'umma ba su san lokacin da suka kamu da cutar ba ko kuma inda suka kamu. An ba da shawarar cewa masu ba da sabis na kiwon lafiya da ke kula da wanda ke da cutar su kula da mutum daidai da ƙa'idodi, kula da tuntuɓar da kula da idanu.
Yin amfani da bayanan wuri ta wayoyin hannu ta hanyar gwamnatoci don wannan dalili ya haifar da damuwa game da rayuwar sirri, kuma Amnesty International da wasu kungiyoyi 100 sun ba da sanarwar game da iyakance irin wannan sa ido.
An aiwatar da ko kuma an ba da shawarar yin amfani da aikace-aikacen hannu da yawa don amfani da kansu, kuma a ranar 7 ga Afrilu, 2020, ƙungiyoyi na masana sama da goma suna aiki akan zaɓuɓɓuka kamar amfani da Bluetooth don yin rajistar kusanci ga mai amfani da ke kiyaye sirrinsa zuwa wasu wayoyin salula.
Sa'an nan kuma idan masu amfani suka zo kusa da wani wanda ya samu gwajin COVID-19, sai su sami saƙo cewa akwai rashin fahimta game da hana kamuwa da cuta, misali, tsabtace hanci da kuma yin laushi ba su da tasiri.
Babu allurar rigakafi ga COVID-19, ƙungiyoyi da yawa suna ƙoƙarin haɓaka allurar rigakafi.
Ana ba da shawarar yin wanka a hannu don hana yaduwar cutar.
Cibiyar Kula da Kula da Cututtuka ta ba da shawarar cewa mutane su wanke hannayensu a kai a kai da sabulu da ruwa na akalla na tsawon dakika ashirin, musamman idan sun shiga bayan gida ko idan hannayensu sun zama marasa kyau a idanunsu, kafin su ci abinci da kuma bayan sun yi ta wanke hanci, suna tari ko kuma suna ta wanke.
Dalilin shi ne, a waje da jikin mutum, ƙwayar cuta tana mutuwa ta hanyar sabulu na gida, saboda sabulu na gida yana lalata tsarin kariya.
Idan babu ruwan sabulu da kuma kayan shafawa, CDC ta ba da shawarar yin amfani da kayan tsabtace hannu da aka yi amfani da su da suka ƙunshi giya aƙalla kashi 60 cikin ɗari.
Hukumar Lafiya ta Duniya ta ba da shawarar kada a taɓa idanu, hanci ko bakinka ba tare da wanke hannu ba.
Abubuwan da ke tattare da gurɓataccen ruwa kamar 62-71% ethanol, 50-100% isopropenol, 0.1% sodium hydrochlorite, 0.5% hydrogen peroxide, da 0.2-7.5% powydone-iodine suna iya kawar da gurɓataccen ruwa daga farfajiya (za a iya lalata farfajiya ta bakin karfe ta amfani da maganin kashewa na minti daya kawai.)
Sauran abubuwa masu narkewa kamar benzalkonium da chromexidine ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan akwai wata sananne ko tabbatacciyar cutar COVID-19 a wani wuri kamar gidajen abinci ko gidajen yara, duk allunan da ke cikin waɗannan yankuna, allunan taɓawa, na'urorin sarrafawa ta nesa, da na'urorin ATM da marasa lafiya ke amfani da su, su kasance masu ƙonewa.
Hukumomin kiwon lafiya sun ba da shawarar cewa idan mutum ya yi tari ko ya yi tari, ya rufe bakinsa da hancinsa da wani kusurwar da ta yi tawaye ko kuma ya yi amfani da kayan da aka yi masa, kuma ya kawar da kayan nan da nan.
Ana ba da shawarar yin amfani da masks na tiyata ga waɗanda suke da yiwuwar kamuwa da cutar, saboda yin amfani da masks zai iya rage yawan saukad da da ke faruwa ta hanyar numfashi yayin magana, ta hanyar yin tawaye ko ta hanyar tari.
Hukumar lafiya ta duniya ta ba da umarni game da lokacin da za a yi amfani da abin rufe fuska da kuma yadda za a yi amfani da shi.
Wani masanin ilimin likitancin mutum daga jami'ar Leeds, Stephen Griffin ya ce, sanya abin rufe fuska zai iya rage yawan mutane da ke taɓa fuskarsu, wanda ke haifar da kamuwa da cuta idan hannayensu ba su da lafiya".
WHO ta ba da shawarar yin amfani da abin rufe fuska ne kawai idan masu lafiya suna cikin haɗari, misali waɗanda ke kula da waɗanda suka kamu da COVID-19, sun kuma yarda cewa yin amfani da abin rufe fuska na iya taimakawa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafawa talakawa su yi amfani da abin rufe fuska.
CDC ta ba da shawarar yin amfani da abin rufe fuska na likita na waje da aka yi da masana'anta a Amurka. China ta ba da shawarar yin amfani da abin rufe fuska na likita na musamman don masu ba da sabis na kiwon lafiya a cikin jama'a, musamman ma lokacin da suke da alaƙa da wasu mutane (1 m (3 ft) ko ƙasa da haka).
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska yayin amfani da tsarin sufuri na jama'a ko kuma yayin da ake cikin taron jama'a.
Hukumomin lafiya na Thailand na karfafa mutane su yi amfani da masks na fata a gida kuma su wanke su a kowace rana.
Jamhuriyar Czech da Slovakia sun haramta fita a wuraren jama'a ba tare da rufe fuska ba ko kuma fita ba tare da rufe hanci da bakinka ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska a lokacin da yake tafiya a wuraren jama'a, don kare kansa da kuma wasu.
Gwamnatin Austria ta tilasta wa mutane su saka abin rufe fuska a lokacin da suke shiga kantin sayar da kayayyaki.
Isra'ila ta umarci dukkan mazauna su sa abin rufe fuska a wuraren jama'a.
Tun daga tsakiyar watan Maris, Taiwan ta samar da masks miliyan goma a kowace rana, kuma tun daga ranar 1 ga Afrilu, fasinjoji za su zama tilas su sa masks a fuskarsu a jiragen kasa da bas na gari.
Panama ta sanya sanya sanya abin rufe fuska a kan hanya ta fita waje kuma ta ba da shawarar cewa wadanda ba za su iya sayen abin rufe fuska ba su yi shi a gida.
Ana amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Kula da nesa ta zamantakewa (wanda ake kira watsa jiki) ya ƙunshi ayyukan sarrafa kamuwa da cuta waɗanda ke nufin rage kusanci tsakanin mutane ta hanyar rage yaduwar cutar.
Tsarin ya hada da warewa, takunkumin tafiya da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko wuraren cin kasuwa.
Mutane za su iya yin amfani da wannan hanyar ta kasancewa a gida, ta hana tafiya, ta guje wa wuraren da mutane suke, ta wajen yin gaisuwa ba tare da taɓa su ba, da kuma ta hanyar nisantar da su daga mutane.
Gwamnatoci da dama sun ba da umarni ko kuma sun ba da shawarar kiyaye nesa ta zamantakewa a yankunan da cutar ta barke.
Hukumomin gwamnatin Amurka da kuma ma'aikatar lafiya sun rage matsakaicin adadin mutanen da za su taru daga mutane 250 (idan ba a san yadda COVID-19 ke yaduwa a yankin ba) zuwa mutane 50 sannan kuma zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron mutane fiye da biyu a wuraren jama'a. CDC ta shawarci tsofaffi da waɗanda ke da cututtuka na likita a wuraren da ke da barkewar cutar su zauna a gida saboda suna fuskantar haɗarin kamuwa da cuta mai tsanani da kuma rikice-rikice na tsarin rigakafi na jini da kuma daidaitawa. A ƙarshen Maris, 2020, WHO da sauran cibiyoyin kiwon lafiya sun ci gaba da amfani da kalmar "nesa ta zamantakewa" ta hanyar rage amfani da kalmar "nesa ta zamantakewa" don kiyaye nesa ta jiki ko kuma kiyaye nesa ta kamala yayin da ake hulɗa da jama'a.
Amfani da kalmar "taɗi na zamantakewa" ya haifar da mutane su rabu da juna ta hanyar zaɓin hanyoyi maimakon ƙarfafa su su kasance cikin haɗin kai na zamantakewa. Wasu jami'ai sun ba da jagororin kiwon lafiya ta jima'i a yayin wannan annobar ta duniya.
Wannan ya ƙunshi shawarwari game da yin jima'i da mutumin da kake zama da shi kuma wanda ba shi da cutar ko kuma ba shi da alamun cutar.
Wadanda suka kamu da COVID-19 kuma waɗanda suka yi shakkar cewa sun kamu da cutar sun bada shawarar yin keɓewa a gida.
Hukumomin lafiya sun ba da cikakkun shawarwari kan yadda za a yi keɓewa. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar a keɓe dukan mutanen da ke zaune a wuraren da cutar ta kamu.
An ba da shawarwari masu tsauri game da keɓancewa ga waɗanda ke cikin rukunin haɗari.
An shawarci waɗanda suke da yuwuwar haɗuwa da mutumin da ke da COVID-19 da kuma waɗanda suka yi tafiya zuwa ƙasar ko yankin da ke da kamuwa da cutar a cikin babban adadin su su yi zaman kansu na kwanaki 14 daga lokacin da aka tuntube su.
Dakatar da yaduwar cutar da kuma hana ta yaduwa sune hanyoyin da za a iya sarrafa cutar.
Ana hana yaduwar cutar ne a farkon fasalin barkewar cutar kuma ana nufin bin diddigin wadanda suka kamu da cutar, ware su, da tsara matakan da za su iya hana kamuwa da cutar da kuma yin allurar rigakafi don hana yaduwar cutar a cikin sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, ana daukar matakan dakile ta: ana daukar matakan rage yaduwar cutar da kuma rage tasirin ta a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya haɗa matakan hana yaduwar da rage yaduwar su.
Don hana yaduwar cutar, ana buƙatar matakan da suka fi ƙarfin gaske don rage yawan adadin haifuwa na asali zuwa ƙasa da 1. Ana ƙoƙarin rage yawan yaduwar cutar a matsayin ɓangare na shirin yaduwar cutar wanda ake kira flattening of the spread graph.
Wannan zai rage yawan matsalolin da ake samu a fannin kiwon lafiya kuma ya ba da lokaci don samar da alluran rigakafi da magunguna.
Abubuwan da ke hana cutar da ke tattare da hana cutar sun hada da hana hannuwan yin tsabta, sanya abin rufe fuska da kuma ware kansu, rufe makarantu, hana taron jama'a da yawa, da kuma karfafa jama'a su shiga cikin su don karɓar tallafi, tare da matakan kare lafiyar mutum kamar tsabtace farfajiyar jiki da kuma tsabtace yanayin da ke kewaye.
Sauran ƙasashe ma sun ɗauki matakai daban-daban don rage yaduwar cutar.
Koriya ta Kudu ta fara yin gwaji mai yawa da keɓewa a gida, kuma ta yi gargadin kasancewa mai hankali game da motsin mutane masu kamuwa da cutar.
Singapore ta ba da tallafi ga waɗanda suka yi zaman kansu a cikin ware, kuma ta ba da horo ga waɗanda ba su iya ba.
Taiwan ta kara yawan samar da abin rufe fuska da kuma sanyawa masu amfani da kayan magani hukunci. Idan aka yi koyi da Birtaniya da Majalisar Dinkin Duniya, manyan kalubale ne a hana yaduwar cutar (ragewa, ba dakatar da yaduwar cutar ba) da kuma hana (dakatar da yaduwar cutar).
Shirye-shiryen da ke da kyau na rage yaduwar cutar na iya rage yawan bukatar kiwon lafiya da kashi biyu bisa uku, kuma ya rage mutuwar mutane da yawa, amma har yanzu yana iya haifar da dubban mutuwar da kuma matsin lamba a kan tsarin kiwon lafiya.
Ana iya yin amfani da shi don hana ko hana yaduwar cutar, amma dole ne a ci gaba da kiyaye shi har sai an sami riga-kafi (ko kuma an sami allurar rigakafi, idan an riga an yi hakan), idan ba haka ba, za a sake yaduwar cutar bayan an sassauta matakan.
Yin tsayi a cikin yin aiki don hana ko hana yaduwar cutar yana haifar da lalacewar tattalin arziki da zamantakewa.
Babu takamaiman magungunan rigakafin cutar COVID-19 da aka tabbatar amma ana ci gaba da kokarin samar da su wanda zai hada da gwajin magunguna da ake samu.
Yin amfani da maganin sanyi da ake samu a kantin magani da kuma shan ruwa da kuma yin hutu zai iya rage alamun.
Ana iya ganin cewa ana bukatar maganin oxygen, kuma a ba da ruwa daga jijiyoyin jiki, da kuma taimaka wa numfashi.
Yin amfani da kwayoyin cuta zai iya sa sakamako ya yi muni.
Ana gudanar da bincike kan wasu mahadi da aka amince da su a baya don magance wasu cututtukan kwayar cutar don magance COVID-19.
WHO ta kuma ce "wararrun magunguna da magunguna na gida" na iya taimakawa wajen kawar da cututtukan da ke tattare da SARS-CoV-2.
WHO ta ce ingantaccen tsarin kula da lafiya da kuma inganta ayyukan kula da lafiyar marasa lafiya na COVID-19 sune mahimman matakan da za a iya ɗauka don magance barkewar cutar.
ECDC da WHO na Turai sun ba da jagororin don ɗaukar hanyoyin da ake samu don asibitoci da kula da lafiya ta asali zuwa matakan da suka haɗa da mayar da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke hanyoyin maye gurbin idan ya yiwu, rarraba marasa lafiya da suka sami gwajin COVID-19 da kuma haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka yawan masu iska da gadaje da ke akwai.
Akwai ka'idoji da yawa game da inda aka samu mutum na farko (wanda ake kira mai cutar sifili).
Za a iya gano farkon cutar ta coronavirus ta hanyar Wuhan, Hubei, China, a ranar 1 ga Disamba, 2019.
A cikin wata daya, adadin masu dauke da cutar ta Corona ya karu a Hubei.
Yawancin hulɗarsu sun kasance tare da kasuwar sayar da kayan abincin teku na Hunan, wanda har ma dabbobin da ke rayuwa za a iya siyarwa, kuma wata ka'ida ce cewa kwayar ta fito ne daga dabbobi iri ɗaya, ko kuma asalin kwayar.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a Wuhan Central Hospital ya gargadi abokan aikinsa game da "SARS-Tassam coronavirus".
Daga cikin waɗannan, likitoci takwas, ciki har da Lee Wenling, sun yi gargadin 'yan sanda game da yada jita -jita, kuma wata mace mai suna Fan ta yi gargadin cewa dattawa sun yi gargadin ta.
Bayan haka, Hukumar Wuhan ta fitar da wata sanarwa ga jama'a kuma ta sanar da WHO.
An samu rahoton mutane da yawa da cutar ta sanadiyyar cutar ta sanannun huhu a wurin jami'an lafiya a Wuhan, wanda ya sa aka fara bincike a farkon watan Janairu.
Saboda yawan ƙaurawar da ake samu a lokacin sabuwar shekara ta kasar Sin da kuma yadda Wuhan ke zama babban cibiyar sufuri da kuma sauya hanyoyin jirgin kasa, cutar ta yada zuwa sauran lardunan kasar Sin a farkon tsakiyar watan Janairu na 2020.
A ranar 20 ga Janairu, an samu kusan mutane 140 a China a rana guda, daga cikinsu akwai biyu daga Beijing da kuma daya daga Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6174 sun riga sun fara nuna alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta fi China da Italiya gaba a cikin mafi yawan lokuta da aka tabbatar a duniya.
Akalla mutum daya ne ya kamu da cutar a kusan kasashe da yankuna 200.
Saboda matsalar ta duniya a Turai, kasashen da dama a yankin Schengen sun sanya takunkumi kan motsi da kuma hana iyakarsu.
Amsoshin da aka samu a matakin kasa sun hada da matakan hana yaduwar (umarnin zama a gida, umarnin zama a ko'ina, da kuma dokar hana fita) da kuma dokar hana fita. Kamar yadda ta kasance a ranar 2 ga Afrilu, kusan mutane miliyan 300 a Amurka, ko kashi 90% na yawan jama'a, suna cikin wani nau'i na dokar hana fita, fiye da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kasance cikin wani yanayi na rashin daidaito, wanda ya karu zuwa biliyan 2.6 a cikin kwana biyu - wanda ya kai kashi daya bisa uku na yawan duniya.
An gano farkon wanda aka tabbatar da COVID-19 a Wuhan kafin 1 ga Disamba, 2019, inda aka gano wani abu mara tabbas a ranar 17 ga Nuwamba.
Dokta Zhang Jishian ya gano cewa yana da cutar huhu da ba a san dalilinsa ba a ranar 26 ga watan Disamba, bayan haka asibitin ya sanar da Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwaje-gwajen farko na samfurori na marasa lafiya na 27 ga Disamba sun nuna cewa akwai kwayar cutar coronavirus kamar SARS.
A ranar 31 ga watan Disamba, Hukumar Lafiya ta Wuhan ta fitar da wata sanarwa ga jama'a.
A wannan rana ne aka sanar da WHO.
Kamar yadda wannan sanarwar ta faru, likitoci a Wuhan sun yi gargadin 'yan sanda game da yada jita-jita game da fashewar.
Hukumar lafiya ta kasar Sin ta ce a farkon lokacin babu wata hujja da ta nuna cewa mutum ya kamu da cutar.
A cikin watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri wanda babban sakataren jam'iyyar kwaminis ta kasar Sin, Shi Jinping, ya kira "yaƙin jama'a" don hana yaduwar cutar.
An bayyana jerin abubuwan da ake kira "babban warewar da aka yi a tarihin 'yan Adam" a ranar 23 ga Janairu, wanda ya kawo karshen tafiye-tafiye na ciki da na waje a Wuhan wanda aka faɗaɗa zuwa birane 15 na Hubei gaba ɗaya wanda ya shafi mutane miliyan 57.
An haramta amfani da motocin sirri a cikin birni.
An soke bukukuwan bikin sabuwar shekara ta kasar Sin a wurare da dama.
Jami'ai sun kuma sanar da gina asibiti na wucin gadi mai suna Hussain Shan Hospital wanda aka kammala cikin kwanaki 10.
An gina wani asibiti da ake kira Liyshenshen don kula da karin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta maida wasu wurare a Wuhan zuwa asibitoci na wucin gadi kamar cibiyoyin taro da wuraren wasanni. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakan dakile barkewar COVID-19, wanda ya hada da sanarwar lafiya ga matafiya da kuma kara hutun bazara.
An rufe jami'o'i da makarantu a kasar.
An yi wasu matakai a yankunan Hong Kong da Macau, musamman a fannin makarantu da jami'o'i.
A wasu sassan kasar Sin, an yi amfani da hanyoyin da za a iya yin aiki a nesa.
An sanya takunkumin hana zirga-zirga na cikin gida da na waje a cikin Hubei.
An yi canje-canje a cikin tsarin sufuri na jama'a, kuma an rufe gidajen tarihi na wucin gadi a duk faɗin China.
An sanya matakan hana tafiye-tafiye a biranen da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci matsalolin tafiya a waje. Lokacin da barkewar cutar ta kai ga duniya a watan Maris, jami'an kasar Sin sun dauki matakan da suka dace don hana cutar ta shiga kasar Sin daga wasu ƙasashe.
Alal misali, Beijing ta tilasta wa dukkan matafiya na duniya da ke zuwa birnin killace su na kwanaki 14. Kashi daya kawai na kamuwa da cutar a gida a kan babban yankin China a ranar 23 ga Maris, kwanaki biyar da suka gabata, wanda ya kasance na matafiyi daga Istanbul zuwa Guangzhou.
A ranar 24 ga watan Maris, 2020, Shugaban kasar Sin Li Keqiangni ya ruwaito cewa an dakatar da yaduwar kamuwa da cutar a cikin gida, kuma an dawo da cutar a China.
A wannan ranar, a Hubei, ban da Wuhan, an sassauta takunkumin tafiye-tafiye na tsawon watanni biyu bayan an yi dokar hana fita. A ranar 26 ga Maris, Ma'aikatar Harkokin Wajen China ta sanar da cewa ingancin masu riƙe da biza ko lasisin zama za a dakatar da su daga shiga bayan 28 ga Maris, kuma ba ta ba da cikakken bayani game da lokacin da shirin dakatarwar zai ƙare ba.
Duk wanda yake son zuwa kasar Sin dole ne ya nemi takardar zuwa ofishin jakadancin kasar Sin ko kuma ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafa ma'aikata da masana'antu su sake budewa a ranar 30 ga watan Maris, tare da ba da tallafin kudi ga masana'antu. Kwamitin Jiha ya sanar da fara ranar makoki a ranar 4 ga Afrilu, da safe da karfe 10 na safe, tare da kiyaye zaman lafiya na minti uku a duk faɗin ƙasar.
An tabbatar da cewa COVID-19 ya bazu daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar lafiya ta kasar ta samu karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda aka mayar da hankali ga taron cocin Yesu na Shinchiongji a Degu.
Shiyasa ake zargin cewa masu bin Shichenoji ne suka jawo barkewar cutar.
A ranar 22 ga watan Fabrairu, an samu alamun cutar a cikin mutane 1,261 daga cikin masu bin cocin 9,336, wato kimanin kashi 13 cikin dari.
A ranar 28 ga Fabrairu, an samu karin shari'o'i 2,000 a Koriya, wanda ya karu zuwa 3150 a ranar 29 ga Fabrairu.
Bayan an tabbatar da cewa sojoji uku sun kamu da cutar, an killace dukkan sansanonin soja na Koriya ta Kudu.
An canza jadawalin jiragen sama don haka Koriya ta Kudu ta fara wani shiri da ake kira mafi girma da kuma tsari a duniya don gwada cutar a kan manyan al'ummomi, ware masu kamuwa da cutar, gano su, ware waɗanda suka tuntube su.
Hanyoyin gwajin sun hada da yin rajistar bayyanar cututtukan da masu shigowa daga kasashen waje suka samu da kansu ta hanyar aikace-aikacen wayar hannu, yin gwajin kwayar cutar ta hanyar motsa jiki, wanda ke nuna cewa ba a sauka daga motar ba, wanda sakamakon ya zo a rana ta gaba, da kuma inganta damar yin gwajin da zai iya yin gwajin mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu na sarrafa annobar ba tare da ware birane ba. An fara yin amfani da tarbiyyar Koriya ta Kudu a matsayin amsa ga matsalar da Shugaba Moon Jae-in ya fuskanta.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman hukuma don su yi zargin ko kuma yabon Moon saboda rashin kulawar da gwamnatin ta yi game da fashewar .
A Koriya ta Kudu, an ruwaito cewa a ranar 23 ga Maris, an samu mafi karancin adadin shari'o'i a cikin kwana ɗaya a cikin makonni huɗu.
A ranar 29 ga watan Maris, an bayyana cewa, daga 1 ga watan Afrilu, za a ware duk wanda ya zo daga kasashen waje na tsawon makonni biyu.
Rahotanni na kafofin watsa labarai sun bayyana cewa, a ranar 1 ga Afrilu, Koriya ta Kudu ta samu buƙatu daga kasashe 121 don neman taimakon gwajin cutar.
Iran ta fara samun mutum na farko da aka tabbatar da kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Com, inda ta samu mutuwar a ranar, a cewar ma'aikatar kiwon lafiya da ilimin likitanci.
Sakamakon da gwamnatin ta gabatar da shi a farkon ya hada da soke bukukuwa da sauran ayyukan al'adu, wasanni da sallar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da tiriliyan biyar na riyal don yaki da cutar.
Shugaban kasa Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 babu wani shiri na ware wuraren da cutar ta shafa, za a ware mutane ne kawai.
An sanar da cewa akwai tsare-tsaren da za su hana zirga-zirga tsakanin biranen, amma har zuwa bayan Sabuwar Shekara ta Farisa, Na'urori masu yawa sun ci gaba da zirga-zirga tsakanin biranen.
A cikin watan Fabrairu, Iran ta zama cibiyar yaduwar cutar bayan China.
A lokacin da ake ikirarin rufe yanayin barkewar cutar a Iran, fiye da kasashe goma sun cire adadin shari'o'insu zuwa Iran har zuwa 28 ga Fabrairu, suna ba da shawarar cewa yanayin barkewar cutar ya fi na 388 da gwamnatin Iran ta yi rajista zuwa wannan ranar.
Majalisar dokokin Iran ta rufe a ranar 3 ga watan Maris bayan da aka samu gwajin cutar a 23 daga cikin mambobi 290.
A ranar 12 ga watan Maris, kungiyar kare hakkin bil adama ta bukaci jami'an kurkuku na Iran da su saki wadanda suka yi tsayayya da cin zarafin bil adama da aka kama saboda rikice-rikice na zaman lafiya ba tare da wani sharadi ba, da kuma barin sauran fursunoni masu cancanta a wucin gadi.
Ya kuma ce a wuraren da ake tsare mutane kamar cibiyoyin tsare mutane, inda kuma babu isasshen kulawar lafiya, akwai babban haɗarin yaduwar cutar.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda ya kasance mafi girma a kasar tun lokacin da cutar ta fara.
A ranar 17 ga watan Maris, aƙalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko na baya na Iran sun mutu.
A ranar 23 ga watan Maris, a Iran, ana samun sabbin mutane 50 da ke kamuwa da cutar a kowace awa, kuma mutum daya da ke mutuwa a kowane minti 10.
Wani jami'in WHO ya ce, akwai yiwuwar samun karin kashi biyar na wadanda aka samu a Iran.
An kuma nuna cewa takunkumin da Amurka ta dauka kan Iran na iya shafar karfin tattalin arzikin kasar wajen magance barkewar cutar.
Babban Kwamishinan kare hakkin bil'adama na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki ga sauran kasashe, ciki har da Iran, wadda ta fi fama da cutar ta duniya.
An tabbatar da cewa cutar ta barke a Italiya a ranar 31 ga Janairu lokacin da aka gwada masu tafiya biyu na kasar Sin da cutar SARS-CoV-2 a Rome.
Yayin da adadin masu kamuwa da cutar ya karu, gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa da kuma shiga kasar Sin, kuma ta bayyana dokar ta baci.
A ranar 21 ga watan Fabrairu, an gano wani rukuni na marasa alaƙa na COVID-19 a Lombardy bayan an fara da shari'o'in da aka tabbatar da su 16.
Firayim Minista Giuseppe Conte ya ce, "Ba za a iya shiga ko fita wuraren da aka yi wa ta'addanci ba".
An riga an ba da umarni a yankin da su dakatar da ayyukan aiki da wasanni. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i gaba daya saboda mutuwar 100 a Italiya".
Duk manyan wasannin wasa, gami da wasannin Serie A, an shirya su ne a filin da aka rufe har zuwa watan Afrilu, amma an dakatar da dukkan wasannin a ranar 9 ga Maris na akalla wata guda.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin rufe kusan dukkanin kasuwancin kasuwanci daga manyan kantuna da kantunan magani. A ranar 6 ga watan Maris, Kwalejin Italiya ta Anesthesia, Analgia, Resetation and Hypertension (SIAARTI) ta fitar da manufofin likita na shawarar irin wannan ɗabi'ar kulawa da za a iya amfani da ita wajen magance cutar.
A ranar 19 ga watan Maris, Italiya ta zarce kasar Sin a matsayin kasar da ta fi yawan mutuwar mutane a duniya sakamakon cutar korona, inda ta samu mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, Rasha ta tura jiragen ta tara zuwa Italiya da kayan aikin likita.
A Italiya, an samu kamuwa da cutar ta 1,289,488 a ranar 5 ga Afrilu, mutane 15,887 ne suka mutu, kuma mutane 2,1815 ne suka warke, kuma mafi yawan sun faru ne a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa rashin iyawar tsofaffin mutanen Italiya da kuma duk mutanen da suka kamu da cutar a yau, na iya haifar da babban adadin mutuwar.
Amsar da Burtaniya ta bayar game da cutar ta kasance mafi sauki daga sauran kasashen da suka kamu da cutar, kuma har zuwa 18 ga Maris, 2020 gwamnatin Burtaniya ba ta sanya wani nau'i na warewar jama'a ko keɓewa ga al'ummarta ba.
A sakamakon haka, an soki gwamnati da kasawa a cikin gano saurin da kuma yadda za ta amsa matsalolin da mutane ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ta ba da shawarar kauce wa duk tafiye-tafiye marasa mahimmanci da kuma hulɗa da jama'a, mutane suyi aiki daga gida idan zai yiwu, da kuma kauce wa wuraren da ake amfani da giya kamar gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, Gwamnatin kasar ta sanar da cewa, za a rufe wuraren nishaɗi kamar gidajen shan giya da kuma wuraren motsa jiki da wuri-wuri, kuma za a ba da tabbacin cewa za a biya 80% na albashi na ma'aikata har zuwa iyakar £ 2,500 a kowane wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga watan Maris, Shugaban kasar ya sanar da matakan karfafa zamantakewa na hana mutane fiye da biyu zuwa taro, da kuma iyakance tafiya da kuma aikin waje kawai.
Wannan ya bambanta da na baya, saboda waɗannan ƙa'idodin na iya sa 'yan sanda su yi hukunci da kuma soke taron.
An ba da umarnin rufe yawancin kasuwancin, tare da abubuwan da aka ɗauka "mafi mahimmanci" na kasuwanci waɗanda suka haɗa da manyan kantuna, shagunan kiwon lafiya, shagunan kayan aiki, famfunan gas da garages.
An tabbatar da mutum na farko da aka sani da cutar COVID-19 a ranar 20 ga Janairu a jihar Pacific Northwest, Washington, a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar aiki ta White House Coronavirus Task Force a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta bayyana dokar ta baci ta kiwon lafiya ta jama'a, ta hana masu tafiya daga kasar Sin shiga kasar.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar hukumar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta ci gaba da samar da kayan gwajin kanta.
Duk da haka, saboda ƙarancin gwajin gwaji a Amurka, ainihin yadda cutar ta ɓarke ba a bayyana ba.
Gwaje-gwajen sun lalace saboda munanan kayan gwajin da Gwamnatin Tarayya ta samar a watan Fabrairu, rashin amincewar Gwamnatin Tarayya da kayan gwajin da ba na gwamnati ba (masana ilimi, kamfanoni da asibitoci) har zuwa karshen watan Fabrairu, da kuma kasancewa da takamaiman ka'idoji ga mutane har zuwa farkon Maris don cancanta don yin gwaji (wanda daga baya ya zama dole a ba da umarnin likita).
A ranar 27 ga Janairu, Washington Post ta ruwaito cewa an yi gwaji kasa da dubu huɗu a Amurka.
A ranar 13 ga Maris, Atlantic ta ba da rahoton cewa an yi gwajin ƙasa da 14,000.
A ranar 22 ga watan Maris, Associated Press ta ruwaito cewa ana daukar sa'o'i da kwanaki kafin a gwada mutane da yawa da kuma umarnin da likitoci ke bayarwa don yin gwaji. Lokacin da aka yi rikodin mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Insley ya sanar da dokar ta baci a jihar, wani aiki da sauran jihohi suka yi koyi da shi ba da daɗewa ba.
A ranar 6 ga watan Maris, 2020, masanan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
A wannan ranar ne Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Karatun Karatun Coronavirus, wanda ya ba da dala 8.3 na gaggawa ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun sanya takunkumi kan tafiye-tafiyen ma'aikata, sun soke majalisa, kuma sun karfafa ma'aikata su yi aiki daga gida.
An soke shirye-shiryen wasanni da yanayi. A ranar 11 ga Maris, Trump ya sanar da iyakancewar tafiya daga Burtaniya zuwa yawancin Turai na kwanaki 30 daga 13 ga Maris.
A rana ta gaba, sun ƙara ƙuntatawa zuwa Ingila da Ireland.
A ranar 13 ga watan Maris, ya bayyana dokar ta baci ta kasa, wanda ya ba da damar samun kudaden tarayya don magance matsalar.
A farkon 15 ga watan Maris, da dama daga cikin kamfanoni a fadin Amurka sun rufe ko kuma rage lokutan aiki don rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da cewa an kamu da cutar a duk jihohi 50 da kuma gundumar Columbia. A ranar 23 ga watan Maris, an ruwaito cewa New York City na da adadin kamuwa da cutar coronavirus 10,700, wanda ya fi yawan adadin kamuwa da cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, Gwamnan ya ce, ana ganin cewa nisantar zamantakewa na kawo canji, saboda an kiyasta cewa adadin masu kamuwa da cutar ya ninka daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an samu mutum 32308 da suka kamu da cutar a birnin New York City, kuma mutane 672 ne suka mutu saboda cutar. A ranar 26 ga watan Maris, an samu Amurka da ta samu karin mutane da suka kamu da cutar fiye da kowace kasa a duniya, ciki har da China da Italiya.
Rahotanni na kafofin watsa labarai na ranar 30 ga Maris sun nuna cewa Shugaba Trump ya tsawaita ka'idodin nisantar zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, jirgin ruwa mai suna USS Comfort, wanda ke da asibiti mai gadaje 1,000, ya isa birnin New York.
A ranar 3 ga watan Afrilu, an samu mutuwar mutane 884 a cikin awanni 24 a Amurka sakamakon cutar Corona.
A ranar 3 ga watan Afrilu, adadin wadanda suka kamu da cutar a jihar New York ya wuce 100,000. An soki White House saboda rage girman barazanar da ake yi da kuma daidaita bayanan da aka yi wa jama'a game da cutar ta hanyar sarrafa saƙonnin kai tsaye daga jami'an lafiya da masana kimiyya tare da aiki tare da mataimakin shugaban kasa Mike Pence.
A duk faɗin, gwamnatin Trump ta kasance mai nuna bambanci da nuna bambanci game da rikicin.
Wasu jami'an Amurka da masu sharhi sun soki Amurka da dogaro da shigo da kayayyaki masu mahimmanci daga China wanda ya hada da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin samfurori na tafiya ta iska don yin zane-zane da kuma ƙayyade yadda ya kamata ya yada, kuma an buga wannan bincike a cikin The Journal of Travel Medicine a tsakiyar watan Janairu.
A shekarar 2018, kungiyar sufuri ta kasa da kasa ta Air Transport Association ta nuna cewa, yawan fasinjoji daga Wuhan zuwa Bangkok, Hong Kong, Tokyo da Taipei sun fi yawa.
Dubai, Sydney, da kuma Melbourne sun kuma bayyana cewa Wuhan ne wuraren da mutane ke zuwa.
A cikin manyan wuraren da aka fi sani da 20 da aka fi sani da su, Bali ta kasance mafi ƙarancin cutar, yayin da biranen Austria suka kasance mafi ƙarancin cutar. Ostiraliya ta sanar da shirin gaggawa na COVID-19 a ranar 7 ga Fabrairu.
Ya ce akwai sauran bincike da yawa da za a yi game da COVID-19 kuma Australiya za ta mai da hankali kan samar da bayanai game da yadda suke amsawa ga annobar duniya a kan kula da iyakoki.
A ranar 21 ga watan Maris, an bayyana dokar ta baci ta kare lafiyar dan Adam a Australia.
Saboda yadda aka yi amfani da hanyoyin sufuri na jama'a a Wuhan da Hubei, kasashen da dama suna shirin fitar da 'yan kasarsu da ma'aikatan su daga yankin, musamman ta hanyar jiragen sama na gida da kuma amincewar jami'an kasar Sin.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance na farko da suka yi shirin ƙaura da 'yan ƙasarsu.
Pakistan ta ce ba za ta fitar da wani dan kasar daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan kasar Poland hudu, da wani dan kasar Sin, da kuma dan kasar Indiya guda 34 da ke Brazil ko kuma iyalansu.
'Yan kasar Poland da China da kuma Indiya sun sauka a Poland inda jirgin Brazil ya tsaya kafin ya isa Brazil.
An ware 'yan kasar Brazil da suka zo Wuhan a sansanin soja kusa da Brazil.
A wannan ranar, an tura 'yan kasar Kanada 215 (na farko 176 daga jirgin sama na farko da na biyu 39 daga jirgin saman gwamnatin Amurka) daga Wuhan zuwa CFB Trenton don zaman kansu na makonni biyu.
Wani jirgin sama na CFB ya sauka a Trenton a ranar 11 ga Fabrairu, yana dauke da 'yan Kanada 185 daga Wuhan.
Jami'an Australiya sun kwashe mutane 277 zuwa Cibiyar Kula da Tsibirin Kirsimeti a ranar 3 da 4 ga Fabrairu, wanda aka sake mayar da shi a matsayin cibiyar keɓewa, inda suka zauna har tsawon kwanaki 14.
A ranar 5 ga watan Fabrairu, lokacin da jirgin da ke ƙaura da mutanen New Zealand ya isa Auckland, an ware fasinjojinsa (waɗanda suka haɗa da wasu 'yan asalin Australiya da Pacific) a tashar jiragen ruwa a Wangaprua, Arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta tura 'yan kasar Amurka a kan jirgin ruwa mai suna Diamond Express.
Jirgin saman Kanada mai dauke da fasinjoji 129 daga Diamond Princess ya sauka a Trenton, Ontario, a ranar 21 ga Fabrairu.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga watan Maris, jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta amince da shi ya kwashe 'yan kasar 112 zuwa ƙasarsu.
An gudanar da gwajin likita kafin tashi kuma an ajiye 'yan Afirka ta Kudu hudu da ke nuna alamun cutar don hana haɗari.
Sai dai mutanen Afirka ta Kudu da suka samu gwajin rashin lafiya ne kawai aka mayar da su gida.
Sakamakon gwajin ya saki dukkan 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, ma'aikatan otal, 'yan sanda da sojoji da suka shiga cikin wannan aikin agaji, waɗanda suka kasance a cikin kulawar tsaro da ke cikin gidan shakatawa na Ranch Resort na kwanaki 14 a matsayin matakan tsaro.
A ranar 20 ga watan Maris, saboda annobar duniya, Amurka ta fara janye dakarunta daga Iraki.
A ranar 5 ga watan Fabrairu, Ministan Harkokin Wajen kasar Sin ya bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimakon likita zuwa kasar Sin.
Wasu daliban kasar Sin daga jami'o'i na Amurka sun haɗu da wani rukuni na haɗin gwiwa a Greater Chicago don aika taimako zuwa yankin da ke da cutar a China wanda aka ce kungiyar ta gudanar da aikawa da 50000 N 95 masks zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da gudummawar dala miliyan 100 ga WHO don tallafawa bincike kan alluran rigakafi da kuma kokarin magance cutar, ciki har da kare rayukan mutane a Afirka da Afirka ta Kudu.
Interaksioni ta ruwaito cewa, a ranar 6 ga watan Fabrairu, gwamnatin kasar Sin ta ba da kyautar masks 200,000 ga Filipinos bayan da Sanata Richard Gordonney ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kamfanin Red Crown na Singapore ya sanar da cewa zai tura tallafin da zai kai China miliyan 2.26 zuwa kasar Sin.
Japan ta ba da kyautar fuska miliyan 1 ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da kayayyakin kiwon lafiya fiye da tan 13 ga Wuhan, Malaysia ta ba da sanarwar bayar da kyautar safofin hannu miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya na 10,000 da suka hada da tufafi masu kare kai, Amurka ta ba da kayayyakin kiwon lafiya na tan 17.8 ga China, kuma ta yi alkawarin cewa za a ba da ƙarin dala miliyan 100 ga kasashen da ke fama da matsalar tattalin arziki. Yayin da al'amuran da ke cikin China suka zama na kwarai a duniya, China ta fara taimaka wa kasashe daban-daban da ke fama da cutar.
A watan Maris, kasar Sin da Cuba da kuma Rasha sun tura kayan kiwon lafiya da kwararrun masana zuwa Italiya don magance cutar coronavirus.
Wani mai sana'a mai suna Jack Ma ya aika da kayan gwaji miliyan 1.1 zuwa Addis Ababa Ethiopia, da masks miliyan 6 da kuma tufafi 60,000 da kungiyar tarayyar Afirka ta bayar.
Daga nan sai suka tura kayan gwaji 5,000, masks 100,000 da kuma na'urori masu numfashi biyar zuwa Panama.
Ma'a'a sun kuma ba da kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwa game da masks da kayan gwaji na kasar Sin.
Alal misali, Spain ta cire kayan gwajin cutar korona na kasar Sin guda 58,000 da suka yi daidai da kashi 30 cikin dari, yayin da Netherlands ta sake bukatar kayan rufe fuska na kasar Sin guda 60,000 da suka yi lahani.
Belgium ta dawo da masks 10,000 da aka yi zaton sun fito ne daga kasar Sin amma na gaskiya sun fito ne daga Colombia.
A gefe guda kuma, tallafin da kasar Sin ta bayar ya samu karbuwa a kasashen Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara aikin gaggawa na bayar da taimako ga kasashe masu tasowa.
Hukumar ta WHO ta yaba da kokarin da jami'an kasar Sin ke yi na gudanar da kuma hana cutar.
WHO ta ba da rahoton bambanci tsakanin barkewar cutar SARS tsakanin 2002-2004 lokacin da aka zargi jami'an China da ɓoyewa wanda ya haifar da matsaloli a ƙoƙarin hana cutar ta hanyar hana cutar da kuma rikicin yanzu inda gwamnatin tarayya ta ba da sanarwar yau da kullun don hana firgita a gaban Sabuwar Shekarar Hasken rana.
A martani ga shawarar da jami'an tsakiya suka yanke na hana zirga-zirga a Wuhan a ranar 23 ga Janairu, wakilin WHO, Gauden Galle, ya ce shawarar da WHO ta bayar ba ta dace ba, kuma hakan ya nuna cewa an yi amfani da shi wajen kama mutane a wuraren da cutar ta fi yawa, kuma hakan ya sa Haas ya kira shi "abubuwan da ba a taɓa gani ba a tarihin lafiyar jama'a".
Darakta Janar na WHO, Tedros Ahanom, ya ce PHIC na haifar da barazanar yaduwar duniya musamman a ƙasashe masu ƙarancin da matsakaitan kudaden shiga inda tsarin kiwon lafiya ba su da inganci.
Da yake mayar da martani ga takunkumin da aka sanya kan tafiye-tafiye, Tedros ya ce "babu bukatar yin wasu matakan da ba su da muhimmanci da za su tsoma baki a cikin tafiye-tafiye da cinikayya ta duniya" kuma "WHO ba ta bayar da shawarar sanya takunkumi kan cinikayya da motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da dala miliyan 675 a matsayin kudade don shirya shirye-shirye a ƙasashen da ke da ƙananan kuɗaɗe, kuma a cikin wannan ta ga gaggawa don taimakawa ƙasashe waɗanda ba su da tsarin gano waɗanda suka kamu da cutar ko da yake suna da farawar kamuwa da cutar.
Tedrosoni ya ci gaba da bayyana cewa "mu na da ƙarfi kamar yadda muke da rauni mafi rauni" kuma ya bukaci al'umma ta duniya da "yi zuba jari a yau ko kuma ku biya karin gobe".
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya, Antonio Guterres, ya yi alkawarin ba da ikon dukan tsarin Majalisar Dinkin Duniya don amsawa.
A sakamakon haka, an kunna ƙungiyar kula da rikice-rikicen UN kuma an ba ta izinin daidaita ayyukan Majalisar Dinkin Duniya gaba ɗaya, wanda WHO ta ce zai ba su damar mai da hankali kan amsawar kiwon lafiya, kuma sauran hukumomi za su iya amfani da ƙwarewar su don magance tasirin zamantakewa, tattalin arziki da ci gaba da yawa.
A ranar 14 ga watan Fabrairu, an fara samar da wata kungiya ta duniya da ta WHO tare da kasar Sin, wadda ta dauki matakin samar da kwararrun masana a duniya da WHO, don taimakawa wajen gudanar da ayyukan gida a kasar Sin, da kuma tantance cutar ta hanyar gudanar da taron bita da kuma gudanar da taro tare da manyan kungiyoyi a matakin kasa, da kuma ziyartar yankunan birane da na karkara a larduna da na kasa don duba sakamakon ayyukan maye gurbin cutar. A ranar 25 ga watan Fabrairu, WHO ta sanar da cewa "duniya ta yi aiki don magance yiwuwar annobar cutar coronavirus a duniya" kuma ta ce har yanzu, ko da yake ana kiran cutar ta duniya gaggawa, kasar tana cikin gaggawa.
A ranar 28 ga watan Fabrairu, jami'an WHO sun ce za a kara yawan bincike na duniya kan barazanar cutar coronavirus daga "karfi" zuwa "mafi girma" wato, zuwa matakin da ya fi dacewa na lura da cutar.
Mike Ryan, darektan gudanarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin cewa lokaci ya yi da kowace gwamnati a duniya za ta bincika gaskiyar lamarin.
Ya kuma ce, idan an dauki mataki mai kyau, zai taimaka wa duniya ta kauce wa mummunan abu.
Ryan ya kara da cewa, bayanan da ake samu a yanzu ba su gargadi jami'an lafiya na jama'a su bayyana cutar a matsayin cuta ta duniya ba, kuma ya ce, yin hakan zai nuna cewa mun amince cewa, duk wani dan Adam a duniya zai kamu da cutar.
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar korona a matsayin annobar duniya.
Daraktan gudanarwa ya ce WHO tana da "karatu sosai game da karuwar kamuwa da cutar da kuma mummunan matakin tsanani da rashin aiki". WHO tana fuskantar sukar da yawa saboda nuna rashin kula da annobar ta duniya wanda ya haɗa da jinkirta sanar da dokar ta baci ta kiwon lafiya da kuma rarraba cutar a matsayin annobar ta duniya.
Wasu daga cikin masu karyata sun hada da takardar neman murabus na darektan WHO, Tedros Adhanom, wanda ya samu sa hannun mutane 733,000 a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, wasu masana kan haƙƙin ɗan adam sun yi kira ga mutane da yawa da su ba da girmamawa ga haƙƙin kowane mutum a lokacin annobar COVID-19.
Masana sun ce kowa yana da hakkin ya shiga tsakani da zai ceci ransa kuma wannan hakkin gwamnati ne.
Wannan rukunin ya jaddada cewa rashin kayan aiki ko rashin inshorar lafiya ba za a iya amfani da shi don bayyana bambancin rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya wanda ya hada da nakasassu, wadanda suka rabu da kananan hukumomi, wadanda suka mutu, wadanda suka yi gudun hijira, marasa gida, wadanda ke rayuwa cikin matsanancin talauci, wadanda aka tsare da kuma wadanda suka yi gudun hijira da sauran wadanda suke bukatar taimakon gwamnati.
Hukumomin duniya suna magance matsalolin tattalin arziki da zamantakewar al'umma na COVID-19.
Kungiyar Tattalin Arziki da Ci gaban Tattalin Arziki ta kaddamar da dandamali wanda ke ba da cikakken bayani game da shirye-shiryen amsawa a duniya, da kuma ra'ayoyi da shawarwari.
Daga tsarin kiwon lafiya da tsarin bunkasa tattalin arzikin duniya zuwa magance tasirin lockdown da kuma takunkumin tafiye-tafiye, Digital Hub ya ƙunshi bin diddigin shirin kasar, kuma yana nufin taimakawa kasashe su koya daga juna da kuma sauƙaƙe daidaitaccen amsawar duniya ga ƙalubalen cutar coronavirus.
Gwamnatin kasar Sin ta yi ta sukar yadda Amurka, Minista Michael Glove na ofishin majalisar dattijai na Birtaniya da kuma Eduardo Bolsonaro, dan shugaban kasar Brazil, Yair Bolsonaro, ke magance annobar da ta barke a lardin Hubei, China.
An kori wasu gwamnoni na jam'iyyar kwaminis ta kasar Sin (CPC) a matakin larduna saboda kokarin da suka yi na warewa kasar ta tsakiya, wanda ya nuna rashin jin dadin da aka samu game da yadda jam'iyyar ta ke fama da barkewar cutar.
Wasu masu sukar sun yi imanin cewa manufar wannan yaƙin shine ya ceci Babban Sakataren Jam'iyyar Kwaminis ta Sin, Shi Jinping, daga fushin mutane game da barkewar cutar korona.
Wasu jami'an kasar Sin kamar Zhao Lijian sun musanta cewa cutar ta farko ta fito ne daga Wuhan, suna goyon bayan ka'idar masana'anta cewa COVID-19 ta fito ne daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta kira cutar ta Corona "Cinese virus" ko "Wuhan virus", kuma ta ce "ta hanyar sirrin kasar Sin, cutar ta zama sanadiyar cutar ta duniya" wanda wasu masu sukar ta yi la'akari da shi a matsayin mai nuna wariyar launin fata da kuma "kamar yadda gwamnatin kanta ta kasa hana cutar".
Jaridar Daily Beast ta samu sakon gwamnatin Amurka wanda ya nuna cewa an yi amfani da shi ne wajen yaudarar abokan gaba, wanda ya samo asali ne daga Majalisar Tsaro ta Kasa, inda ya ce shirin "duk game da China ne".
Ana gaya mana mu yi kokarin bayyana wannan sakon ta kowane irin hanya, kamar halartar taron manema labarai da kuma nuna talabijin, da dai sauransu. Kafofin yada labarai kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin tura agaji zuwa yankunan da ke da cutar a kasar Sin, yunƙurin neman rinjaye ne na duniya.
Joseph Borel, shugaban harkokin wajen EU, ya yi gargadin cewa, a cikin juyin juya hali da "siyasan 'yanci" wani abu ne na siyasa na ƙasa wanda ya ƙunshi gwagwarmayar rinjaye.
Borel ya kuma ce kasar Sin tana tura sakon da ya dace cewa ita ce abokiyar da ta fi Amurka da kuma abin dogara.
China ta bukaci Amurka ta soke takunkumin da ta yi wa Syria da Venezuela da Iran, kuma ta yi zargin ta tura taimakon da ta yi wa Venezuela da Iran.
An dakatar da taimakon da aka ba Jack Ma na fuska dubu goma zuwa Cuba a ranar 3 ga Afrilu saboda takunkumin Amurka.
An kuma zargi jami'an Amurka da karbar tallafin da suke yi wa wasu kasashe a kasarsu.
An kuma ruwaito cewa wasu ƙasashe sun yi jayayya game da abin rufe fuska, kamar Jamus, Austria da Switzerland; da kuma Jamhuriyar Czech da Italiya.
A sakamakon haka, Turkiyya ta kama daruruwan na'urorin iska da ke turawa Spain.
A farkon watan Maris, gwamnatin Italiya ta zargi Tarayyar Turai da rashin haɗin kai da Italiya, inda cutar ta barke.
Jakadan Tarayyar Turai na Italiya, Maurizio Masari, ya ce "Kamar dai kasar Sin ce ta ba da amsa ta biyu".
Wannan ba alama ce mai kyau na haɗin kai na Turai ba".
A wata hira ta waya da ya yi da Firayim Ministan Italiya Giuseppe Conte a ranar 22 ga watan Maris, Shugaban Rasha Vladimir Putin ya ba da shawarar cewa sojojin Rasha za su tura kayan aikin soja, motocin kashe kwayoyin cuta da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi amfani da wani "babban ma'aikatar siyasa" da ba a san ta ba, inda ta ce kashi 80% na kayan tallafin da Rasha ta aika sun kasance marasa amfani ko kuma ba su da amfani sosai ga Italiya.
Majiyar ta zargi Rasha da yin "kamfen na cin hanci da rashawa na siyasa da na siyasa".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi de Mayo, sun musanta rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin sama mai jigilar kayayyaki zuwa Amurka.
Kakakin Kremlin Dmitry Piskov ya ce, "A lokacin da yake ba da taimako ga abokan aikin Amurka, [Putin] ya yi tunanin cewa idan masu samar da kayayyakin kiwon lafiya da kayayyaki na Amurka suka yi sauri, za su biya su daidai idan ya cancanta".
A cikin shirin NATO na Defender 2020, za a gudanar da wani shiri na dakarun NATO a Jamus, Poland, da kuma Baltic States a cikin wani karamin tsari, wanda ya kasance mafi girma a NATO shirin bayan karshen Cold War.
Kate Hudson, Sakatare Janar na Kamfen na Kashe Makamai na Nukiliya, ta soki shirin Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, wannan shirin ba kawai yana barazana ga sojojin Amurka da sauran kasashen Turai ba, har ma da mazaunan ƙasar da suke aiki". Gwamnatin Iran ta sami mummunan tasiri daga cutar kuma kusan 'yan majalisa biyu sun kamu da cutar, kamar yadda wasu tsoffin' yan siyasa na yanzu ko na baya.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta jama'a zuwa ga shugabannin duniya don taimakawa a ranar 14 ga Maris, 2020, inda ya ce kasarsa na fama da fama da annobar saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin da Amurka ta yi mata.
Masu nazarin siyasa sun yi hasashen cewa hakan zai shafi yadda za a sake zaben shugaban kasa na 2020 ga Donald Trump.
Koriya ta Kudu ta soki "ƙoƙarin shiga cikin Japan da ba a yi ba" lokacin da Japan ta sanar da cewa za a ware duk wanda ya zo daga Koriya ta Kudu a wuraren da gwamnati ta tsara na tsawon makonni biyu.
A farkon, al'ummar Koriya ta Kudu sun kasance masu ra'ayi ko kuma masu ra'ayi game da yadda Shugaba Moon Jae-in ya amsa wa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tuhume su ko kuma su yaba wa Moon saboda yadda gwamnatin ta bi da shi ta hanyar da ta dace.
Wasu masu sukar sun nuna damuwa cewa hakan zai ba gwamnatoci damar karfafa ikonsu.
A Hungary, majalisa ta amince da Firayim Minista Viktor Orbán don ba da izinin mulki na dindindin, soke majalisa da zaɓuɓɓuka, da kuma mulki ga waɗanda ake ganin sun yi amfani da cutar don yada ƙarya, da kuma magance matsalar gwamnati.
An yi zargin barkewar cutar ta Corona saboda abubuwa da dama da suka faru, ciki har da karancin kayayyaki, wanda ya samo asali ne daga karuwar amfani da kayan aikin yaki da cutar a duniya, da kuma fargaba da cin kasuwa da kuma tasowa da kuma hana zirga-zirga.
Hukumar Kula da Abinci da Magunguna ta Amurka ta yi gargadin cewa akwai karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma hana masu samar da kayayyaki.
A wasu yankuna, an ga cewa ana cin kasuwa da tsoro, kuma sakamakon haka, an rasa kayan da ake bukata kamar abinci, takarda na gidajen wanka, da kuma ruwa da aka kwalliya daga cikin kantunan sayar da kayayyaki, kuma hakan ya haifar da karancin kayayyaki.
An yi gargadin masana'antun fasaha game da jinkirin jigilar kayayyakin lantarki.
A cewar Tedros Adhanam, darektan gudanarwa na WHO, bukatar kayan kariya ta mutum ta karu sau 100.
Saboda wannan karuwar bukatar, farashin ya karu zuwa sau ashirin na farashin yau da kullum, kuma samar da kayayyakin kiwon lafiya ya yi jinkiri na makonni hudu zuwa shida.
Wannan ya haifar da karancin kayan kariya na mutum a duniya, wanda ya sa Hukumar Lafiya ta Duniya ta yi gargadin cewa hakan zai iya kawo hadarin ga ma'aikatan kiwon lafiya.
Wannan annoba ta duniya a Ostiraliya ta ba da sabuwar dama ga masu sayen kayan da ke cikin gida don sayar da kayayyakin Ostiraliya zuwa China.
Wannan ya haifar da karancin kayan abinci a wasu manyan kasuwanni kuma daga baya gwamnatin Ostiraliya ta haramta shi. Duk da yawan cututtukan COVID-19 a arewacin Italiya da yankin Wuhan da kuma babban bukatar abinci mai zuwa, dukansu sun tsira daga karancin abinci.
China da Italiya sun yi nasara wajen hana cinikin kayayyaki da kayayyakin da ake bukata, kuma hakan ya hana samun wadataccen abinci a Turai da Arewacin Amirka.
A Arewacin Italiya, yawan aikin gona bai ragu ba, amma masana'antun sun ce farashin zai iya tashi.
A Wuhan, an yi amfani da kayan abinci na wucin gadi don samar da abinci, yayin da jami'an kasar Sin suka bude shagon naman alade don wadatar da yawan jama'a.
A Italiya, ana yin irin wannan dokar, kuma hakan ya sa masu samar da abinci suna bukatar su ajiye abinci don irin wannan gaggawa.
Wani rahoto daga wata majiya a ranar 16 ga watan Maris ya ce, tattalin arzikin kasar Sin ya yi matukar rauni a farkon watanni biyu na shekarar 2020 sakamakon matakan da gwamnatin kasar ta dauka na hana yaduwar cutar, inda ta samu raguwar kaso 20.5 cikin dari a cikin sayar da kayayyaki.
Kasar Sin ce babbar tattalin arziki da cibiyar samar da kayayyaki, kuma ana ganin barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demaris na Cibiyar Ilimin Tattalin Arziki ya yi hasashen cewa kasuwanni za su kasance masu saurin tashi har sai an gano sakamakon.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa cutar za ta iya janye tattalin arzikin duniya daga lokacin da SARS ta barke a 2002-2004.
Wani masanin jami'ar Washington a St. Louis ya kiyasta cewa, za a iya samun tasirin dala biliyan 300 a sarkar samar da kayayyaki a duniya har tsawon shekaru biyu.
Kungiyar Kasashen Fitar da Man Fetur (OPEC) ta ce farashin mai ya yi koma baya saboda karancin bukatar kasar Sin.
Kasuwancin Kasuwancin Duniya ya fadi a ranar 24 ga Fabrairu, yayin da adadin masu kamuwa da COVID-19 ya karu sosai a waje da babban yankin China.
A ranar 27 ga watan Fabrairu, wasu manyan alamun jari na Amurka, gami da NASDAQ-100, S&P 500 da Dow Jones Industrial Average, sun nuna cewa sun fadi da karfi tun bayan shekara ta 2008, saboda damuwa game da barkewar cutar coronavirus, kuma sun fadi da darajar Dow ta 1191 wanda ya kasance mafi girma a cikin rana guda bayan rikicin tattalin arzikin 2007-08.
Dukkanin alamun sun fadi kasa da kashi 10 cikin 100 a wannan makon.
A ranar 28 ga watan Fabrairu, Kamfanin ZMBH ya amince da cinikayya ta duniya da kasar Sin, amma ya ci gaba da nuna rashin amincewa.
A sakamakon tsoron cutar Corona, hannun jari ya sake faɗuwa, ya fi faɗuwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi kasawa.
Masanin tattalin arziki Mohammed Al Ariyan ya yaba da matakin gaggawa da aka dauka na Bankin Tsakiya da na jihohi a kan lokaci.
Babban Bankuna na kasar Sin sun yi matukar damuwa fiye da yadda suka yi a lokacin matsalar kudi ta 2008.
Kasashen da suka fi fama da mummunan tasiri shine yawon bude ido, wanda ya shafi rufe wuraren jama'a da wuraren da ake sha'awar yawon bude ido, da kuma shawarwarin gwamnatoci da kada su yi tafiya a ko'ina cikin duniya.
A sakamakon haka, kamfanonin jiragen sama da dama sun soke jiragen su saboda karancin bukatar da aka samu, ciki har da British Airways, China Eastern Airlines da kuma Quantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flyby ya rufe.
Sakamakon da ake samu a masana'antar jirgin ruwa ya kai matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin kasa da jiragen ruwa da yawa.
Wannan annoba ta faru ne a lokacin babban lokacin hutun Sabuwar Shekara ta kasar Sin, a garin Chunyan.
Gwamnatocin ƙasa da na gida sun soke wasu abubuwan da suka faru da yawa da suka shafi jama'a, ciki har da bukukuwan Sabuwar Shekara na shekara-shekara, kuma kamfanoni masu zaman kansu sun rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wasu abubuwan bikin Sabuwar Shekara ta hasken rana da wuraren yawon bude ido don hana taron jama'a, ciki har da birnin Farbidon da ke Beijing da kuma bikin alloli na gargajiya.
A cikin larduna 24, gundumomi da yankuna 24 daga cikin 31 na kasar Sin, jami'ai sun tsawaita hutun Sabuwar Shekara har zuwa 10 ga Fabrairu, kuma sun ba da umarnin cewa yawancin wuraren aiki ba za su bude ba.
Wannan yanki na wakiltar kashi 80 cikin 100 na GDP na kasar da kuma kashi 90 cikin 100 na fitarwa.
Hong Kong ta kara yawan matakan da ta samu na amsawa ga cutar ta kamuwa da cuta kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin Sabuwar Shekara.
Kasashen Turai da Latin Amurka sun yi kasa da kashi 40 cikin dari na masu sayen kayayyaki.
Kasashen Arewacin Amirka da Gabas ta Tsakiya sun ragu da kashi 50 zuwa 60 cikin 100.
Wannan ya haifar da raguwar kashi 33 zuwa 43 cikin dari na masu siye a cikin shagon da ke tafiya a kan ƙafa a watan Fabrairu idan aka kwatanta da watan Maris.
Masu cinikayya a duniya sun bukaci ƙarin matakan tsaftacewa, sanya masu duba zafin jiki na masu amfani, da kuma soke taron. Hukumar tattalin arziki ta Majalisar Dinkin Duniya don Latin Amurka ta ce, za a jefa mutane fiye da miliyan 14 zuwa 22 cikin talauci a Latin Amurka, idan ba a yi haka ba.
A lokacin da cutar ta kamuwa da cuta a birnin Wuhan ta kai ga ci gabanta, kusan mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin a watan Janairu da Fabrairu.
Kusan ma'aikata masu hijira miliyan 300 a yankunan karkara na kasar Sin sun makale a gidajensu ko kuma a lardin Hubei. Sama da Amurkawa miliyan 10 sun rasa ayyukansu a watan Maris na 2020 kuma sun nemi taimakon gwamnati.
A cewar Hukumar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da kula da kula da kula da kula da kula da kula da kula da kula da kula da kula da kula da kula da kula da kula da da da da da kula da da da da da da kula da kula da da da da da kula da da da kula da da da da da da da kula da kula da da da da da da kula da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da da
A cikin rabin watan Maris, ma'aikata miliyan hudu na Faransa sun nemi tallafin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan daya na Birtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan biyar a Jamus sun tura ma'aikatansu aiki a kan tsarin aiki na gajeren lokaci mai suna Kurzsarbyte, wanda ke da tallafin gwamnati.
Faransa da Birtaniya sun amince da tsarin biyan kuɗin gajeren aiki na Jamus.
Wannan annoba ta shafi al'amuran fasaha da al'adun gargajiya na gabatarwar da suka shafi duniya sosai, kuma ta shafi kungiyoyi da mutane a duniya duka, masu aiki da marasa aiki.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da gudanar da kamfen din su (da yawa daga cikin su na samun kudade na jama'a) wanda ya haɗa da ba wa al'umma damar jin al'adun al'adu, kiyaye lafiyar ma'aikatan su a wuraren jama'a da kuma taimaka wa masu fasaha a duk lokacin da zai yiwu.
Har zuwa watan Maris na shekarar 2020, an rufe gidajen tarihi, dakunan karatu, wuraren taro, da sauran cibiyoyin al'adu na duniya har abada, kuma an soke ko kuma a jinkirta nune-nunen su, abubuwan da suka faru da kuma gabatarwa.
Hakan ya haifar da wani gagarumin kokarin samar da ayyuka na madadin ta hanyar dandamali na dijital. Wani nau'i na rashin lafiya da ke faruwa a yanzu shine soke ayyukan addini, manyan abubuwan wasanni da sauran bukukuwa na kiɗa da kuma taro, tarurruka na fasaha da kuma nunin zamani.
A cikin taron, an yi sanarwa cewa an soke bikin mako-mako na addini a Roma, wanda ya kasance a makon ƙarshe na lokacin tuba na Kirista na Lent.
Ƙungiyoyin da ke ƙarƙashin ikon wasu bishops sun gaya wa Kiristoci masu ibada su tsaya a gida maimakon zuwa addu'ar Lahadi, wasu suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta kan layi ko talabijin, wasu suna ba da zaɓi na drive-in.
Sa'ad da yankin da ke ƙarƙashin ikon Roman Katolika na Roma ya rufe majami'unsu da ɗakin sujada, kuma St. Peter's Square ya zama mara masu bautar jama'a, sauran ƙungiyoyin addinai sun dakatar da ayyukan su kuma sun ƙuntata taron jama'a a cikin majami'u, masallatai, majami'u, majami'u, majami'u da gurdura.
A lokacin da ma'aikatar lafiya ta Iran ta soke addu'ar da ta faru a yankin da ta barke a ranar Juma'a kuma ta rufe bayan tsakar rana, Saudiyya ta haramta baƙi da mazauna zuwa Makka da Madina.
Wannan annoba ta haifar da babbar matsala a cikin jadawalin wasanni a duniya bayan yakin duniya na biyu.
An soke ko kuma an dage manyan wasanni da dama, ciki har da gasar zakarun Turai ta 2019-20, gasar Premier ta 2019-20, UEFA Euro 2020, 2019-20 NBA Season, da kuma 2019-20 NHL Season.
Fashewar ta katse shirin gasar Olympics ta bazara ta 2020, wanda a baya aka fara a karshen watan Yuli; kwamitin Olympics na duniya ya sanar a ranar 24 ga Maris cewa "za a sake tsara jadawalin abubuwan da za su faru bayan shekarar 2020, amma kafin lokacin bazara na shekarar 2021".
Wannan ya haifar da yawan caca ta yanar gizo, wanda ya haifar da ƙaruwa mai yawa a cikin adadin sababbin masu shiga yanar gizo. Ƙungiyoyin kiɗa da yawa sun jinkirta ko soke ziyara, wanda ya shafi masana'antar nishaɗi.
Yawancin manyan gidajen wasan kwaikwayo kamar Broadway sun jinkirta gwajin su.
Wasu masu fasaha sun gano hanyoyin da za su iya yin fasaha a kan intanet a matsayin madadin ga gabatarwa ta ainihi ta gargajiya da kuma ci gaba da raba ta, kamar ƙirƙirar "ƙungiyoyi" na yanar gizo don yin gabatarwa, rarrabawa da kuma tallata aikin su ga masu fasaha.
Akwai wasu labarai da yawa a Intanet game da cutar coronavirus da ke yadawa, da yawa suna yin aiki don ƙirƙirar ban dariya da kuma jan hankali a cikin wannan yanayin rashin tabbas.
Tun bayan barkewar COVID-19, akwai rashin jin daɗi da nuna bambanci tsakanin jama'ar Sin da mutanen yankin Gabashin Asiya da kuma mutanen da ke cikin wuraren zafi a Turai, Amurka da sauran ƙasashe.
A wasu ƙasashe na Turai, Gabashin Asiya, Arewacin Amirka da kuma yankin Asiya-Pacific, an samu rahotanni na tsoro, shakka da kuma nuna ƙiyayya.
Rahoton da aka yi a watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke da iyaka ga China) ya nuna cewa mutanen China sun cancanci kamuwa da cutar ko kuma sun cancanci samun sakamako mai kyau.
Wasu ƙasashen Afirka sun kuma nuna cewa suna da ra'ayin da ya saɓa wa China.
Mutane da yawa daga Wuhan da Hubei sun nuna cewa an nuna bambanci dangane da asalin yankin.
Muna ba da tallafi ga jama'ar Sin da kuma mutanen da ke yankunan da cutar ta shafa, a kan layi da kuma wajen layi.
Mutane a Italiya, kasar Turai ta farko da ta fara fuskantar mummunan barkewar cutar COVID-19 bayan barkewar cutar ta bazu a cikin sabbin ƙasashe masu zafi, sun kasance suna fuskantar shakku da jin tsoron cin zarafi.
A Japan, #ChinaDonTankMutuJapan ya zama batun da ake tattaunawa sosai a shafin Twitter.
A Ingila da Amurka, 'yan kasar Sin da sauran 'yan Asiya sun samu karuwar nuna bambanci da hare-hare.
Shugaban Amurka Donald Trump ya fuskanci zargi da cewa coronavirus "Cinese virus", wanda masu sukar suka ce yana nuna wariyar launin fata da kuma adawa da kasar Sin.
Masu zanga-zangar a Ukraine sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da kuma 'yan gudun hijira daga Wuhan zuwa Novi Zhanzari.
An ruwaito cewa daliban da suka zo daga arewa maso gabashin Indiya daga yankin da ke kan iyakar Sin suna karatu a manyan biranen Indiya suna fuskantar tsanantawa dangane da barkewar cutar Corona.
Shugaban jam'iyyar Bharatiya Janata Party a West Bengal, Dilip Ghosh, ya bayyana cewa, kasar Sin ta lalata yanayi, kuma "Allah ya yi musu sakamako".
Daga bisani, ofishin jakadancin kasar Sin a Kolkata ya yi tir da wannan furucin, ya kira shi "mai laifi". A China, cutar ta haifar da tashin hankali da nuna wariyar launin fata a kan mutanen da ba mazauna kasar Sin ba, inda ake bayyana baƙi a matsayin "washe na waje" da kuma niyyar "karɓar su".
Wasu 'yan jarida da ke da takardar biyan kuɗi sun cire wasu takardun biyan kuɗi ko dukansu don yin bincike game da cutar.
Yawancin masu wallafa kimiyya sun ba da kyauta ta hanyar bincike na kimiyya game da fashewar.
Wasu masana kimiyya sun zaɓi hanyar da za su iya ba da sakamakon su a kan sabobin da aka riga aka buga kamar bioRxiv.
Cutar da ta taso - Cutar da ta taso da ke tattare da cututtuka masu yaduwa, sau da yawa ba a san yadda za a yi annobar ko kuma yadda za a yada ta ba.
Duniya da cututtuka - Binciken Duniya da Yaduwar Cututtuka
Jerin cututtuka da annoba - yawan mutuwar da ake samu daga cututtuka masu yaduwa
Cinikin namun daji da kuma cin zarafin da ake yi wa mutane - haɗarin kiwon lafiya da ke tattare da cinikin dabbobi masu rarrafe
Gwaje-gwajen dakin gwaje-gwaje na cutar coronavirus ta hanyar numfashi 2019 (COVID-19) da kuma SARS-CoV-2 da suka shafi cutar sun haɗa da hanyoyin gano cutar da ke gano cutar da kuma gano kwayoyin cutar da suka haifar da amsawa ga kamuwa da cuta.
Ana tabbatar da kasancewar cutar a cikin gwajin ta hanyar RT-PCR, wanda ke gano RNA na cutar Corona.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da kamuwa da cutar da ta faru kwanan nan ko kuma ta yi aiki.
Ana iya amfani da gwajin maganin rigakafi (serology) don tantancewa da kuma bin diddigin yawan jama'a.
Ana gwada mutane da yawa da ke da cutar ta hanyar yin gwajin rigakafi, ko dai waɗanda ba su da alamun cutar ko waɗanda ba su da alamun cutar.
Wannan gwajin zai iya ba da damar sanin ainihin mutuwar da kuma matakin rigakafin da ke tsakanin al'umma.
Saboda karancin gwajin, babu wata ƙasa da ta sami tabbataccen bayani game da yaduwar cutar a cikin yawanta har zuwa Maris 2020.
A ranar 23 ga watan Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin 100 na yawan jama'arta, kuma akwai bambanci sosai tsakanin ƙasashe game da yawan gwajin.
Wannan canjin na iya shafar yawan mutuwar da aka samu, wanda zai iya zama da yawa a wasu ƙasashe.
Ana iya gwada samfurin numfashi da aka samu ta hanyoyi daban-daban ta amfani da Real-Time Reverse Transcription Polymerase Chain Reaction (RRT-PCR), wanda ya haɗa da zane-zane na nasopharyngeal swab ko samfurin sputum.
Sakamakon zai iya samuwa a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya tabbatar da gwajin RT-PCR na ƙuƙwalwa a farkon mako na rashin lafiya.
Daga baya, cutar za ta iya fita daga cikin hanci kuma yawanta zai ci gaba da ƙaruwa a cikin huhu.
Za a iya yin gwajin a mako na biyu na masu kamuwa da cutar ta hanyar ɗaukar samfurin daga cikin iska mai zurfi ta hanyar catheter na tsotsa ko kuma amfani da wani abu mai kama da tari.
An kirkiro daya daga cikin gwaje-gwajen PCR na farko a Charity, Berlin, a watan Janairun 2020 wanda ya yi amfani da Real-Time Reverse Transcription Polymer Chain Reaction (RRT-PCR) kuma ya kasance tushen kayan aikin gwajin 250,000 da aka samar don rarrabawa ta WHO.
A ranar 28 ga watan Janairu, 2020, kamfanin Koriya ta Kudu, Kogenbiotech, ya kirkiro wani kit din gano SARS-CoV-2 mai asibiti, mai tushen PCR (Powercheck Coronavirus).
Wannan gwajin ya gano wani nau'in "E" da aka raba ta dukkan kwayoyin cutar coronavirus da kuma wani nau'in RdRp na SARS-CoV-2 wanda ke da alaƙa da SARS-CoV-2. BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izini don amfani da gaggawa daga Hukumar Kula da Kayan Aikin Likita ta China don kit ɗin gano SARS-CoV-2 na PCR a China. Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) a Amurka suna rarraba 2019 Novel Coronavirus (2019-Encovir) Real-Time RT-PCR Diagnostic Panel ta hanyar Regent Resources International.
Kusan kashi ɗaya cikin uku na gwajin kwayoyin halitta a cikin tsofaffin sigogi na gwajin ya haifar da sakamako mai ban mamaki, wanda ya haifar da rikice-rikice a cikin gwaje-gwaje a CDC a Atlanta; sakamakon haka, an sami nasarar aiwatar da samfurori sama da 100 a kowace rana a matsakaici a cikin Fabrairu 2020.
Har zuwa 28 ga Fabrairu, 2020, ba a yarda da gwajin da aka yi ta amfani da abubuwa biyu ba, kuma har zuwa wannan lokacin ba a ba da izinin fara gwajin ga manyan dakunan gwaje-gwaje na jihar da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa.
A ranar 5 ga Maris, 2020, Lab Corp ta sanar da samun gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Hakazalika, a ranar 9 ga Maris, 2020, Quest Diagnostics ta ba da damar yin gwajin COVID-19 a duk faɗin ƙasar.
Babu wani iyaka a kan yawa; Samfurin samfurin da kuma sarrafawa dole ne a yi daidai da bukatun CDC.
An ci gaba da samar da gwajin COVID-19 ta hanyar Cibiyar Nazarin Virology da Biotechnology ta Vector a Rasha.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ta Hukumar Kula da Kiwon Lafiya ta Tarayya don lura da kiwon lafiya. A ranar 12 ga Maris, 2020, an ruwaito cewa Mayo Clinic ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, an ba da izinin FDA ga Roche Diagnostics don gwaji mai yawa wanda za'a iya yi a cikin awanni 3.5, don haka an ba da izinin yin gwaji kimanin 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da Abbot Laboratory (EUA) don gwaji akan tsarin M2000 na Abbot; FDA ta ba da izinin irin wannan ga Hologic, LabCorp da Thermopisher Scientific.
A ranar 21 ga Maris, 2020, SafeFid ta samu takamaiman takardar EUA daga FDA don gwajin da zai ɗauki kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Ba a buƙatar jerin zafin jiki na daban don yin amfani da wannan hanyar, saboda haka, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti biyar, ko da a cikin ɗan gajeren lokaci, kuma a cikin minti 13.
A halin yanzu, akwai kimanin na'urori 18,000 a Amurka, kuma ana sa ran Abbott zai bunkasa samarwa zuwa gwaje-gwaje 50,000 a rana. Gwaje-gwaje na amfani da maganin rigakafi na monoclonal wanda ke ɗaure ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar
A watan Maris na shekarar 2020, wani bincike ya nuna cewa "Rashin amfani da ra'ayoyin X-ray na kirji wajen gano cututtukan a farkon lokaci, amma sakamakon CT [computed tomography] zai iya bayyana kafin bayyanar cututtuka".
Abubuwan da ke da alaƙa da CT sun haɗa da rarraba gefen gefe na biyu tare da bilateral multilobar ƙasa-glass opatification.
Yayin da cutar ta ci gaba, sai a samu ci gaba da rinjaye da kuma halayen da suka shafi mutane.
Wani bincike na kwatanta PCR da CT a Wuhan a wurin da cutar ta samo asali a yanzu ya nuna cewa CT yana da matukar damuwa fiye da PCR duk da cewa ba shi da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran.
A watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "ba za a yi amfani da CT a matsayin gwaji na farko ba don gano ko gano COVID-19". CDC ta ba da shawarar PCR don yin gwaji na farko a watan Maris na 2020.
Ana yin maganin rigakafi, gami da IgM da IgG, a matsayin ɓangare na amsawar rigakafi ga kamuwa da cuta.
Ana iya amfani da gwajin don gano kamuwa da cuta, ƙayyade rigakafi da kuma lura da yawan jama'a kusan kwanaki 7 bayan bayyanar cututtuka ko kuma daga baya. Ana iya yin gwajin ta cikin dakin gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin kulawa (PoCT).
A cikin manyan dakunan gwaje-gwaje da yawa, ana iya yin gwajin ta hanyar sarrafawa ta atomatik a cikin wani lokaci na musamman, amma ana iya samun su ta hanyar samar da kayayyaki don kowane tsarin.
Ko da yake ana iya amfani da samfurori da yawa don bin diddigin amsawar rigakafi, ana amfani da samfurin jini guda ɗaya na jini don CLT.
A cikin POCT, ana samun samfurin jini guda ɗaya ta hanyar shan jini.
A ranar 26 ga Maris, 2020, FDA ta ba da sunayen abubuwa 29 waɗanda suka ba da umarni ga hukumar bisa buƙata kuma saboda haka suna iya ba da gwajin rigakafin su.
A ƙarshen watan Maris na 2020, Euroimune Medical Laboratory Diagnostics da Aptome Diagnostics sun sami amincewar ƙungiyar Turai don samfuran gwajin su, wanda zai iya gano IgG da IgA antibodies a cikin yanayin ƙwayoyin cuta a cikin samfurin jini.
Ana iya gwada gwajin da ya kai ga gwada ɗaruruwan samfurori a cikin 'yan sa'o'i kaɗan, kuma wannan ya sa gwajin ya fi sauri sau da yawa fiye da na PCR na gargajiya na RNA na kwayar cuta.
A cikin kwanaki 14 bayan kamuwa da cutar, ana iya gano maganin rigakafi. A farkon watan Afrilu, ba a sami wani gwajin rigakafi da suka saya a Ingila da ya dace da amfani da shi ba.
Hong Kong ta shirya cewa, a cikin abin da marasa lafiya masu tuhuma za su iya zama a gida, "sashen gaggawa za su ba da samfurin tube ga mai haƙuri", su yi ta busa shi, su mayar da shi, kuma a cikin ɗan lokaci za su sami sakamakon gwajin. NHS ta Burtaniya ta sanar da cewa tana nazarin shirin farko na gwajin gida na masu tuhuma, wanda zai hana masu cutar kamuwa da cutar ta hanyar cutar ta hanyar haɗari idan sun zo asibiti ko kuma ba a buƙatar kashe su a cikin motar asibiti idan an yi amfani da motar asibiti.
Cibiyoyin motsa jiki sun taimaka wa Koriya ta Kudu ta yi gwaje-gwaje mafi sauri, mafi girma fiye da kowace ƙasa. A Jamus, a ranar 2 ga Maris, Ƙungiyar Likitocin Kula da Lafiya ta Kasa ta bayar da rahoton cewa suna da damar yin gwajin gwaji kusan 12,000 a rana a cikin tsarin kewayawa, kuma an gwada 10,700 a makon da ya gabata.
Idan likita ya ce a yi gwajin, ana biyan kuɗin ta hanyar inshorar lafiya.
A cewar shugaban cibiyar Robert Koch, Jamus na da damar yin gwaji guda 1,60,000 a mako.
Har zuwa 19 ga watan Maris, an gudanar da gwajin tuki a cikin manyan birane da yawa.
Har zuwa 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
Binciken farko a dakin gwaje-gwaje ya gano cewa an gwada aƙalla samfura 4,83,295 a cikin duka, har zuwa wannan makon na 12/2020 da kuma makon 12/2020, kuma an tabbatar da cewa samfura 33,491 (6.9%) sun kasance masu kyau ga SARS-CoV-2.A cikin Isra'ila, masu bincike daga Technion da Rambam Hospital sun haɓaka kuma sunyi amfani da hanyar da za su bincika samfurori na marasa lafiya 64 a lokaci guda, wanda aka tattara dukkan samfurori kuma aka gano cewa samfurori sun kasance masu kyau.
An gina shi a cikin kwanaki 5 a karkashin kulawar Wanda ya kafa BGI, Wang Jian, kuma wannan samfurin ya nuna cewa idan ba a fara gwajin ba a kan lokaci, Hubei zai sami kashi 47% na ƙarin shari'o'i kuma zai ninka farashin da ke tattare da gudanar da killace.
A total, an bi dakin gwaje-gwaje na Wuhan da sauri ta hanyar dakin gwaje-gwaje na Hue-Yan a cikin birane 12 a China, kamar su Shenzhen, Tianjin, Beijing da Shanghai.
A ranar 4 ga Maris, 2020, an yi gwajin gwaji 50,000 a kowace rana. Wannan zane mai mahimmanci wanda aka buga ta Origami Essays, yana ba da damar yin gwajin COVID-19 a cikin samfurin 1122 na marasa lafiya ta amfani da gwaji 93 kawai.
A watan Maris, rashin isasshen reagent da kuma rashin isasshen kwayoyin halitta sun zama matsala ga gwaji mai yawa a cikin EU, UK da Amurka.
Wannan ya sa wasu marubuta suka fara amfani da tsarin shirye-shiryen samfurin da ya haɗa da dumama samfurori 98 ° C (208 ° F) na minti 5 don sake gwadawa na RNA. A ranar 31 ga Maris, an sanar da cewa, a cikin Hadaddiyar Daular Larabawa, mutane yanzu suna yin gwaji don cutar coronavirus fiye da kowane ƙasa a cikin yawanta, kuma suna kan hanyar haɓaka matakan gwaji don isa ga babban yawan jama'a.
Wannan ya faru ne ta hanyar haɗuwa da ƙarfin tuki da sayen kayan aikin samar da kayayyaki daga Group 42 da BGI (bisa ga dakin gwaje-gwaje na gaggawa na "Hu-Yan" a China).
An gina shi a cikin kwanaki 14, kuma wannan dakin gwaje-gwaje ne da ke da ikon yin dubban gwaje-gwaje na RT-PCR a kowace rana kuma shi ne na farko a duniya da ke da irin wannan babban aiki a wajen kasar Sin.
An ci gaba da gudanar da gwaje-gwaje daban-daban a China, Faransa, Jamus, Hong Kong, Japan da Amurka, wanda ke niyya ga sassa daban-daban na bayanan kwayoyin cutar Corona.
Hukumar lafiya ta duniya ta amince da matakin da Jamus ta dauka na tura kayayyakin samarwa ga ƙasashen da ba su da albarkatun samar da kayayyakin samarwa.
An buga matakin Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta kasance ba har zuwa ranar 28 ga Janairu, wanda ya sa gwajin da ke cikin Amurka ya kasance a kan layi. A farkon barkewar cutar, China da Amurka suna da matsaloli game da amincin kayan aikin gwaji, kuma waɗannan ƙasashen da Ostiraliya ba su iya samar da isasshen kayan aiki don biyan shawarar gwajin da ke zuwa daga buƙata da kuma ƙwararrun likitocin lafiya ba.
A akasin haka, gwaji mai yawa a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar korona.
Gwamnatin Koriya ta Kudu ta gina manyan gwaje-gwaje a cikin wani dakin gwaje-gwaje na kamfanoni masu zaman kansu a tsawon shekaru.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta ba da umarni da a kara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau don rage yaduwar cutar COVID-19. Babban bukatar gwaji saboda yaduwar cutar ta haifar da raguwar daruruwan gwaje-gwaje a cikin dakunan gwaje-gwaje masu zaman kansu a Amurka, kuma ta haifar da karancin wadatar swabs da sinadarai.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton matsaloli game da daidaito na kayan gwajin ta.
A Amurka, kayan gwajin da CDC ta haɓaka sun kasance "masu lahani"; daga baya gwamnati ta kawar da shingen da ke hana gwajin sirri. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioezy Biotechnology Co., Ltd. na China, amma ta gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa rashin samun samfurori ko kuma yin amfani da saitin da ya dace na iya haifar da sakamakon da bai dace ba.
Ma'aikatar Spain ta ce za ta mayar da kayan gwajin da aka samu da ba daidai ba kuma a maimakon haka za ta ba da kayan gwajin daban da Shenzhen Biozyn ya samar.
A cewar Ates Kara na ma'aikatar lafiya ta Turkiyya, an sayi wasu kayan aikin gwaji da suka dace da kasar Sin, amma a farkon watan Afrilu na shekarar 2020 Birtaniya ta sayi wasu kayan gwajin gwajin miliyan 35 daga kasar Sin, inda ta bayyana cewa ba su dace da amfani ba.
Gwajin, sannan a ware masu gwajin da suka yi nasara, da kuma bin diddigin wadanda suka yi hulɗa da mutanen da suka kamu da cutar SARS-CoV-2, sun sami sakamako mai kyau.
Masu bincike da ke aiki a garin Voh na Italiya, inda aka fara samun mutuwar COVID-19, sun yi gwaji biyu a kan kusan mutane 3,400 a cikin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da wata alama kuma an ware wadanda aka gano.
Yayin da al'umma suka rage tafiye-tafiye, an kawar da sabon kamuwa da cuta gaba ɗaya.
Tare da bin diddigin lamba, takunkumin tafiye-tafiye na cikin gida, gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta yi jinkiri sosai fiye da sauran ƙasashe masu tasowa, kuma ba a buƙatar sanya takunkumin ƙuntatawa kamar rufe gidajen abinci da shagunan sayar da kayayyaki da ƙarfi ba.
An soke wasu bukukuwa kuma tun daga ranar 28 ga watan Maris, Singapore ta fara ba da shawarar 'yan ƙasa su zauna a gida, amma makarantu sun sake buɗewa a ranar 23 ga watan Maris, a lokacin da aka tsara bayan lokacin hutu.
Yawancin sauran ƙasashe kamar Iceland da Koriya ta Kudu sun yi nasarar sarrafa cutar ta hanyar bin diddigin lamba, hana tafiye-tafiye na cikin gida, gwaji da keɓewa, amma ta hanyar rage yawan kulle-kulle.
Wani bincike na kididdiga ya nuna cewa kasashen da suka yi gwaji da yawa fiye da wadanda suka mutu, suna da ƙananan mutuwar, saboda haka, mafi yawan lokuta, ana iya gano mutanen da ba su da alamun cutar.
Hukumar lafiya ta duniya ta ba da shawarar cewa kasashen da ba su da damar yin gwaji kuma masu binciken na kasa da ke da iyakantaccen gogewa game da COVID-19 su aika da samfurori biyar na farko na COVID-19 da kuma samfurori goma na farko na COVID-19 zuwa ɗayan dakunan gwaje-gwaje 16 da WHO ta ambata don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka ambata, bakwai suna Asiya, biyar suna Turai, biyu suna Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
"% na gwajin da aka samu" a cikin teburin da ke ƙasa yana da tasiri ga manufofin gwajin ƙasar.
Duk da haka, idan aka gwada sauran abubuwan, ko an gano alamun cutar ko a'a, za a sami kashi kashi sama da ɗari na waɗanda suka sami gwaji a asibiti fiye da waɗanda aka gwada a cikin ƙasa.
Wanke hannu, ko kuma wanke hannu, aikin wanke hannu ne da ake yi don kawar da ƙasa, ruwa, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Yin wanka a kai a kai a lokutan da suka fi muhimmanci a rana yana hana kamuwa da cututtuka da yawa, kamar tari da kuma ciwon kumburi, wanda ke sa hannuwanmu su shiga bakina.
Mutane za su iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannu kafin su taɓa idanunsu, hancinsu, ko bakinsu ba (watau, fata mai laushi).
Abubuwa biyar da suka fi muhimmanci a rana da ake bukatar wanke hannu da sabulu su ne: kafin da bayan wanka, bayan wanke ko kuma sauya kayan wanka, kafin a yi wa jariri nono, kafin a ci da kuma dafa abinci, ko kuma bayan da aka yi amfani da nama mai naman gwangwani, kifi ko tsuntsu.
Idan babu ruwa da sabulu, za a iya wanke hannuwanka da ruwa, Hukumar Lafiya ta Duniya ta ba da shawarar yin wanka a sau da yawa:
Kafin dafa abinci, lokacin dafa abinci, da kuma bayan.
Kafin ka kula da wani mai ciwo da kuma bayan ka kula da shi.
Bayan an canja gashin gashi ko kuma an wanke gashin yaro da ya yi lalata.
Bayan ka yi tari, ka yi tari, ko kuma ka yi tari.
Bayan ka taɓa dabba, abinci ko naman dabba.
Sanin hannu na likita shine tsabtace jiki da ke tattare da hanyoyin likita.
Yin wanka kafin a ba da magani ko kuma a kula da mutum zai iya hana ko kuma rage yaduwar cutar.
Babban manufar maganin wanke hannu shi ne tsabtace hannu daga abubuwa masu cutarwa (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta) da kuma sunadarai masu cutarwa ko masu cutarwa.
Wannan abu ne mai muhimmanci ga mutanen da suke sarrafa abinci ko kuma waɗanda ke aiki a fannin kiwon lafiya, amma kuma yana da muhimmanci ga talakawa.
Yin wanka hannu yana da fa'idodi masu yawa na kiwon lafiya, ciki har da rage yaduwar cutar influenza, coronavirus da sauran cututtukan da ke kamuwa da cuta; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Kuma wannan ya hada da rage yawan mutuwar jarirai a cikin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa yin wanka a hannu zai iya inganta tsayin yara a ƙasa da shekara biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da kuma tari ta hanyar fara sauya halaye kamar wanke hannu da sabulu.
Wannan sauƙin aiki zai iya rage yawan mutuwar da ke tattare da cututtukan nan da kusan kashi 50 cikin ɗari.
Yin amfani da kayan da ke motsa wanke hannu zai iya rage yawan yawan zubar da jini da kusan kashi ɗaya bisa uku, kuma zai iya kwatanta shi da samar da ruwa mai tsabta a cikin ƙananan albashi.
Rashin safa a gidaje, makarantu da al'ummomi a duniya shine hanya mafi inganci da arha don hana tari da cututtukan numfashi (ARIs).
Rashin ƙwayar cuta mai suna ARI, yana da babbar sanadin mutuwar yara a ƙarƙashin shekara biyar, wanda ke haifar da mutuwar kimanin yara miliyan 18 a kowace shekara.
Kusan yara miliyan 35 ne ke mutuwa a kowace shekara sakamakon ciwon kumburi da kumburi.
UNICEF ta ce, fiye da allurar rigakafi ko kuma maganin rigakafi, yin amfani da sabulu don wanke hannu kafin cin abinci da bayan bayan wanka zai iya ceton rayuka da yawa, yana rage mutuwar da ke tattare da tari da kusan rabin, da kuma mutuwar da ke tattare da cututtukan numfashi da ke fama da ciwon.
Ana haɗa wanke hannu da sauran ayyukan tsabtace hannu a matsayin ɓangare na ayyukan ruwa, tsabtace jiki da tsabtace jiki (wash).
Yin wanka yana ba da kariya daga cutar Impetigo, wadda ta shafi jiki.
Ƙananan sakamako mai illa na wanke hannu shi ne, wanke hannu a kai a kai zai iya sa fata ta bushe.
Wani bincike da aka yi a shekara ta 2012 a Denmark ya nuna cewa yawan wanke hannu zai iya haifar da cututtukan fata kamar cinye hannu, zubar da hanci da aka sani da "hanci" ko cututtukan fata, wanda ke faruwa musamman a cikin ma'aikatan kiwon lafiya.
Ana kuma ganin wanke hannu sau da yawa a matsayin alamar rashin daidaito na tunanin aiki (OCD).
Akwai lokatai biyar a rana da ake bukatar a wanke hannayenku da sabulu don rage yaduwar cutar: bayan zuwa gidan wanka (ƙananan, wanka), bayan wanke ɗakunan jariri (bayan canza ɗamara), kafin a shayar da jariri, kafin cin abinci da kuma dafa abinci, ko kafin/bayan da aka yi amfani da nama mai naman kaza, kifi ko tsuntsaye.
A wasu lokatai, a lokacin da ya kamata a yi amfani da hanyoyin wanke hannu don hana yaduwar cutar, kafin da bayan da aka yi wa raunuka da aka yanke ko kuma wasu raunuka; bayan da aka yi masa tawaye, ya yi tari ko ya yi masa tawaye; bayan da ya taɓa ƙashin dabba ko kuma ya yi wa dabba tawaye da kuma bayan ya taɓa shara.
A ƙasashe da yawa, sabulu ba ya wanke hannu sosai.
Wani bincike a shekara ta 2015 a kasashe 54 ya nuna cewa a matsakaita, 38.7% na gidaje suna wanke hannu da sabulu. Wani bincike a shekara ta 2014 ya nuna cewa yawan wanke hannu a Saudiyya ya kai kashi 95 cikin dari, a Amurka kusan kashi 77 cikin dari, kuma a China ya kai kashi 23 cikin dari. Wasu hanyoyin da suka sauya ayyuka yanzu suna nuna cewa ana samun karuwar wanke hannu da sabulu a lokutan da suka dace.
Shirin Kula da Lafiya na Muhimmanci da Ma'aikatar Ilimi ta Philippines ta gabatar a matsayin misali na yadda za a inganta lafiyar yara da kuma inganta ilimin yara.
Kasancewa da maganin kashe kwayoyin cuta sau biyu a shekara, da kuma wanke hannu da sabulu a kullum, da kuma goge hakora da fluoride, na cikin muhimmin shirin kasa.
An yi nasarar aiwatar da shi a Indonesia.
Ana samun karuwar kwayoyin cuta daga fata ta hanyar amfani da sabulu ko kuma wankewa tare da ruwa.
Babban aikin sabulu da kuma wankewa shine rage hana narkewa da kuma kara narkewa.
Ruwan da ya kamata ya wanke fata bai isa ba domin kitse da furotin da ke cikin ƙasa ba su iya narkewa cikin ruwa nan take ba.
Duk da haka, ana yin tsabtace ta ta hanyar samun ruwa mai kyau.
Saboda yadda ake sake amfani da sabulu, akwai yiwuwar cewa sabulu mai ƙarfi yana da ƙwayoyin cuta daga amfani da shi a baya.
Wasu nazarin da aka yi game da yadda kwayoyin cuta ke yin hijira ta hanyar sabulu mai ƙonewa sun nuna cewa ba zai yiwu ba a yi hijira ba saboda kumfa ta lalata kwayoyin.
CDC har yanzu tana cewa "sabo mai ruwa wanda ba a taɓa shi da hannu ba ne mafi kyau a yi amfani da shi".
An kara yawan amfani da sabulu na maganin rigakafi a tsakanin mutanen da ke da faɗakarwa game da lafiyarsu.
Har zuwa yau, babu wani adadin maganin kashe kwayoyin halitta ko kuma maganin kashe kwayoyin halitta da aka ba da shawarar.
Duk da haka, sabulu na maganin rigakafi suna da wasu kwayoyin rigakafi na yau da kullum, kamar trichlosan, wanda ke da jerin jerin abubuwan da ke hana damuwa na kwayoyin.
Saboda haka, ba a zaɓa maganin rigakafin damuwa don sabulu na kashe kwayoyin ba, amma ba za su iya zama kamar yadda aka ambata ba.
Baya ga surfactants da kuma magungunan da ke kare fata, ana iya samun acid (acetic acid ascorbic acid, lactic acid), maganin rigakafi mai aiki benzogenic acid, da sauran kayan kwantar da fata (coughfoods, bitamin, methyl, kayan tsami). Wani bincike mai zurfi na masu amfani da jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullum suna da tasiri wajen hana cututtukan cututtuka kamar su trichlorinated disinfectants.
Ruwan da ke da zafi sosai da zai iya wanke hannuwanmu bai isa ya kashe kwari ba.
A jiki, ƙwayoyin cuta suna ƙaruwa sosai (37 ° C).
Amma, ruwa mai laushi ya fi ruwan sanyi na sabulu kyau wajen cire man fetur daga ƙasa da kuma ƙwayoyin cuta.
Duk da haka, bisa ga abin da mutane suke imani, binciken kimiyya ya nuna cewa ruwa mai laushi ba shi da tasiri wajen rage nauyin kwayoyin halitta daga hannayensu.
Wani kayan tsabtace hannu wanda ba shi da ruwa ko maganin hana hana kwayar hannu.
A cikin ƙarshen 1990s da farkon karni na 21, kayan tsabtace hannu marasa ruwa (wanda aka fi sani da ruwan sha-tushen hannu, antiseptic hannu, ko kuma mai tsabtace hannu) sun fara zama sananne.
Yawancin isopropyls suna cikin nau'i na gel tare da wakili mai narkewa kamar carbomers (polymers na acrylic acid) tare da alcohol ko ethanol da aka tsara, ko a cikin ruwa mai danshi kamar glycerin, ko kuma a cikin kumfa don rage tasirin bushewar giya.
Aƙalla kashi 60 zuwa 90 cikin 100 na maganin hana shan giya da ke cikin maganin hana shan magani yana kashe ƙwayoyin cuta.
Abincin da ke kashe kwayoyin cuta, da kuma ƙwayoyin cuta masu yawa (MRSA da VRE), da kuma tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, harps, RSV, rhinovirus, vaccinia, influenza, da hepatitis) da kuma fungi.
Abincin da ke cikin wani sanitizer mai amfani da giya ya ƙunshi kashi 70 cikin dari na giya, kuma bayan 30 seconds na amfani da shi, yana kashe 99.97 cikin dari na hannayen hannu (ƙarancin log 3.5 wanda ya yi daidai da rage 35 decibels) da kuma 99.99 cikin dari zuwa 99.99 cikin dari na hannu (ƙarancin log 4 zuwa 5).
Ana amfani da maganin hana shan giya don hana shan magani da kuma shan giya don tsabtace hannu don tsabtace hannu.
Ka shafa hannunka gaba da baya da kuma yatsunka na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da kuma na gaba da na gaba da kuma na gaba da na gaba da na gaba da na gaba da kuma na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da zuwa na gaba da na gaba da na gaba da na gaba da na gaba da na gaba da zuwa na gaba da na gaba da na gaba da zuwa na 30 da zuwa zuwa zuwa zuwa.
Ka wanke yatsanka, ka shafa su a kafafunka. Cibiyoyin Kula da Cututtuka na Amirka sun ba da shawarar cewa ka wanke hannuwanka da tsabtace hannu bayan ka wanke hannuwanka idan ka ga hannuwanka sun ƙazantu.
Ana amfani da su sosai saboda sauƙin amfani da su da kuma saurin kashe kwayoyin halitta. Amma, kada su zama maye gurbin wanke hannu idan babu sabulu da ruwa.
Ana iya amfani da maganin hana shan giya sau da yawa don ya bushe fata, don haka a saka mai laushi da/ko mai shafawa.
Wannan ƙirar za ta iya rage ko kawar da tasirin shan giya ta hanyar ƙara glycerin da/ko wasu kayan taushi na fata.
A cikin gwaji na asibiti, maganin shan giya mai ƙunshe da hannu mai ƙunshe da emollients ya rage yawan zazzabi da bushewar fata fiye da sabulu ko maganin rigakafi.
Ba a yawan samun abinci a cikin hanci ko kuma a cikin fata mai haɗari, cututtukan hanci masu haɗari, ko kuma a cikin hanci masu haɗari.
Saurin shan ruwa da sabulu ya jawo hankalin mutane da ke da rashin lafiyar fata fiye da wanke hannu.
Duk da ingancin su, wakilai marasa ruwa ba sa wanke hannuwan kayan aiki, suna kashe su kawai.
Wannan shi ne dalilin da ya sa tsabtace hannu ba ta da tasiri sosai wajen hana kamuwa da cuta ta hanyar sabulu da ruwa, domin suna zama a hannun masu kamuwa da cuta.
Aikin tsabtace hannayen hannu na da yawa daga cikin abubuwan da ke cikinsa da kuma tsarinsa, kuma ya fi karfin giya da kuma shan giya.
Kwanan nan, an nuna ci gaba da kuma adana aikin antibacterial a cikin maganganun da ke amfani da benzalkonium chloride, sabanin abin sha, inda aka nuna raguwar aiki bayan amfani da shi akai-akai, wanda zai iya zama sakamakon ci gaba da mummunan halayen fata.
Mutane da yawa a cikin talakawa ba su iya sayen sabulu ba kuma suna amfani da toka da ƙasa.
Ash da ƙasa suna iya zama da tasiri fiye da ruwa amma ba su da tasiri fiye da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko toka sun lalace da kwayoyin cuta, za su iya sa yaduwar cutar ta yi yawa maimakon ta rage.
Kamar sabulu, ƙasa tana da maganin kashe kwayoyin halitta domin tana da wani abu mai ƙanshi wanda yake sa ta zama mai ƙanshi.
WHO ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin lokacin da sabulu ba ya samuwa.
Tsarin wanke hannu da aka ba da shawarar da Cibiyar Kula da Cututtuka ta Amurka ta bayar don hana yaduwar cutar ya ƙunshi matakai masu zuwa:
Ka wanke hannunka da ruwa mai gudana.
Ana ba da shawarar yin amfani da ruwa mai gudana saboda tafkuna na iya zama masu gurɓataccen yanayi, kuma yanayin zafin ruwan ya nuna cewa ba shi da bambanci sosai.
Ka zuba sabulu mai yawa a hannunka, ka shafa shi, ka zuba shi a bayan hannunka, a yatsunsu, a ƙarƙashin kusoshi, kuma ka yi turɓayarwa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannu sosai idan aka yi amfani da sabulu fiye da wanke hannu da ruwa mai tsabta.
Ka yi amfani da hannunka na akalla na biyu.
Saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin sa.
Ka wanke hannunka a ƙarƙashin ruwa mai gudana.
Yin wanka a cikin tafki na iya gurɓata hannayenmu.
Ka wanke hannunka da tufafi masu tsabta ko kuma ka bar iska ta bushe.
Hannun da suka yi ta ɗumi da kuma na rashin ƙarfi suna da saurin gurɓatawa.
Kayan aikin wucin gadi da kuma na'urar da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da kuma aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da da a da su da aka yi da aka yi da da aka yi da da aka yi da aka yi da da da aka yi da aka yi da da da aka yi da da da da da da da da aka yi da aka yi da aka yi da da aka yi da da da aka yi da aka yi da aka yi da da aka yi da aka yi da da da da aka yi da da da da da aka yi da da da aka yi da aka yi da da da aka
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana bushewar hannu; bushewar fata na iya cutar da fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya yin zaɓuɓɓukan da suka fi dacewa don yin amfani da wanke hannu a wuraren da babu ruwa na famfo da / ko sabulu. Misali, a cikin ƙasashen da ke tasowa, idan ya cancanta, zuba ruwa daga cikin jerican da aka rataye ko kuma amfani da toka tare da ramuka masu dacewa. Akwai zaɓuɓɓukan kiyaye ruwa a ƙarƙashin yanayin iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashen da ke tasowa), kamar "tippi taps" da sauran zaɓuɓɓukan da suka fi dacewa, kamar su "tippi taps" da sauran zaɓuɓɓukan da suka fi dacewa.
Tape wani fasaha ne mai sauki wanda ake amfani da shi wajen rataye wani gwangwani da igiya don zuba ruwa kadan a hannayenmu da kuma sabulu, tare da hanci da ke motsa hanci.
Yin bushewa da hannuwanmu a hanya mai kyau wani ɓangare ne na tsarin tsabtace jiki, amma akwai ɗan muhawara game da yadda za a bushe hannuwanmu a cikin wanka na jama'a.
Ƙara yawan bincike ya nuna cewa tawul ɗin takarda suna da kyau fiye da na'urar busar hannu mai lantarki a cikin wanka.
A shekara ta 2008, Jami'ar Westminster ta London da kuma taron Turai na Tissue Symposium sun ba da tallafi ga binciken don kwatanta matakan tsabtace da aka bayar ta hanyar takarda, kayan bushewa na hannu da ke amfani da iska mai zafi, da kuma na zamani na jet-air.
Bayan an wanke hannayenmu da bushewa da iska mai zafi, an ga cewa adadin ƙwayoyin cuta a yatsunsu ya ƙaru da kashi 194 cikin ɗari, kuma a cikin tanda ya ƙaru da kashi 254.
Bayan da jirgin sama ya bushe, adadin kwayoyin da ke yatsunsu ya karu da kashi 42 cikin 100 a kan matsakaici, kuma adadin kwayoyin da ke cikin tukunyar ya karu da kashi 15 cikin 100.
Bayan wanke hannu da tawul ɗin takarda, adadin kwayoyin da ke yatsunsu ya ragu da kashi 76 cikin ɗari, kuma a kan tafasa ya ragu da kashi 77 cikin ɗari. Masana kimiyya sun gudanar da gwaje -gwaje don bincika ko akwai yiwuwar gurɓatawar sauran masu amfani da wanka da kuma yanayin wanka a sakamakon kowane irin bushewa.
Jirgin sama mai bushewa wanda ke fitar da iska daga cikin na'ura a saurin mita 180 a dakika (kilomita 650 a kowace awa; 400 mph) yana iya fitar da ƙwayoyin cuta daga hannayensu da na'urar kuma ya gurɓata masu amfani da wanka da kuma yanayin wanka har zuwa mita 2.
Da amfani da na'urar busar da iska mai zafi, kwayoyin cuta suna yaduwa daga na'urar busar da iska mai zafi zuwa mita 0.25.
Babu wani yaduwar da aka samu daga takarda. A shekara ta 2005, wani binciken da TUV Produkt und Umwelt ya yi ya nuna cewa akwai hanyoyi daban-daban na juya hannu.
Bayan an bushe hannu, an lura da canje -canje a cikin adadin ƙwayoyin cuta:
Akwai masana'antun bushewa da yawa a duniya, kuma an kwatanta bushewa da kayan wanka da takarda.
A lokacin tafiya, wanke hannu idan babu sabulu da ruwa, wanke hannu yana da zaɓi don wanke hannu.
Dole ne a ƙunshe da akalla kashi 60 cikin 100 na giya a cikin kayan tsabtace hannu na giya.
Magungunan Hungary Ignaz Semmelweis sun tabbatar da cewa yin wanka a hannu ya zama wajibi bayan sun bincika yadda yake da tasiri a cikin yanayin asibiti (a cikin 1846).
Akwai na'urori na lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa yin amfani da su ya rage yawan kamuwa da cuta.
Aikin wanke hannu na likita na tsawon dakika 15 ne, kuma yana bukatar a yi amfani da sabulu da ruwa da kuma gel da yawa, kuma a yi wanka da hannu da hannu.
Dole ne a haɗa hannayensu a cikin wani wuri kuma a haɗa su tare.
Idan ƙusa ta yi kama da ƙusa, za a iya cire ta ta amfani da bristles.
Saboda haka, yana da muhimmanci a wanke hannuwanmu da kuma wanke su da tsabta.
Bayan an bushe, sai ka yi amfani da takarda don rufe ruwa (kuma ka buɗe ƙofar waje idan ya cancanta)
Wannan zai hana hannuwanmu su sake gurɓata.
A cikin kiwon lafiya, wanke hannu yana nufin kawar da kwayoyin cuta masu cutarwa da kuma hana su yaduwa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu a yawancin yanayin kiwon lafiya ya kasance da rashin yarda, inda likitoci da ma'aikatan jinya da yawa suke manta da wanke hannu kafin su taɓa marasa lafiya, kuma hakan yana haifar da kamuwa da kwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu hanyoyin da suka dace za su iya rage yawan cututtukan jini da ke tattare da kateter da kashi 66 cikin ɗari.
Za a iya samun jagorar tsabtace hannu ta hanyar hukumar a shafin yanar gizon su don yin tsokaci ga jama'a.
Whitby da sauransu sun shirya wannan bita.
Idan ana bukatar a nuna cewa an bi da shi a kai a kai, ana iya auna da kuma tabbatar da tsabtace hannu ta hanyar na'urorin kasuwanci.
Hukumar lafiya ta duniya ta ce akwai "lokaci biyar" da za a yi amfani da su wajen wanke hannu:
Idan akwai wani abu da ya shafi jini ko kuma wani abu da ke cikin jikin mutum
Kafin aikin kashe kwayoyin cutar,
Bayan an yi wa mai haƙuri magani, sabulu da ke dauke da sinadarai masu hana kamuwa da cuta (abin da ake kira "farfadowa da miyagun ƙwayoyi" ko "sanyawa da ƙwayoyin cuta") yana sa hannu ya yi wanka.
Ana iya yin amfani da maganin kashewa kafin tiyata ko a wuraren da ke da ƙwayoyin cuta masu yawa, don motsa jiki na tiyata, ana buƙatar famfo mai kunnawa da rufewa ba tare da taɓa hannu ba, chlorhexide ko iodine wash, tawul mai tsabta don bushewa bayan wanka, da kuma wasu kayan aikin tsabtace tsabta don tsabtace ƙafafun hannu da yatsunsu don shafawa.
Dole ne a cire dukan kayan ado.
Don yin wannan aikin, dole ne a wanke hannuwan da hannuwan daga kusurwa zuwa kusurwa na tsawon minti 2-6.
Ba za ku yi dogon lokaci ba (minti 10)
Idan kana wanke hannu, kada ka bar ruwa ya koma hannunka daga wuyan hannu zuwa gefen hannu.
Bayan an gama wanke hannu, ana yin wanke hannu da kayan wankewa da aka yi da rigar da ba ta da ƙwayoyin cuta kuma ana saka shi a kan rigar tiyata.
Don rage yaduwar kwayoyin cuta, ya fi kyau a wanke hannu kafin kuma bayan kula da mai ciwo ko kuma a yi amfani da maganin kashe kwayoyin cuta.
Don sarrafa kamuwa da cutar ta Staphylococcal a asibiti, an gano cewa mafi yawan amfanin wanke hannu ya fito ne daga wanke 20% na farko, kuma lokacin da aka ƙara yawan wanke hannu sama da 35%, an sami fa'ida mafi girma.
Idan aka kwatanta wanke hannu da sabulu mai laushi, ana samun cutar ta kamuwa da kwayoyin cuta fiye da sau uku a cikin abinci. Kamar yadda a kowane dakika 30, idan aka kwatanta wanke hannu da maganin hana shan kwayoyin cuta da wanke hannu da sabulu mai hana shan kwayoyin cuta, an gano cewa wanke hannu da maganin hana shan kwayoyin cuta ya rage kamuwa da kwayoyin cuta da kashi 26% fiye da wanke hannu da maganin hana shan kwayoyin cuta.
Amma sabulu da ruwa sun fi tasiri wajen rage cutar H1N1 Influenza A da kuma Clostridium daga hannayen da ke dauke da kwayoyin halitta masu wuya fiye da ruwan sha na barasa.
Ana bukatar karin bincike kan abin da ya fi tasiri a cikin tsarin kiwon lafiya daban-daban.
A kasashe masu tasowa, wanke hannu da sabulu ana ganin shi ne hanya mai arha da kuma bukata don samun lafiya da kuma ingantaccen abinci mai gina jiki.
Amma rashin wadatar ruwa mai amintacce, rashin sabulu ko kuma wanke hannu a gidajen mutane, a makaranta da kuma wuraren aiki ya sa samun halayyar wanke hannu a duniya ya zama ƙalubale.
Alal misali, duk da cewa mafi yawan yankunan karkara na Afirka suna da zaɓi mai araha don yin wanka, babu wanka a kusa da kowane gidan wanka na jama'a ko na masu zaman kansu.
Amma, rashin wanke hannu zai iya zama sakamakon rashin amfani da sabulu ko ruwa fiye da rashin amfani da sabulu.
Ingantawa da kuma bayar da sabulu don wanke hannu na iya tasiri kan yanke shawara, yana iya haifar da wayar da kan jama'a game da fa'idodin wanke hannu, da kuma canza halaye na tsawon lokaci na yawan jama'a.
Don aiwatar da shi yadda ya kamata, dole ne a lura da kimanta shi.
Binciken da aka yi na nazarin 70 ya nuna cewa tsarin zamantakewa na zamantakewa yana da tasiri wajen kara yawan wanke hannu a cikin LMIC, yayin da ayyukan tallan zamantakewa ke da tasiri. Misali mai tasiri game da wanke hannu a makarantu shine "hanyar tauraro uku" ta UNICEF wanda, a tsakanin sauran bukatun tsabta, ya ƙarfafa makarantu suyi sauki, mai araha don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu.
Idan an samu mafi ƙarancin ƙimar, za a iya samun ci gaba daga ɗaya zuwa uku.
Wannan zai iya zama wani ɓangare na ayyukan da ake yi na inganta wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya, wadda ke kokarin kawo sauyi a dabi'a, misali ne na wani shiri na wayar da kan jama'a.
Wasu bincike sun yi la'akari da yadda ake hana yin amfani da kayan wanke hannu a ƙasashe masu tasowa.
Amma, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi araha fiye da wankewa da ruwa da kuma wasu hanyoyin tsabtace jiki.
Ga mutanen da ke cikin yanayi mafi rauni, kamar uwaye da suka haifi yara ko kuma waɗanda suka ji rauni a asibiti - farkon tsakiyar karni na 19 ne manyan mutane biyu da suka yi aiki a kan tsabtace hannu suka fahimci muhimmancin wanke hannu ga lafiyar ɗan adam: Igna Zsemel, likitan Hungary da ke aiki a Vienna, Austria, da kuma "Fundar Turanci na Nursing na zamani" Florence Nightingale.
A lokacin, mutane da yawa sun gaskata cewa miyagun ƙwayoyi suna sa mutane su kamu da cutar.
A cikin 1980, cibiyoyin kula da cututtuka da rigakafi a Amurka sun karfafa hannuwan hannu a matsayin babban mataki na hana yaduwar cututtuka sakamakon barkewar cutar abinci da cututtukan da suka shafi kiwon lafiya.
Futar da ake yi na Swine Flu a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa kasashen da dama su fahimci muhimmancin wanke hannu da sabulu don kare kansu daga irin wadannan cututtukan.
Alal misali, a Jamus, a cikin gidajen wanka na jama'a da kuma a cikin gine-ginen ofis da kuma a cikin gidajen wanka a kan tashar jiragen sama, an kafa zane-zane a kusa da wanke-wanke.
Yin wanka da hannu a wani abu yana nufin cewa mutum yana son ya ɗauki alhakin wani abu ko kuma ya raba abubuwan da suka faru.
Wannan furucin ya fito ne daga nassi na Matta inda Pantius Pilate ya wanke hannunsa game da shawarar da ya yi na gicciye Yesu Kristi, amma a wasu al'ummomin Turanci, wannan furucin ya zo da amfani da shi sosai.
A littafin Shakespeare na Macbeth, Lady Macbeth ta yi amfani da wankewa don ta nuna cewa tana da laifi game da laifuffukan da ta aikata da kuma laifuffukan da aka tilasta wa mijinta ya yi.
An kuma gano cewa mutane sukan riƙa wanke hannuwansu sau da yawa fiye da wasu idan suka tuna ko kuma suka yi tunani a kan wani abu marar kyau, kuma suna da halin da ya fi muhimmanci a wajen yin amfani da na'urar wanke hannu.
Hakazalika, waɗanda aka ba da izinin wanke hannuwansu bayan yin tunani suna da ƙarancin haɗari su shiga wasu ayyukan da ke ba da "tsabta" kamar aikin sa kai.
Ana yin amfani da ruwa don wanke hannu, amma ba tare da amfani da sabulu ba, yana nufin wanke hannu na alama, wani ɓangare ne na al'adar wanke hannu, wanda ya haɗa da Baha'u'llah, Hindu, Tewilah da Ne'elital a cikin Yahudanci, Lawab a cikin Kiristanci, da kuma Wudu a cikin Musulunci.
A Hindu, Yahudanci da Musulunci, wanke hannu bayan shiga gidan wanka ya zama wajibi.
Kuma a cikin addinai na Hindu, Buddha, Sikh, Yahudanci da Musulunci, wanke hannu kafin da kuma bayan cin abinci wajibi ne.
Gudanar da haɗarin aiki na COVID-19
Gudanar da hadarin aiki na COVID-19 shine aikace-aikacen aminci da kiwon lafiya na kasuwanci don sarrafa hadarin don hana cutar COVID-19 (COVID-19)
Ingantaccen kula da haɗari a wurin aiki ya dogara da yanayin wurin aiki da yanayin aiki, wanda ya dogara da tushen kamuwa da cuta, tsanani na cutar a cikin al'umma da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya zama mai rauni ga COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA), a cikin ayyukan da ke da ƙananan haɗarin kamuwa da cuta, akwai ƙarancin hulɗa na kasuwanci tare da mutane da sauran abokan aiki waɗanda ke ba da shawarar matakan hana kamuwa da cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida yayin da suke rashin lafiya, da kuma tsabtace numfashi da kuma lalata wuraren aiki.
Ayyuka masu haɗarin kamuwa da cuta na matsakaici sun haɗa da ayyukan da ke buƙatar kasancewa a saman ko kusa da waɗanda ba a san ko suna da wata shakka game da kamuwa da COVID-19 ba, amma waɗanda za su iya kamuwa da cutar ta hanyar kamuwa da cuta ta al'umma ko tafiya ta duniya.
Wannan ya haɗa da ma'aikata da ke hulɗa da jama'a, kamar makarantu, wuraren aiki masu yawan jama'a da wasu manyan wuraren sayar da kayayyaki.
Baya ga matakan hana kamuwa da cuta na asali, kula da haɗari ga wannan rukunin ya haɗa da kula da iska ta amfani da matattarar iska mai ƙarfi, amfani da tsaro na sneez, da kuma samun kayan tsaro na mutum idan mutum yana fama da COVID-19.
OSHO ta ɗauki ma'aikatan kiwon lafiya da ma'aikatan gawa da suka sadu da wanda aka sani ko kuma ake zargi da kamuwa da COVID-19 a matsayin masu haɗarin kamuwa da cutar, wanda zai iya haifar da haɗarin kamuwa da cutar idan ma'aikaci ya yi aiki da ke samar da aerosol ko kuma ya tattara ko ya yi amfani da samfurin wanda aka sani ko ake zargi da COVID-19, wanda zai iya haifar da haɗarin kamuwa da cutar.
Waɗannan matakan haɗari da suka dace da ma'aikata sun haɗa da sarrafa injiniya kamar dakunan iska masu ƙarancin matsa lamba da kayan aikin tsaro na mutum waɗanda suka dace da wannan aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya kasancewa a wurin aiki saboda rashin lafiya, bukatar kula da wasu, ko kuma tsoron kamuwa da cutar.
A cikin ma'anar abin da ake buƙata da kuma yadda ake samun waɗannan abubuwa, samfuran kasuwanci na iya bambanta (kamar sayen a lokacin da akwai ƙananan jama'a ko sayen ta hanyar rarrabawa ko sabis na tuki).
A ƙarshe, ana iya hana shigowar kaya daga yankunan da COVID-19 ke da tasiri sosai. Ana iya amfani da shirye-shirye da shirye-shiryen amsawa don cutar don ɗaukar matakan kariya.
Suna magance matakan haɗari da ke tattare da wurare daban-daban na aiki da aiki, ciki har da tushen kamuwa da cuta, abubuwan haɗari daga gida da zamantakewa, da kuma abubuwan haɗari ga kowane ma'aikaci, kamar tsufa ko yanayin likita na tsufa.
Suna kuma tsara tsarin gaggawa don magance haɗarin da ake buƙata da kuma yanayin da zai iya faruwa a sakamakon barkewar cutar.
Shirye-shiryen shiri da kuma mayar da martani ga cututtukan cututtuka na iya zama batun shawarwari na kasa ko na kasa.
Manufofin da ake da su na amsawa ga barkewar cutar sun hada da rage watsawa tsakanin ma'aikata, kare mutanen da ke fuskantar haɗarin samun rikitarwa, kula da ayyukan kasuwanci da rage tasirin da ba daidai ba ga sauran abubuwan da ke cikin sarkar wadatar su.
A cikin al'ummomin da ake kasuwanci, yadda ake fama da cutar yana shafar yadda ake amsawa.
Akwai tsarin tsarin kula da haɗari wanda aka yi amfani dashi sosai a cikin aminci da lafiya na kasuwanci don tsarawa bisa ga tasirin kula da haɗari.
Inda ba za a iya kawar da haɗarin COVID-19 gaba ɗaya ba, ingantattun sarrafawa sune sarrafawa ta injiniya, sannan sarrafawa, kuma ƙarshe, kayan tsaro na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayyar ma'aikaci ba, kuma yana iya zama mafi arha don aiwatar da shi.
Gudanar da gudanarwa yana nufin sauya manufofi ko hanyoyin aiki wanda ke buƙatar aiki da ma'aikaci ko ma'aikaci.
Ana ganin cewa kayan aikin kare mutum (PPE) ba su da tasiri sosai fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu cututtuka.
Ya kamata a zabi dukkan PPE bisa ga hadarin da ke tattare da ma'aikaci, ya kamata su dace da yadda ake amfani da su (misali masu numfashi) kuma a sanya su yadda ya kamata, a duba su akai-akai, a kula da su kuma a maye gurbin su kamar yadda ake bukata, kuma a cire su yadda ya kamata, a tsabtace su da kuma kiyaye su, ko kuma a kawar da su yadda ya kamata don hana kamuwa da cuta.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHO), ayyukan da ke da ƙananan haɗarin kamuwa da cuta suna da ƙarancin hulɗa na kasuwanci da jama'a da sauran abokan aiki.
Ana ba da shawarar yin amfani da matakan rigakafin kamuwa da cuta na asali ga kowane irin wurin aiki, wanda ya haɗa da wanke hannu gaba ɗaya da gaba ɗaya, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, bin ɗabi'un numfashi tare da rufe bakinsu yayin tari da taɓawa, samar da kwanduna don zubar da takarda da shara, shirya don sadarwa ko yin aiki daban-daban idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da kuma tsabtace da lalata wuraren aiki na yau da kullun.
Ganowa da kewaye da masu cutar da ke faruwa da su nan take yana da muhimmanci wajen kiyaye ma'aikata, masu amfani, baƙi da sauransu a wuraren aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke nuna alamun cututtukan numfashi masu tsanani su zauna a gida har sai sun sami zazzabi aƙalla awanni 24 ba tare da shan wasu magunguna masu rage zazzabi ko sauya alamun ba, alamun zazzabi da sauran alamun ba, kuma manufofin izinin rashin lafiya suna da sassauƙa, wanda ke ba ma'aikata damar kasancewa a gida don kula da wani mai rashin lafiya a cikin danginsu, kuma ma'aikata suna sane da waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin kamuwa da cuta mai matsakaici sun haɗa da ayyukan da ke buƙatar samun kusanci na tsawon ƙafa shida (1.8m) daga mutanen da ba a san su ko kuma ba a yi zargin suna da cutar COVID-19 ba, amma saboda watsawar al'umma da ke gudana a kusa da yankin kasuwanci ko kuma mutumin da ya yi tafiya ta duniya kwanan nan zuwa wuraren da COVID-19 ya yadu.
Wannan ya hada da ma'aikatan da suka samu hulɗa da jama'a na yau da kullun, kamar makarantu, wuraren aiki masu yawan jama'a da wasu manyan wuraren sayar da kayayyaki a wurare masu yawa. Waɗannan sun haɗa da shigar da matatun iska masu inganci a cikin kulawar injiniya don su da kuma manyan kungiyoyin masu haɗari, haɓaka yawan kula da kayan wasan kwaikwayo na iska, sanya kayan toshewa na zahiri kamar Snizz Guard na filastik mai haske da kuma shigar da taga mai motsawa don sabis na abokin ciniki. Waɗannan sun haɗa da shigar da matatun iska masu ƙarfi don haɗari da manyan kungiyoyin ilimi don ƙarfafa masu cutarwa a gida, haɓaka matakan tsaro na masu lafiya ta hanyar sadarwar kai tsaye, da samar da hanyoyin sadarwa na yau da kullun, da kuma samar da hanyoyin sadarwa na COVID-19 da ke buƙatar shigar da hotunan mutum ko kuma sanya kayan aiki na zamani don kula da yanayin aiki, da kuma samar da kayan aiki masu haɗari, da kayan aiki masu haɗari, da kuma samar da kayan aiki masu haɗari, da kuma samar da kayan aiki masu dacewa don kula da lafiyar jiki da masu amfani da kayan aiki, da kuma samar da kayan aiki masu dacewa don kula da lafiyar jiki da ke da yanayin aiki, da kuma samar da kayan aiki na yau da kullun, da kullun, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kuma kayan aiki.
Ma'aikata da ke cikin wannan rukunin haɗari ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da keɓe mutumin daga sauran mutane da nisan ƙafa 6, sanya wani memba na jirgin don yin hidimar mutumin da ke rashin lafiya, da ba da abin rufe fuska ga mutumin da ke rashin lafiya, ko kuma gaya wa mutumin da ke rashin lafiya ya rufe bakinsa da hanci da takardar ƙwayoyin cuta yayin da yake tari ko kuma ya yi tari.
Idan kana hidimar wani mai tafiya mai rashin lafiya ko kuma ka taɓa jikinsa ko kuma wata hanyar da za ka iya kamuwa da cutar, dole ne ka sa sa safofin hannu na likita da za a iya kawar da su kuma idan mai tafiya mai rashin lafiya yana da zazzabi, tari ko kuma yana da wahalar numfashi, dole ne ka sa ƙarin kayan tsaro na sirri tare da ma'aikatan jirgin.
Don jiragen ruwa masu tasowa da sauran jiragen ruwa masu jigilar kaya, har da jiragen ruwa masu jigilar kaya, ana buƙatar cire safofin hannu da sauran kayan da za a iya amfani da su a cikin jaka mai haɗari, sannan a tsabtace da kuma kashe wuraren da ke da cutar.
Idan aka gano wani mutum mai cutar a makaranta da kuma cibiyar kula da yara, CDC ta ba da shawarar rufe shi na ɗan lokaci don tsabtace da kuma kashe kwayoyin cutar, ko yana yadawa ko a'a.
Inda akwai karamin zuwa matsakaiciyar yaduwar al'umma, ana iya aiwatar da manufofin nesa da zamantakewa, kamar dakatar da wasu manyan ayyuka, gami da tafiye-tafiye na filin, taron jama'a da koyar da jiki ko cin abinci a cikin aji na addu'a ko gidan abinci, ƙara nisa tsakanin tebur, canza lokacin zuwa da fita, ƙuntata baƙi marasa mahimmanci, da kuma kafa cibiyoyin kiwon lafiya daban don yara masu alamun cutar kamar mura.
A yayin da ake samun kamuwa da cutar a cikin rukunin gida, tare da dabarun kiyaye nesa ta zamantakewa, ana iya yin la'akari da rufe makarantu na tsawon lokaci. Ma'aikatan da ke aiwatar da doka waɗanda ke yin ayyukan yau da kullun, CDC ta ɗauka cewa haɗarin gaggawa na kiwon lafiya ya ragu.
An shawarci jami'an tsaron da suke bukatar tuntuɓar wasu mutane da suka kamu da COVID-19 ko kuma waɗanda ake zargin suna da cutar su bi ka'idodin da ke tattare da kayan kariya na mutum, kamar yadda ake yi da masu ba da agaji na gaggawa.
Idan akwai kusanci a lokacin kulawa, ma'aikata su tsabtace su kuma su kashe su ta amfani da tsabtace gida ko wanke kafin su sake amfani da belts da kayan aikin su, kuma su bi ƙa'idodin aiki na yau da kullun don kawar da PPE da aka yi amfani da shi, warewa da wanke tufafi don tsawon lokaci mai sarrafawa.
OSHA ta ce wasu ma'aikatan kiwon lafiya da kuma gawawwakin suna fuskantar haɗarin kamuwa da cutar sosai ko kuma sosai.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da rarraba kiwon lafiya, taimako, dakin gwaje-gwaje da ma'aikatan sufuri na likita waɗanda ke hulɗa da sanannun ko waɗanda ake zargi da cutar COVID-19.
Idan ma'aikata suna gudanar da aikin samar da aerosol ko kuma suna tattara samfurori ko kuma suna kula da marasa lafiya da aka sani ko ake zargi da cutar COVID-19, suna da haɗarin kamuwa da cutar.
Ayyukan samar da aerosol sun haɗa da intubation, cuff induction, bronchoscopes, wasu tsarin hakori da kuma gwaji ko tattara samfurori masu haɗari.
A cikin ayyukan da ake yi a cikin gidajen jana'izar da ke da haɗarin kamuwa da cutar, akwai ma'aikatan da ke aiki don shirya gawawwakin waɗanda aka sani ko ake zargi da cutar COVID-19 a lokacin mutuwa; idan aka yi musu jana'izar, suna fuskantar haɗarin kamuwa da cutar.
Wasu wuraren kiwon lafiya da kuma gidajen jana'iza na iya samun iska mai ƙarancin matsa lamba.
Dole ne a yi amfani da samfurori tare da matakan tsaro na 3 na tsari.
Hukumar lafiya ta duniya (WHO) ta ba da shawarar cewa idan akwai masu zuwa da ake zargin suna da cutar COVID-19, a ware su a cikin dakin jira na musamman. Kamar sauran PPE, OSHA ta ba da shawarar cewa ma'aikatan da suka san cewa suna da cutar SARS-CoV-2 ko kuma suna aiki a cikin ƙafa 6 daga marasa lafiya da ake zargin suna aiki da kuma yin aikin samar da aerosol su yi amfani da na'urorin numfashi.
A Amurka, dole ne a yi amfani da N95 respiratory masks da aka amince da su ta NIOSH ko mafi kyau a cikin mahallin tsarin rigakafin numfashi na rubuce-rubuce, wanda ya haɗa da gwajin dacewa, horo, da gwajin likita.
Sauran nau'ikan rigakafin numfashi na iya samar da kariya mafi kyau kuma ma'aikata na iya zama mafi kwanciyar hankali. WHO ba ta ba da shawarar kare jiki gaba ɗaya, saboda COVID-19 cuta ce ta numfashi, ba ta yaduwa daga sauran hanyoyin jiki ba.
Hukumar ta WHO ta ba da shawarar cewa ma'aikatan da ke bincika wuraren shiga su yi amfani da abin rufe fuska kawai.
WHO ta ba da shawarar cewa ma'aikatan da ke tattara samfurori na numfashi, kula da su, ko kuma sufuri na marasa lafiya da ke ci gaba da maganin COVID-19 ba tare da wani aikin samar da aerosol ba, su yi amfani da masks na tiyata, tabarau ko kuma sutura, riguna da safofin hannu.
Idan an yi aikin samar da aerosol, ya kamata a yi amfani da N95 ko FFP2 na rigakafin numfashi maimakon abin rufe fuska.
Saboda rashin wadatar PPE a duniya, ana ba da shawarar yin amfani da shinge na zahiri kamar telemedicine, windows masu tsabta, wanda zai ba masu ba da sabis na kiwon lafiya damar shiga cikin ɗakunan da ke da marasa lafiya na COVID-19 ta hanyar amfani da PPE na musamman kawai don aiki, rage buƙatun amfani da PPE a gare su, amfani da abin numfashi guda ɗaya ba tare da barin ba yayin kula da marasa lafiya da yawa da aka gano iri ɗaya, kula da haɗin kai a cikin sarkar samar da PPE, da kuma ba da shawarar ba da ƙarfafa masu amfani da masks ga waɗanda ba su da alamun cutar.
ta: Catherine Meyer, Babban Jami'in Gidauniyar Wikimedia
Ga: Duk ma'aikatan Wikimedia Foundation
Labari: [COVID-19] Rage nauyi da kuma shirya don nan gaba
Ranar aikawa: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙoƙi da aka tanada
A wannan watan, mun ga cewa muna cikin yanayi mai muhimmanci.
COVID-19 annobar ta duniya ta bayyana yadda 'yan Adam na duniya ke da alaƙa da juna da kuma alhakin da muke da shi ga juna.
Ba mu da tabbacin wannan kalubale a baya, amma mun san cewa amsarmu mafi kyau ta dogara ne akan tausayi na duniya, haɗin kai da kuma gina ƙungiya da ke cikin zuciyar ƙungiyarmu.
Wani abu mai ban mamaki da ya tabbatar da cewa muna da sa'a sosai don yin aiki tare da mutane masu ban mamaki shi ne cewa duk abokanmu suna nuna alheri da kulawa ta hanyar imel, waya da tattaunawa.
Ina godiya da kuma alfahari da ku fiye da yadda nake yi na kira ku abokan aikina.
A makon da ya gabata, wani ya yaba mini don aikin da na yi.
Ya tunatar da ni cewa yana da muhimmanci a duniya a yanzu a karanta Wikipedia, kuma yana nuna yadda wannan muhimmin kayan aiki yake a kan layi da kuma yadda yake da iko a gare kowa.
Wannan ya faru ne saboda aikinku na ci gaba da sabunta wannan shafin ko biyan ma'aikatanmu ko kuma kiyaye ƙungiyar ku.
Duniya tana bukatar bayanai da Wikipedia ke bayarwa fiye da yadda ake bukata na Irv.
Wannan lokaci ne da ba abin da muke yi kawai ba, amma yadda muke yi zai iya shafar duniya.
Muhimmancin wannan yaƙi da kuma rawar da kuke takawa a ciki ya sa za mu yi wasu canje-canje masu muhimmanci a yadda muke aiki tare, wanda zai fara a mako mai zuwa.
Za mu iya yin canje-canje a ayyukanmu da kuma jadawalinmu.
Kamar yadda Robin ya ambata a baya, a daren jiya ne kungiyar C ta gana don tattauna hangen nesa da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna yadda za mu amsa wa abin da muke fuskanta da kuma yadda za mu ci gaba da kasancewa da ƙungiyar a wannan lokacin.
Muna son mu kawar da damuwa kuma mu taimaka wa aikinmu a cikin dogon lokaci.
Idan kana so ka sake yin amfani da wayar, to, ba ka da matsala.
Ga dukan ma'aikata, 'yan kwangila da ma'aikatan kwangila:
Za mu yi tsammanin za mu yi aiki na kusan awa 4 a rana ko awa 20 a mako har sai an ba mu ƙarin bayani.
Ba za mu yi hutun ba, amma idan za ku iya yin aiki a cikin sa'o'i na yau da kullum, za a iya amfani da ku a wannan aikin.
Amma a yanzu, ba za mu iya tunanin yadda duniya za ta kasance ba, kuma ko kuna son kula da ƙaunatattunku, ko ku kawo kayan kiwo ko ku je wurin likita, lafiyarku ita ce fifiko.
Ba mu lura da lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ba ne a ce, amma muna faɗi haka.
Babu buƙatar izinin rashin lafiya ko PTO - kawai gaya wa manajanka kuma ka taimaki ƙungiyarka ta gyara jadawalin da jadawalin don tabbatar da cewa an kammala mahimman abubuwan da ake bukata.
(Idan an gano cewa kana da cutar COVID-19, ka gaya wa Brian a T&C Opps don T&C ta iya tallafa maka kuma ta tabbata cewa manajan sun kula da yanayinka yadda ya kamata).
Za a biya ma'aikatan da ke aiki na tsawon sa'o'i cikakken albashi.
Mun riga mun faɗi kuma mun sake tabbatar da ƙaddamarwarmu don girmama ƙaddamarwarmu ga 'yan kwangila da abokan aikinmu waɗanda ke aiki a kan sa'o'i.
Kowa za a biya shi bisa ga sa'o'in aikinsa da ya yi a cikin al'amuransa na yau da kullum.
Idan kana rashin lafiya kuma ba za ka iya yin aiki ba, hakan zai haɗa da yin aiki.
Idan kana son yin aiki, za mu taimake ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su kawar da damuwa game da duniya da ke kewaye da su.
Musamman a lokacin da muke ciki, abin da muke yi zai iya kawo mana sakamako mai ban mamaki.
Wannan kuma game da kula da kanka ne.
Muna rokon ku ku tattauna da manajojin ku don mu san abin da za mu yi tsammani kuma mu yi canje-canje bisa ga hakan.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
SRE, HR Ops, Trust & Safety da kuma Fundraising teams (a tsakanin wasu) suna yin aiki mai mahimmanci, wanda zai iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu kuma mu mai da hankali kan taimakawa abubuwan da suka dace don kamfen ɗinmu.
Akwai aiki mai yawa da za mu yi domin mu duka, za mu mai da hankali ne kawai ga ayyukan da suka fi muhimmanci.
Idan ka yi aiki a hankali yanzu, ba za ka yi asara ba.
Da zarar wannan ya faru a duniya, ba mu da shirin "yin aiki sau biyu don kammala aikin".
Ba za ku yi tsammanin yin aiki na tsawon sa'o'i ba don ku bi tsarin aiki da ba shi da kyau.
Mun yarda cewa yanayin ya canza kuma idan ya dace, za mu yi aiki don kafa sababbin manufofi da jadawalin.
Mene ne ke faruwa da APP?
Yayin da muke daidaita tsammaninmu game da sabon lokacin aiki na gaskiya da na yau da kullun, burinmu shine daidaita lokacin don isar da Shirin Shekararmu na 2020-2021.
Manufarmu ita ce mu gabatar da takardar fadada shirinmu na 2019-2020, wanda zai ba ma'aikata karin lokaci don yin kasafin kudi don fifita ayyuka masu mahimmanci, kula da kansu da kula da abokanmu, waɗanda suke buƙatar aiki a cikin makonni masu zuwa ko waɗanda suke son yin aiki na ɗan gajeren lokaci.
Wannan tsawaitawa na lokaci zai rage yawan aiki da kuma damuwa a cikin tsarin shiri a duk faɗin kungiyar.
A mako mai zuwa za mu gabatar da shawarwarinmu ga kwamitin, kuma idan muka samu tabbacin hakan, za mu sanar da wakilanmu da kungiyoyinmu game da abubuwan da za su faru.
Na gode wa ƙungiyar APP don jagorancin da suka yi.
Yadda ake yin aiki a ofishi, yadda ake yin aiki da kuma yadda ake tsabtace shi
A makon da ya gabata ne muka samu labari cewa wani ma'aikacinmu a cikin SF yana da yiwuwar kamuwa da COVID-19.
Duk da haka, da matuƙar taka tsantsan, mun sanya tawagar tsabtace rigakafi a ofisoshinmu na San Francisco don kawar da cutar a duk yankuna.
Suna amfani da maganin rigakafi mai inganci don kashe kowace farfajiya, da kuma lobbies da kuma gefen tashar da ke zuwa cikin bene.
A cikin wannan ginin, ta yi amfani da kayayyakin da ke taimaka wa mazaunan ta su kasance cikin aminci.
Muna farin ciki cewa idan muka yanke shawarar komawa, za mu iya samun waɗannan ofisoshin a shirye don aiki.
Ofishinmu na DC yana cikin WeWork Zone, inda muke raba matakanmu na COVID-19 tare da mu da sauran ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma cikin tsarin nesa, bisa ga ka'idojin da muka raba tare da San Francisco.
Kamar yadda wasu abokanmu a yankunan NYC suka sani, muna tattaunawa game da haya don samun wuri a Brooklyn.
Wannan yana ci gaba, amma za mu iya jinkirta shi.
Wasu abokan aikinmu suna aiki a nesa a karon farko.
Abokan aiki na dogon lokaci sun san cewa wannan zai zama daidaitawa ne kawai, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon lokacin da kake taruwa zuwa sa'a ɗaya ko biyu.
Idan kana bukatar zaman lokaci mai tsawo, ka yi la'akari da yadda za ka iya raba su zuwa kwanaki da yawa.
Ka bayyana jadawalin taron a fili kuma ka aika musu da littattafan da suka shafi hakan.
Ka sa bidiyon ta zama tsoho ta hanyar kayan aiki kamar Google Docs da Zoom don yin aiki tare da kai tsaye da kuma haɗa kai.
Ka tambayi wani ya jagoranci kowane taro don ya sauƙaƙa shi, wanda zai lura da hira don tambayoyin da aka yi, ya duba jerin masu magana, kuma ya tambayi wani ya taimaka wajen yin rubutu (ko kuma ya yi rubutu tare da juna).
Idan kana son wani na'urar kai mai sauƙi, ka aika wa mai ba da shawara imel.
Ku yi amfani da kuɗin da kuke samu don cin abinci.
Ka shiga tashar #Remote on SLACK don yin magana da abokan aikinka game da aikin da aka ba ka.
Ƙungiyar HR tana neman ingantaccen aikin yanar gizo don taimakawa wajen haɓaka aikin da aka rarraba a cikin dukan ƙungiyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafin al'umma su dakatar da taron jama'a na tallafin Wikimedia kamar "Editathons" har sai WHO ta sanar da ƙarshen annobar.
Mun gaya musu cewa mun fahimci cewa roƙonmu na dakatar da ayyukan da kuma sauran abubuwan da za a hana su zai sa ba za su iya cika yarjejeniyar da suka yi na ba da tallafi ba, kuma mun kuma ce ba za a hukunta kowa ba don jinkirta wannan kuma don sauya wannan manufa.
A mako mai zuwa za mu duba ƙarin jagororin da aka bayar don taron Wikimedia da sauran taron yanki da na al'umma.
Wannan na nuna cewa akwai wani abu da ke da kyau ga dukan al'umma a duniya, wanda yake da ban tausayi game da wannan rikici, amma kuma yana da kyau ga wannan bayyanar da kuma ikonmu na mayar da hankali ga al'ummominmu, Wikimedia da sauransu.
Yayin da muke ci gaba, CRT na aiki don kafa shafi a kan Meta-Wiki don taimaka wa al'ummomi su lura da wannan tasiri da kuma samar da sarari ga al'umma don bin diddigin yadda muke sadarwa da su.
Kasancewa a cikin hulɗa da batutuwan da suka shafi COVID-19.
Za mu aika muku da gayyata zuwa taron ma'aikata na musamman a ranar Alhamis mai zuwa, 14: 00 UTC/ 07: 00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ciyar da lokaci don fahimtar juna.
Muna tare a wannan kuma muna son taimakawa da duk abin da za mu iya.
A halin yanzu, bari mu ci gaba da samun bayanai ta hanyar imel ɗinmu da kuma sauran mahimman bayanai game da COVID-19 a kan ofishin-wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma za ta ci gaba da samun duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatanmu, waɗanda ke zaune a ƙasashen da ke fama da mummunan tasiri.
Idan kana da wata tambaya game da tafiya, wani biki, wani babban aiki, ko wasu kalubale da kake tunani, ko kuma kana bukatar taimako game da wani abu, kada ka yi shakka ka sanar da CRT kuma ka yi aiki tare da su.
Muna nan don taimakawa da kuma tallafawa, kuma mu tuntube idan ya cancanta.
Idan kana da wani abu mai mahimmanci ko kuma mai mahimmanci, don Allah ka aika da imel zuwa ga Daraktan HRD Brian Judan.
Kada a ɗauki kowane irin wannan canji a matsayin wani abu da ya sa mu daina aiki.
Maimakon haka, sun amince da cewa a yanzu za mu yi aiki da kuma daukar nauyinmu a hanyar da ba mu taɓa yi ba.
Waɗannan su ne matakan da muke ganin ya kamata mu ɗauka don mu yi aiki tare, don mu ci gaba da aiki, don mu biya bukatunsu, da kuma ba su sabis ɗin da suke dogara da su.
A lokacin da lokaci ya yi, ayyukan da muke tsarawa za su taimaka mana.
A yanzu, lokaci ne da za mu yi aiki tare da juna kuma mu samar da sarari don ayyukan da za a yi a mako mai zuwa da kuma wata mai zuwa.
Don mu yi hakan, muna bukatar ku duka, don haka dole ne ku kula da kanku da kuma iyalanku don ku iya yin iyakar ƙoƙarinku a duk lokacin da ake bukata.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Catherine, CRT (Amanda K, Amy V., Brian J., Doreen D., Gregory V., Joel L., Lynette L. Ryan M., da Tony S.) da sauran mambobin tawagar shugabanci (Grant I., Heather W., Jamie V., Jennie U, Lisa S., Robin A. Ryan M., da Toby N.).
B'angiotensin-converting enzyme 2 (ACE2) wani enzyme ne wanda ke haɗe da farfajiya (ƙungiyoyin ƙwayoyin cuta) na ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, koda da hanji.
Ta hanyar rage adadin angiotensin -II da kuma ƙara adadin Ang1 -7) yana hana aikin ACE2 na ƙwayoyin cuta na angiotensin-converting enzyme (ACE), kuma saboda haka yana da tabbacin magani don magance cututtukan zuciya da jijiyoyin jini. ACE2 yana aiki a matsayin hanyar shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta.
Ana kiran wannan adadi na mutum hACE2.
Angiotensin-converting enzyme 2 shine zinc-containing metallol-enzyme wanda yake a saman endothelial da sauran kwayoyin halitta.
Protein ACE2 yana da wani N-terminal peptide M2 domain da kuma C-terminal colectrain renal amino acid transporter domain.
ACE2 wani furotin ne na fata mai ƙyama wanda ke aiki ta hanyar aikinsa a saman ƙwayoyin ƙwayoyin cuta a cikin huhu da sauran ƙwayoyin cuta.
Ƙarin ƙwayoyin halitta na ACE2 ana cire su daga wani ƙwayar cuta mai suna shades, wanda ke haifar da sakin furotin mai narkewa cikin jini kuma a ƙarshe ya narke cikin fitsari.
ACE2 yana cikin dukkan gabobin jiki: yana da alaƙa da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta na nau'in II a cikin huhu, ƙwayoyin cuta a cikin ƙananan hanji, ƙwayoyin cuta na jijiyoyin jini da jijiyoyin jini, da kuma ƙwayoyin jijiyoyin jijiyoyin jiki a cikin gabobin jiki.
Ana samun ACE2 mRNA a cikin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa, stratoma, hypothalamus, da kuma brainstorm.
Yin aiki a matsayin mai tsayayya da ACE2 shine babban aikin ACE2.
ACE angiotensin I yana ba da izinin shiga cikin vascoconstricting angiotensin II.
A maimakon haka, ACE2 yana karɓar amino acid mai carboxylic-terminal daga anjiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyzing shi zuwa vasodilator anjiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
[des-Arg9]- ACE2 na iya karya wasu wasu peptides da suka hada da bradykinin, apelin, neurotensin, dinorphine A, da ghrelin.
ACE2 kuma yana sarrafa ƙwayar ƙwayar ƙwayar cuta na SLC6A19, mai ɗaukar amino acid mai tsaka tsaki, kuma yana cikin cututtukan zuciya.
A matsayin furotin mai canzawa, ACE2 yana aiki a matsayin babban hanyar shiga cikin kwayoyin halitta don wasu ƙwayoyin corona, gami da HCoV-NL63; SARS-CoV (wanda ke haifar da SARS); da kuma SARS-CoV-2 (wanda ke haifar da COVID-19).
Musamman, an yi amfani da endocytosis don ɗaure ƙwayoyin ACE2 na enzymatic domain zuwa saman sel ta hanyar SARS-CoV da kuma spike S1 na SARS-CoV2 zuwa endocytosis, kuma ana yin amfani da duka ƙwayoyin cuta da enzyme a cikin endosomes da ke cikin sel.
Don samun damar shiga, TMPRSS2 mai ba da sabis na sirrin na kuma buƙatar yin amfani da furotin S, wanda ake hanawa a cikin binciken da ake yi a yanzu a matsayin magani mai yiwuwa. Saboda haka, wasu sun kammala cewa rage matakan ACE2 a cikin ƙwayoyin zai taimaka wajen yaki da kamuwa da cuta.
Koyaya, yawancin kungiyoyi masu sana'a da hukumomi sun ba da shawarar ci gaba da maganin ACE mai hanawa da ARB.
A cikin wani nazari da kuma meta-bincike da aka buga a ranar 11 ga Yuli, 2012, an gano cewa "amfani da masu hana ACEs ya kuma shafi rage hadarin kamuwa da cutar huhu da kashi 34% idan aka kwatanta da na kulawa".
Ban da haka ma, waɗanda suke da haɗarin kamuwa da cutar huhu, musamman waɗanda suke fama da bugun jini da kuma bugun zuciya, waɗanda aka yi amfani da su don magance cutar sun rage haɗarin shan maganin ACE.
Ko da yake tasirin ACE inhibitors ya fi haɗarin kamuwa da cutar pneumonia, amfani da ACE ya kasance mai mahimmanci wajen rage yawan mutuwar da ke tattare da cutar pneumonia.
Ana ganin cewa kwayar cutar ta mutum mai rikibinant ACE 2 (rhACE2) wani sabon magani ne ga mummunan rauni na huhu, kuma ya inganta haɓakar huhu da kuma iskar oxygen a cikin jarirai na alade da ke da cutar ta shan numfashi mai tsanani da ke haifar da lipopolysaccharide.
A cikin mutane, rabi na rayuwar rhACE2 yana da kimanin sa'o'i 10, yana ɗaukar minti 30 don farawa da kuma tsawon sa'o'i 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke fama da rashin haƙuri a cikin cututtuka masu ƙarancin tsarin RAS (Rainine-angiotensin System Inhibitors) ko kuma waɗanda ke da matsayi mai girma na rashin daidaituwa.
Aikace-aikacen b-COVID-19 aikace-aikace ne na software a cikin wayoyin hannu, waɗanda aka tsara don taimakawa sadarwa a cikin martani ga annobar COVID-19 na 2019-20, wanda shine tsarin gano mutumin da ke hulɗa da mutum mai kamuwa da cutar ("taɗi").
An ci gaba da kuma gabatar da aikace-aikace da yawa tare da tallafin gwamnati a wasu yankuna da yankuna.
An kirkiro tsarin da yawa don ƙirƙirar APPs na gano lamba.
Akwai damuwa game da sirrin sirri musamman a cikin tsarin da ke bin diddigin yanayin masu amfani da app.
Zaɓuɓɓukan da ba a san su ba sun haɗa da amfani da siginar Blue Tooth don yin rajistar bayanan da ke cikin wayar hannu ta mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za a haɗa ayyukan don tallafawa irin waɗannan ƙa'idodin tushen Blue Tooth kai tsaye a cikin tsarin aikin su na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Alipe, ta samar da wani app wanda zai ba da damar duba ko 'yan kasar sun samu hulɗa da mutanen da suka kamu da COVID-19.
Ana amfani da wannan app a birane fiye da 200 a kasar Sin. A Singapore ana amfani da app mai suna Trace Together.
An samar da wannan app ne daga wata kungiyar IT ta gida kuma an samar da shi a matsayin tushen budewa kuma za a mika shi ga gwamnati.
An samar da wannan app ne daga ma'aikatar sadarwa da fasaha da ma'aikatar lafiya.
A ranar 14 ga Afrilu, 2020 ne Apple ya nemi amincewar Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, 2020, Gwamnatin ta ce, app din yana cikin ci gaba kuma zai kasance a cikin 'yan makonni.
Australia da New Zealand suna tunanin yin amfani da apps bisa ga Singapore's Trace Togahedr da Blue Tooth Protocol.
Ross Anderson, Farfesa a jami'ar Cambridge na aikin tsaro, ya lissafa matsaloli masu yawa a aikace-aikacen da ke tattare da aikace-aikacen, ciki har da rashin amfani da aikace-aikacen da ke da tasiri idan an iyakance amfani da shi ga ƙananan alƙaluma.
Da yake nuna damuwa game da yaduwar "Coronavirus" apps masu ɓatarwa ko cutarwa, Apple ya sanya iyaka ga irin kamfanoni da za su iya ƙara aikace-aikacen da suka shafi coronavirus zuwa shagunan aikace-aikacen su, yana iyakance su ga "masu izini" ko kuma wasu kamfanoni masu daraja.
Google da Amazon sun sanya irin wannan takunkumin.
Masu tallata sirrin sun nuna damuwa game da tasirin saka idanu da yawa ta amfani da aikace-aikacen Corona Virus, musamman game da ko za a lalata kayan aikin saka idanu da aka gina don magance cutar.
Amnesty International da wasu kungiyoyi 100 sun yi wata sanarwa da ta bukaci a takaita irin wannan sa ido.
Cibiyoyin sun bayyana sharuɗɗa guda takwas don ayyukan gwamnati:
Dole ne sa ido ya zama "doka, dole, kuma daidaitacce";
Za a yi amfani da sassan sunset don fadada kulawa da kulawa.
Dole ne a iyakance amfani da bayanai don dalilai na COVID-19;
Dole ne a tabbatar da tsaro da kuma anonymity na bayanai kuma a tabbatar da cewa an kiyaye su bisa ga cikakkun bayanai;
Kula da dijital yana buƙatar hana nuna bambanci da watsi da gaske;
Sharing bayanai tare da wasu kamfanoni ya kamata a bayyana shi a cikin doka;
Hakkin 'yan ƙasa na kare kansu daga cin zarafi da kuma amsawa ga cin zarafi;
Dukkanin "masu ruwa da tsaki masu alaƙa" da suka haɗa da ƙwararrun masanan kiwon lafiya da kuma ƙungiyoyin da aka watsi da su suna buƙatar haɗin kai mai ma'ana.
Da zarar an kawar da bukatar bin diddigin, shirin da aka gabatar na Google / Apple shine don magance matsalar cirewa da saka idanu na dindindin daga tsarin aiki na na'urar su.
Wasu ƙasashe suna amfani da bin diddigin wuri na hanyar sadarwa maimakon apps wanda ke kawar da buƙatar sauke apps don hana bin diddigin.
An amince da bin diddigin da ke kan hanyar sadarwa a Isra'ila.
Yanayin da ke tattare da hanyoyin sadarwa wanda ke da damar samun bayanai na wuri mai mahimmanci yana da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa ba ne ke buƙatar samun damar bayanan wuri na mutum; an kirkiro tsarin tsare sirri da yawa waɗanda ke amfani da cibiyar sadarwa kawai don sadarwa.
Koriya ta Kudu ta yi amfani da tsarin da ba a dogara da app ba don samar da bayanan tuntuɓar.
Maimakon amfani da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'u da ƙa'idodin ƙa'idodin ƙa'idodin ƙa'u da ƙa'idodin ƙa'u da ƙa'u da ƙa'idodin ƙa'u da ƙa'idodin ƙa'u da ƙa'idodin ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da ƙa'u da
Baya ga amfani da wannan bayanin don faɗakar da yiwuwar tuntuɓar, gwamnati ta ba da bayanan wurin a fili, saboda canje-canje masu yawa a cikin Dokar Sirrin Bayanai bayan barkewar cutar MERS a ƙasar, wani abu ya ba da izini.
Wasu ƙasashe, ciki har da Jamus, sun yi la'akari da tsarin da ke da tsakiya da kuma tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Sirri - Kula da Sadarwa na Sadarwa wani kyakkyawan ra'ayi ne, wanda ya ƙunshi bincike na bincike daga akalla 2013. Kamar yadda aka yi a ranar 7 ga Afrilu, 2020, fiye da rukuni na masana suna aiki a kan matakan sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rajistar kusanci ga mai amfani da wasu wayoyin salula.
Duk da haka, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi tsarin da aka daidaita da na rarraba kuma ba yarjejeniya guda ɗaya ba. Tsarin da aka rarraba ya haɗa da ɓoye sirrin ɓoye - ganowa (DP-PPT/DP-3T), lambar tuntuɓar ta wucin gadi (TCN, fka Contact Event Numbers, CEN), yarjejeniyar sirri da tsarin tuntuɓar tuntuɓar wayar hannu (PACT) da sauransu.
Waɗannan ladabi ba sa barin bayanan sirri da za a iya ganowa a cikin na'urar kuma duk abubuwan da aka haɗa suna kan na'urar.
Kungiyar masu zaman kansu a MIT Media Lab suna haɓaka SafePath, dandamali don amfani da fasahohin kare sirrin yayin tattarawa ko amfani da wuraren shiga ko hanyar shiga don bin hanyar COVID-19.
Wannan ya dogara ne akan binciken da aka yi a cikin wata takarda mai suna "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic", wanda aka buga a watan Maris na 2020. Wani irin wannan yunƙurin shine SafeTrace, wani kamfanin da ke haɓaka fasahar sirri wanda Enigma MPC ta ƙirƙira, wanda aka kafa a cikin MIT Media Lab.
SafeTrace yana ba da damar mai amfani don raba bayanan wuri da lafiyar masu mahimmanci ga sauran masu amfani da jami'ai, ba tare da yin jayayya da sirrin bayanan ba, ta amfani da ingantaccen fasahar kayan aikin bayanai na SafeTrace.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da suka haɗu a kusa da tsarin daidaitaccen tsarin da kuma yarjejeniyar da aka rufe sun kafa TCN Global Alliance, wanda ke nufin rage rarrabuwa, dawowa da ba da damar yin amfani da aikace-aikacen gargadi, wanda shine babban ɓangare na aiwatar da shi.
A ranar 9 ga Afrilu, 2020, Gwamnatin Singapore ta sanar da cewa ta bude tushen yarjejeniyar BlueTrace ta hanyar aikace-aikacen ta na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa Android da iOS mobile platforms, sun sanar da wani shiri don gano abokan hulɗa dangane da haɗin gwiwar fasaha na Bluetooth low energy da kuma sirrin sirri, inda suka ce za a kiyaye sirrin.
Ya kuma bayyana fasahar da ake amfani da ita a cikin tsarin.
Apple da Google sun ce za a iya rarraba tsarin a matakai uku:
Rollout na kayan aiki don ba da damar gwamnatoci don ƙirƙirar sirrin gwamnati - Kare aikace-aikacen gano cutar Corona.
Haɗuwa da wannan aikin kai tsaye a cikin iOS, AndroidGoogle da Apple yana nufin magance matsalolin ci gaba da kulawa ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki na farko da kuma magance matsalar ta hanyar da ta dace bayan an kauce wa barazana.
Sake amfani da miyagun ƙwayoyi (wanda ake kira sake amfani da miyagun ƙwayoyi, sake yin amfani da su, sake sakewa, sake dawowa, ko sauyawar magani) shine amfani da magani wanda aka amince da shi don cutar ko kuma cutar don magance wata cuta.
Wannan shi ne irin binciken da ake yi a yanzu don samar da ingantaccen magani ga COVID-19.
Maganin karɓar jini don rigakafi da kuma sake dawo da lafiya. SARS-CoV-2 yana da sunadarai 66 masu ƙonewa, kowannensu yana da wasu wurare masu alaƙa.
Binciken irin wannan sararin ya samar da ingantaccen maganin rigakafi na COVID-19 akan furotin.
Abubuwan da ke da muhimmanci sosai a cikin sars-cov-2 sune proteins kamar papene, RNA mai dogaro RNA polymerase, helix, S protein, da ADP ribophosphatase.
Hussain AA da sauransu sun yi nazarin wasu magungunan candidate sannan suka bincika su don gano kamanceceniya da su da kuma irin wannan magani da aka amince da shi wanda zai ba da shawarar a cikin tsarin binciken asibiti ta hanyar haɓaka maganin anti-SARS-CoV-2 a cikin binciken su na farko.
Ana amfani da chloroquine don magance wasu cututtukan da ke hana mutum kamuwa da cutar.
A ranar 18 ga watan Maris, WHO ta sanar da cewa kwayoyi hudu da za a yi nazari a kansu a matsayin wani ɓangare na gwajin asibiti na Solidarity za su ƙunshi chloroquine da kuma related hydroxychloroquine.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa za a fara gwajin New York State na chlorine da hydroxychloroquine daga ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chlorine phosphate a ƙarƙashin Dokar Amfani da Gaggawa (EUA).
An ba da izinin yin gwaji ne kawai a cikin EU ga marasa lafiya da ba a yarda da su ba ta hanyar FDA ta hanyar gwajin gwaji na asibiti.
CDC ta ce, "Ba a tabbatar da amfani da Hydroxychloroquine ba, sashi, ko tsawon lokacin da za a yi amfani da shi don hana ko magance cutar SARS-CoV-2".
Likitoci sun ce ana amfani da wannan magani ne a lokacin da "babu wani zaɓi da ya rage".
Wani karamin bincike da kungiyar bincike ta Turkiyya da ke Istanbul suka gudanar ya nuna cewa ana amfani da Chlorokine tare da zinc, A, C da D.
A jami'o'in Duke da na Oxford, akwai ci gaba da bincike sosai.
Makarantar likitancin NYU Langon tana gwada amincin da ingancin hydroxychloroquine a matsayin hanyar rigakafi.
A cikin gwajin asibiti na kasar Sin a Wuhan da Shenzhen, an yi ikirarin cewa Favipirvir yana da "cikakken tasiri".
A cikin kwanaki 4 da suka gabata, an gwada marasa lafiya 35 a Shenzhen, yayin da marasa lafiya 45 da ba a samu ba sun kasance marasa lafiya na kwanaki 11.
A wani bincike da aka gudanar a Wuhan, an yi wa mutane 240 da ke fama da cutar huhu, rabin su sun karɓi maganin Fevipirvir, kuma rabin su sun karɓi Yumifenovir.
Hukumar Magunguna ta Italiya ta tunatar da mutane cewa, a halin yanzu, tallafin da ake samu na magani bai isa ba kuma yana da mahimmanci.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adanawa, kuma za ta ba da shi ga asibitocin jami'a tare da taimakon sojojin, inda za a yi amfani da shi wajen kula da marasa lafiya da COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi tattaunawa da gwamnatin Trump game da sayen magunguna. Magungunan na iya zama marasa inganci ga marasa lafiya masu cutarwa saboda an riga an sami karuwar cutar.
Wannan ba zai zama lafiya ba ga mata masu ciki ko kuma waɗanda suke ƙoƙarin yin ciki.
Wani bincike na lopinavir/retonavir (Calletra) wanda ya hada da lopinavir da retonavir, ya gano cewa "ba a samu wani sakamako ba".
An yi amfani da maganin don hana kwayar cutar HIV ta hanyar ɗaure shi da furotin.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gano mahaɗan da ke ɗaure da furotin na SARS-CoV-2 ta hanyar inganta waɗannan magunguna. Ana fuskantar ƙalubalen amfani da magungunan da aka yi don yin amfani da su don sabon dalili a cikin kimiyyar kimiyya.
WHO ta haɗa Lopinavir/Ritonavir a cikin gwajin hadin kai.
Gilled Sciences ta kirkiro Remdesivir don magance kamuwa da cutar Ebola da Marburg. Gilled Sciences ta gano cewa Remdesivir ya nuna aikin antibacterial na zuciya da ke dauke da cutar Fifo, Numo, Paramixso, da Corona.
Wata matsala a maganin rigakafi na ƙwayoyin cuta ita ce rashin ƙarfi da ke tasowa daga canjin da ke haifar da cututtuka da cututtuka masu tsanani.
Wasu binciken da aka yi kafin a gwada sun nuna cewa Remdesivir yana da matukar karfin jini ga rigakafi. Wasu gwaje-gwaje na asibiti suna gudana, tare da gwaje-gwaje biyu da ke gudana a asibitin Jami'ar Cleveland; daya ga mutanen da ke da rashin lafiya mai laushi, ɗayan kuma ga mutanen da ke da rashin lafiya mai tsanani.
Ana gudanar da gwaje-gwaje uku na asibiti don ba da bitamin C a cikin jijiyoyin marasa lafiya masu cutar COVID-19 da ke cikin asibiti; biyu na placebo a China, Kanada) da kuma daya ba tare da kulawa ba (Italiya).
Jihar New York ta fara gwajin maganin rigakafi na azithromycin a ranar 24 ga Maris.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) ta shirya gudanar da gwajin asibiti na alvesco de Tijin (siclesonide) don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Ana gudanar da gwajin gwaji na II akan angiotensin-transfer vector 2, wanda zai hada da 200 daga cikin marasa lafiya masu tsanani da ke asibiti a Denmark, Jamus, da Austria.
Masu bincike na Cibiyar Zuciyar Montreal a Kanada suna nazarin matsayin Calcusein a cikin rage kumburi da cututtukan huhu a cikin marasa lafiya masu dauke da alamun COVID-19.
Ana daukar manya 6000 da suka kai shekaru 40 da haihuwa, da aka gano suna da COVID-19 kuma suna da alamun rashin lafiya wadanda ba za su bukaci shiga asibiti ba don gudanar da binciken da ake kira Colcorona.
Mata masu ciki ko masu shayarwa da kuma wadanda ba su da amfani da maganin hana haihuwa ba sun cancanta.
Ana gwada wasu kayan rigakafi a Italiya.
Ana amfani da hyparine mai ƙarancin nauyin kwayoyin don magance marasa lafiya, wanda ke ƙarfafa cibiyoyin kiwon lafiya a Italiya su buga jagorori.
Kasar Italiya ta sanar da wani bincike mai zurfi a kan 300 marasa lafiya a ranar 14 ga Afrilu, don gudanar da bincike kan maganin rigakafi da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar.
Saboda cutar SARS-CoV-2 ita ce cutar, an ba da ƙarin hankali ga ilimin kimiyya kan amfani da maganin rigakafin cutar da aka amince da shi a lokutan cutar MERS, SARS, da West Nile.
Ribarine: An ba da shawarar Ribarine don maganin COVID-19 bisa ga Shafin 7 na Jagorancin China.
Yumifenovir: An bada shawarar Yumifenovir a matsayin magani na COVID-19 bisa ga Shafin 7 na Jagorancin China.
Wasu magungunan maganin rigakafi sun gano cewa za a iya amfani da su don sabon manufar maganin COVID-19:
Tocilizumab (IL-6 anti-receptor): An amince da shi daga kasar Sin
Ka duba gwajin gwaji a China da Italiya da kuma Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 rigakafin rigakafin cutar COVID-19 ne.
Ko da yake ba a kammala gwajin asibiti na kowane magani ba, ana ci gaba da ƙoƙari don samar da irin wannan maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce, ana sa ran cewa ba za a samu allurar rigakafin cutar SARS-CoV-2 ba har sai watanni 18.
A watan Afrilu, an gudanar da binciken tsaro na farko a kan takardun shan magani guda biyar.
An gano COVID-19 a watan Disamba na 2019.
A shekarar 2020, cutar ta barke a duniya, kuma hakan ya haifar da babban zuba jari da bincike don samar da rigakafi.
Kungiyoyi da dama suna amfani da bayanan da aka wallafa don samar da maganin SARS-CoV-2 mai yuwuwa.
Kamar yadda aka sanar a watan Afrilu, abubuwan da ke cikin shirin CEPI na samar da allurar rigakafi sune saurin aiki, samarwa, tsarawa da kuma isa ga duniya.
A watan Afrilu, masana kimiyya na CEPI sun gano cewa, a farkon shekarar 2020, ana gudanar da bincike da ci gaba a kan dandamali daban-daban na fasaha 10 don samar da allurar rigakafi mai tasiri akan COVID-19.
Babban burin dandamali na binciken tsaro na Prevaasta I shine:
DNA da RNA: Masu samar da allurar rigakafi na farko: Moderna, MRNA-1273.
Viral vector (Mai haɓaka I da kuma mai neman allurar rigakafi:Cancassino Biology, Adenovirus Type 5 vector)
A watan Afrilu, masana kimiyya na CEPI sun gano cewa, akwai allurai 115 na alluran rigakafi a cikin ci gaba, wanda aka tabbatar da cewa akwai ayyukan 78 a cikin aiki (a cewar Cibiyar Milken 79) da kuma wasu 37 da aka sanar da su, kuma ba a bayyana su ba.
Ana yin bincike na farko kan lafiyar da kuma maganin rigakafi a cikin gwajin I-II, wanda yawanci ana yinsa a wurare da yawa, a bazuwar, placebo-controlled, da kuma wurare da yawa don ƙayyade madaidaicin, ingantattun sashi.
A cikin gwaji na III, yawanci akwai ƙarin masu shiga, wanda ya ƙunshi ƙungiyar sarrafawa da kuma duba ingancin allurar rigakafi don hana cutar, tare da lura da sakamako masu illa bayan an ba da isasshen kashi.
Daga cikin alluran 79 da ke ci gaba da aiki (wanda aka tabbatar a farkon watan Afrilu na 2020), 74 har yanzu ba a tantance su a cikin mutane ba.
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar Clamp ta kwayoyin halitta wanda zai haifar da amsa ta rigakafi ta hanyar gyaran kwayoyin cutar ta hanyar gyaran kwayoyin cutar.
A ranar 24 ga Janairu, 2020, Cibiyar Kula da Alurar riga kafi ta Duniya (VIDO-INTERWACK) a Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi a Kanada, wanda za a yi gwaji a kan mutane a 2021.
Cibiyar Kula da Cututtuka ta kasar Sin da Jami'ar Hong Kong sun sanar da shirin samar da rigakafin cutar a ranar 26 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, Kamfanin Jansen Pharmaceutical, wanda Hannek Skytaker ke jagorantar, ya sanar da cewa yana aiki kan samar da allurar rigakafi.
Jansen yana aiki tare da abokin aikinsa na fasaha na rayuwa, Vacart, don samar da maganin maganin baki.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwa tare da Vaxart don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, Cibiyar Oncogene Lab a Romania ta wallafa wani bincike game da tsarin samar da allurar rigakafi kamar yadda ake amfani da ita a maganin maganin rigakafin cutar kansa.
A ranar 25 ga watan Maris, shugabannin cibiyar bincike sun sanar da cewa sun yanke shawarar yin maganin kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, kamfanin haɗin gwiwar Genrex, Neogenex Immuno-Oncology, ya sanar da ƙaddamar da aikin rigakafin rigakafin COVID-19 Li-Key Peptide.
Sun yi niyyar samar da wani samfurin rigakafi wanda zai iya yin gwaji a cikin mutane a cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirin ta na samar da allurar rigakafi.
Cibiyar bincike ta Amurka ta Army Medical Research da Materials Command a Fort Detrick da Walter Reed Army Institute a Silver Spring, duka biyu a West Maryland, sun sanar da cewa suna aiki akan allurar rigakafi a ranar 5 ga Maris, 2020.
A ranar 10 ga watan Maris, 2020, Emergent Biosolutions ta sanar da cewa tana aiki tare da Novavax Inc.
Don samar da allurar rigakafi.
Waɗannan abokan sun sanar da gudanar da gwajin asibiti na farko da na farko har zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana aiki a kan wuraren killace 11 kuma za a dauki kusan shekaru biyu da rabi don samar da rigakafi duk da cewa suna aiki sosai.
A ranar 12 ga watan Maris, 2020, kamfanin fasaha na kayan kwalliya na Quebec City, Quebec, Medicago, ya ba da rahoton cewa ya samu wani ɓangare na kudade daga Cibiyar Nazarin Lafiya ta Kanada don samar da kwayoyin cutar Corona.
Ana ci gaba da bincike a cikin dakin gwaje-gwaje kan candidate na allurar, wanda za a yi gwaji a jikin mutum a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa shugaban Majalisar Dinkin Duniya Donald Trump ya nuna shirye-shiryensa na ba da "babban kuɗi" ga QURWAK don samun damar yin amfani da allurar COVID-19 guda ɗaya, wanda gwamnatin Jamus ta yi ta nuna rashin amincewa da shi.
A ranar 17 ga Maris, 2020, kamfanin kera magunguna na Amurka Pfizer ya sanar da cewa ya yi tarayya da kamfanin BioNTech na Jamus don samar da allurar rigakafin mRNA.
Ana gudanar da gwajin farko na gwajin rigakafin mRNA-based candidate BNT162 a halin yanzu, wanda ake sa ran gwaji a watan Afrilu 2020.
A ranar 17 ga Maris, 2020, a Italiya, kamfanin ta'addanci na Ta'aziyya ta Italiya ta sanar da cewa za ta karɓi sakamakon gwajin farko a watan Afrilu na 2020, sannan za a yi gwajin mutum na takarar rigakafin ƙarshe.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) a Faransa ta sanar da saka hannun jari na US$4.9 ga ƙungiyar taimakon bincike kan allurar COVID-19 wanda ya kawo jimlar saka hannun jari na CEPI don haɓaka allurar COVID-19 tare da haɗin gwiwar Cibiyar Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh zuwa US$29 a cikin haɗin gwiwa.
CEPI ta sami abokan hulɗa don haɓaka allurar COVID-19 daga Moderna, Quarvac, Inovavo, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga watan Maris na shekarar 2020, jami'an lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin kwayoyin halitta na takaddun shaida guda shida.
A ranar 20 ga watan Maris, 2020, masu bincike a Kwalejin Imperial ta London sun sanar da cewa suna samar da maganin RNA mai kara girman kai don COVID-19.
An samar da takardar neman rigakafin a cikin kwanaki 14 bayan an samu umarni daga China.
Gwamnatin Kanada ta sanar da kudade na C$275 miliyan don ayyukan maganin COVID-19 guda 96 a ƙarshen watan Maris, wanda ya haɗa da masu neman allurar rigakafi daga kamfanoni da jami'o'i a Kanada, kamar su Medicago da Saskatchewan Initiative.
A daidai wannan lokacin, Gwamnatin Kanada ta ba da sanarwar dala miliyan 192 don haɓaka allurar rigakafi musamman don COVID-19, wanda ya haɗa da shirin kafa "Bankin allurar rigakafi" na ƙasa wanda za a iya amfani da shi a lokacin da cutar ta sake barkewa.
A ranar 2 ga Afrilu, 2020, Makarantar Likitancin Jami'ar Pittsburgh ta sanar da cewa tana gwaji da yiwuwar rigakafin COVID-19 na Pitkovak a cikin beraye, yana ba da rahoton cewa "An gwada tasirin maganin rigakafi na musamman na maganin rigakafi na SARS-CoV-2 S1 subunit na SARS-CoV-2 wanda MNA ta bayar [a cikin beraye] wanda ya fara karɓar sashi makonni 2 bayan an yi allurar".
A ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo a Kanada ta sanar da cewa tana da shirin samar da takaddun shaida na DNA-based vaccine candidate a cikin hanyar da za a iya amfani da shi don yin maganin rigakafi.
Za a yi amfani da kwayoyin cuta don samar da DNA wanda zai samar da kwayoyin da ba su da lahani kamar kwayar cutar ta hanyar yin kwayar halitta a cikin kwayoyin mutum, wanda zai haifar da ƙwayoyin cuta masu ƙonewa da ke haifar da rigakafin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Majalisar Dinkin Duniya, masana'antu da jami'o'i uku sun hada kai da albarkatun kamfanin Hevelot Packard Enterprise, Cloud Computing Resources, Amazon, Microsoft da Google don samun damar kwamfutar IBM ta Supercomputer.
Wasu rigakafin suna da sakamako mai ban mamaki, wanda za a iya cewa sakamako ne wanda ba a zata ba.
Wannan yana nufin cewa, ban da hana cutar, za a iya samun wasu amfanin.
A nan gaba, za a yi wa ma'aikatan kiwon lafiya 4,170 aiki don yin gwaji a bazuwar a Ostiraliya.
Ana iya ganin cewa allurar da ake ci gaba da samarwa ba ta da lafiya ko inganci.
Binciken da aka yi a baya don kimanta ingancin rigakafin COVID-19 a kan takamaiman dabbobi kamar ACE2-transgenic mice, sauran dabbobi na dakin gwaje-gwaje da kuma mutane, ya nuna cewa akwai buƙatar daidaitaccen haɗin kai na duniya don tabbatar da matakan kiyayewa na Level 3 da kuma ingantaccen tsari don sarrafa kwayar cutar mai rai.
An gwada alluran rigakafin SARS da MERS a kan dabbobi ba tare da mutane ba.
Har zuwa shekarar 2020, babu maganin SARS ko allurar rigakafi da ta dace da ita ga mutane.
A cewar binciken da aka buga a 2005 da 2006, ganowa da kuma samar da sabon allurar rigakafi da magunguna don magance SARS ya kasance aiki na farko ga gwamnatoci da hukumomin kiwon lafiya na jama'a a duniya.
Lokacin da cutar ta kara karuwa, an yi zaton cewa binciken da ake yi a kan SARS zai samar da samfurin da zai taimaka wajen gano alluran rigakafi da magunguna don cutar ta MERS-CoV.
A watan Maris na shekarar 2020, an kammala gwajin asibiti na kashi na farko na allurar MERS a cikin mutane, kuma ana aiki a kan wasu alluran rigakafi guda uku, dukansu alluran rigakafi ne na kwayar cutar, biyu adenoviral vectored (ChAdOx1-MERS, BFRS-Gamvac), da kuma daya MVA-vectored (MVA-MERS-S).
Wannan labarin ya haifar da tattaunawa game da wurin aiki, wanda ya nuna cewa an san cutar da ke haifar da COVID-19 kuma riga an sami allurar rigakafi.
Patents da aka gabatar a matsayin hujja daga wasu posts a kan kafofin watsa labarun suna nufin wasu patents na asali da kuma rigakafin da ke wanzu don wasu nau'ikan coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ke faruwa daga cutar ta shan numfashi ta SARS-CoV-2.
Alamomin da aka fi sani da su su ne zazzabi, tari, da kuma rashin numfashi.
Sauran alamun za su iya kasancewa gajiya, rashin ƙarfi, tari, ƙishirwa, ƙishirwa, da kuma ciwon ciki.
A yawancin lokaci, bayyanar cututtuka daga cutar tana da kwanaki biyar, amma zai iya kasancewa daga kwana biyu zuwa kwana 14.
Yawancin marasa lafiya suna da alamun rashin lafiya, wasu kuma suna da ciwon huhu da ke haifar da cututtukan jiki da yawa.
A ranar 17 ga Afrilu, 2020, an samu karin mutane miliyan 2.24 a kasashe 210 da yankuna, daga cikinsu akwai mutane 153,000 da suka mutu.
Mutane fiye da 5,68,000 sun warke daga cutar. Mutane suna samun cutar ta hanyar kai tsaye, sau da yawa ta hanyar tari ko kuma ta hanyar saurin magana.
Sa'ad da suke numfashi, ana fitar da su daga ƙasa ko kuma a ƙasa, ba sa kaiwa ga kamuwa da cutar a nesa.
Idan mutum ya taɓa gurɓataccen wuri, idanunsa, hanci da bakinsa, zai iya kamuwa da cutar.
Wannan kwayar cutar tana rayuwa har tsawon sa'o'i 72 a kowane farfajiyar.
A cikin kwanaki uku na farko bayan bayyanar cututtuka, yana da matukar yaduwa, amma yana iya yaduwa kafin bayyanar cututtuka da kuma bayan bayyanar cututtuka.
Ana ba da shawarar cewa duk wanda ya yi zargin cewa yana da cutar kuma wanda ke ba da sabis ya yi amfani da abin rufe fuska.
Mutane da yawa suna ba da shawara game da amfani da abin rufe fuska, wasu jami'ai suna adawa da amfani da abin rufe fuska, wasu suna ba da shawara game da amfani da shi, wasu kuma suna cewa ya zama dole.
Babu takamaiman maganin rigakafi ko allurar rigakafi ga COVID-19 a halin yanzu.
Yawancin ƙasashe a cikin dukkanin sassan shida na WHO sun sami ƙwayoyin cuta na gida.
A wasu lokatai, marasa lafiya da suka kamu da cutar ba sa nuna alamun cutar ko kuma suna nuna alamun mura kamar zazzabi, tari, gajiya da kuma rashin numfashi.
Alamun rashin numfashi na gaggawa, ciwon kirji ko damuwa, jin kamar ba a iya yin aiki ba, wahalar tafiya, da kuma fuska da lebe masu launin shuɗi; idan an gano waɗannan alamun, ana ba da shawarar zuwa asibiti nan da nan.
Abubuwan da ke faruwa a cikin jiki suna iya zama bayyanar cututtuka na numfashi kamar su haushi, narkewar hanci ko kuma ƙishirwa.
Wasu marasa lafiya sun nuna alamun rashin abinci a cikin ƙananan ƙananan ƙananan, kamar su kumburi, ƙishirwa, da tari.
Wasu marasa lafiya a kasar Sin sun fara nuna alamun ciwon kirji da kuma bugun zuciya.
Wasu sun kamu da ciwon huhu, rashin lafiya da kuma mutuwa.
Wannan shi ne abin da ake kira lokacin incuba.
Lokacin incubacin COVID-19 yawanci yana da kwanaki biyar zuwa shida, amma a wasu mutane yana iya zama daga kwana biyu zuwa 14.
Rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar suka kamu da cutar ba ne suka kamu da cutar.
Ba a bayyana matsayin masu dauke da cutar ba, amma an ce suna da hannu wajen yada cutar daga farkon matakan.
Ba a san adadin marasa lafiya da ba su da alamun cutar ba kuma ana gudanar da bincike kan su, yayin da aka ba da rahoton cewa kashi 20% na marasa lafiya da aka tabbatar da su daga Cibiyoyin Kula da Cututtuka na KCDC sun ce ba su da alamun cutar har sai sun shiga asibiti.
Hukumar Lafiya ta kasar Sin ta fara hada marasa lafiya marasa bayyanar cututtuka a cikin marasa lafiya na yau da kullun daga 1 ga Afrilu; daga cikin marasa lafiya 166 da aka gano a wannan ranar, marasa lafiya 130 (78%) ba su da wata alama a lokacin binciken.
A cikin ƙwayoyin cuta da na ganye, akwai ƙwayoyin cuta masu yawa.
Idan kana magana da babbar murya, za ka iya fitar da ƙwari fiye da yadda ake magana da kowa.
Wani bincike da aka yi a Singapore ya nuna cewa, ƙanƙara da ba ta rufe baki ba zai iya kaiwa tsawon mita 4.5 ba.
Ko da yake ba a samar da kwayar cutar daga iska ba, amma National Academy of Sciences ta yi hasashen cewa ana iya watsa ta ta ta hanyar bioaerosol kuma an gano RNA mai kyau a cikin samfurori daga masu tara iska a waje da gidajen mutane.
Wasu hanyoyin da ake yi na likita, kamar su yin amfani da bututu a jikin mutum da kuma sake dawo da jijiyoyin jini da zuciya, suna iya sa ruwa ya fita daga cikin numfashi kuma hakan yana iya sa ya yi ta yaduwa ta iska.
Idan ana damuwa da yaduwar cutar ta hanyar ganye, ana ganin cewa yana da ƙananan haɗari, kuma waɗanda ke da alamun cutar suna da mafi yawan kamuwa da cutar; kuma.
Cibiyar Turai don Rigakafin Cututtuka da Kulawa (ECDC) ta ce, ko da yake ba a san yadda cutar take yaduwa ba, amma ana iya samun kamuwa da ita daga mutum ɗaya zuwa mutane biyu zuwa uku.
A zahiri, an gano cewa kwayar ta kasance a kan takarda na kwana daya, a kan filastik da farar bakin karfe (AISI 304) na kwana uku, kuma a kan farar bakin karfe na kashi 99 cikin dari na tagulla na tsawon sa'o'i hudu.
Duk da haka, wannan ya dogara da yanayin zafi da yanayin zafi na yanayi kuma yana canzawa.
Sabulu da kuma tsabtace-kayan da ake amfani da su suna da tasiri sosai idan aka yi amfani da su yadda ya kamata. Sabulu yana rage ƙwayar cutar, yana hana ta aiki, kuma yana cire ta daga fata da kuma sauran farfajiyar.
Wasu magunguna, kamar su benzaconum chloride da chlorhexidine gluconate (wani nau'in maganin kashe kwayoyin cutar da ake yi wa tiyata) ba su da tasiri sosai. A wani binciken da aka yi a Hong Kong, an ɗauki samfurin kumburi a cikin kwanaki biyu bayan an shigar da shi asibiti.
A cikin mutane biyar cikin shida, samfurin farko ya sami mafi yawan ƙwayoyin cuta, kuma a cikin mutum na shida, an sami mafi yawan ƙwayoyin cuta a gwajin rana ta biyu.
Cutar Coronavirus ta 2 (SARS-CoV-2) wani sabon cutar coronavirus ne mai dauke da alamun numfashi mai tsanani. An fara gano shi daga cikin marasa lafiya uku da ke fama da cutar huhu da ke da alaƙa da Cibiyar Kula da Cututtukan numfashi mai tsanani a Wuhan.
Dukkanin siffofin sabon SARS-CoV-2 suna bayyana a cikin kwayar cutar Corona da ke tattare da shi a cikin yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida wanda ke samar da kumfa mai kariya.
COVID-19 ya fi tasiri a huhu, saboda cutar ta shiga cikin ƙwayoyin cuta ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda yake da yawa a cikin wasu nau'ikan ƙwayoyin cuta na huhu.
Wannan kwayar cutar tana amfani da wani nau'in glycoprotein na musamman da ake kira spike don yin aiki tare da ACE2 da kuma shiga cikin kwayoyin halitta.
Kashi 12 cikin 100 na marasa lafiya da aka kwantar a asibitoci a Wuhan, China, sun sami ciwon zuciya mai tsanani kuma suna da yawa a cikin cututtuka masu tsanani.
A lokacin da cutar ke yaduwa, akwai alamun cututtukan zuciya da yawa saboda rashin amsawar jiki da kuma lalacewar rigakafi, amma cututtukan zuciya na iya kasancewa da alaƙa da abubuwan da ke karɓar ACE2 a cikin zuciya.
Abubuwan da ke cikin ƙwayar ACE2 suna da yawa a cikin zuciya kuma suna cikin aikin zuciya.
An gano karin misalai na jini (31%) da kuma jini mai daskare jini (25%) a cikin marasa lafiya masu tsanani na COVID-19. Wannan na iya kasancewa tare da rashin ganewar asali. An gano cewa an sami cutar kumburi (dandami na huhu) daga gawawwakin marasa lafiya da suka mutu saboda COVID-19 da kuma samun ƙwayoyin ƙwayoyin cuta masu kumburi a cikin huhu.
Ko da yake SARS-COVID-2 na da yanayin kamuwa da cututtukan cututtukan numfashi tare da cututtukan numfashi na ACE2, ana nuna alamun hyperinflammation a cikin marasa lafiya masu tsanani na COVID-19.
Musamman: An gano cewa kwayoyin cutar GM-CSF-syring T-cell suna da alaƙa da sanyawa na IL-6-syring monocytes masu kumburi a cikin marasa lafiya na COVID-19 da kuma gano cutar huhu mai tsanani.
An kuma gano cewa akwai wasu kwayoyin da suka shiga cikin jikin mutum.
Hukumar lafiya ta duniya (WHO) ta wallafa dokoki da dama don gwada cutar.
Ainihin lokacin da aka yi amfani da shi wajen fassarar fassarar polymerase da aka yi amfani da shi a cikin jerin sunayen da aka yi amfani da su a cikin jerin sunayen da aka yi amfani da su a cikin jerin sunayen da aka yi amfani da su a cikin jerin sunayen da aka yi amfani da su a cikin jerin sunayen da aka yi amfani da su a cikin jerin sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sunayen sun sunayen sunayen sunayen sunayen sunayen sunayen sun sun sun sunayen sunayen sun sun sun sunayen sunayen sun sun sun sun bayyana a suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna suna sun sun sun sun sun
Ana gwada shi a kan samfurori na numfashi da aka samu daga cikin hanci; amma ana iya amfani da samfurori na numfashi ko kuma na numfashi.
Ana samun sakamakon gwajin a cikin sa'o'i ko kwana biyu.
Ana iya yin gwajin jini, amma yana bukatar a ɗauki jini biyu a tsakanin makonni biyu kuma sakamakon ya zama mai ƙarancin ƙima.
Masana kimiyya na kasar Sin sun samu damar gano nau'in cutar ta coronavirus da kuma wallafa kwayoyinta, wanda ya ba da damar ci gaba da gwajin polymerase chain reaction (PCR) wanda ke gano kamuwa da cutar a cikin dakin gwaje-gwaje a duniya.
Har zuwa ranar 4 ga Afrilu, 2020, ana ci gaba da yin gwajin rigakafi (wanda zai iya gano kamuwa da cuta ta yanzu kuma ya gaya wa mutum ko ya riga ya kamu da cutar) amma ba a amfani da su sosai.
Kwarewar gwajin da aka yi a kasar Sin ta nuna cewa an gwada shi da daidaito ne kawai na kashi 60 zuwa 70 cikin 100.
FDA a Amurka ta amince da gwajin farko na Point of Care don amfani a ƙarshen wannan watan a ranar 21 ga Maris, 2020. Jagororin bincike da aka fitar da asibitin Zhongnan na Jami'ar Wuhan sun ba da shawarar hanyoyin gano kamuwa da cuta dangane da halaye na sinadarai da haɗarin kamuwa da cuta.
A farkon kamuwa da cutar, rashin daidaituwa na biyu da yawa da aka yi a ƙasa-glass ba su da kyau, tare da rarraba a cikin layi, rashin daidaituwa da kuma baya.
Ƙarfi na rashin lafiya na iya haifar da rinjaye na subplural, ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ
Akwai wasu bayanai game da ilimin mutum game da COVID-19 da kuma cututtukan da ke tattare da cutar.
Waɗannan su ne wasu muhimman bayanai game da binciken da aka yi a jikin mutum:
Abubuwan da idanu za su iya gani: kumburi a cikin huhu, ciwon zuciya, kumburi da kumburi a cikin huhu
Akwai nau'i hudu na cutar huhu da aka gano:
Nune-nune masu saurin kamuwa da su: kumburi a cikin huhu, yawan kwayoyin huhu, manyan kwayoyin huhu da ba su da alaka, kumburi tsakanin tsokoki da kuma samar da manyan kwayoyin cuta masu yawa.
Rashin ƙwayar huhu mai tsanani: Rashin ƙwayar huhu da kuma zubar da jini daga huhu
Rashin ƙwayar cuta na alveolar cuta yana haifar da ciwon numfashi mai tsanani (Acute Respiratory Disturbance Syndrome) da kuma rashin iskar oxygen.
Cutar huhu mai warkarwa: zubar da jini a cikin huhu da kuma cututtukan huhu na interstitial fibrosis
Jini: jini yana samun jini daga cikin jijiyoyin jini (aikin narkewa na intravascular coagulation);
Abubuwan da ake yi don rage yiwuwar kamuwa da cutar sun haɗa da zama a gida, guje wa wuraren da ke da jama'a, wanke hannuwanku da sabulu da ruwa a kai a kai da kuma aƙalla na tsawon dakika 20, tsabtace hanyoyin numfashi, guje wa taɓa idanu, hanci ko bakinka da hannayen da ba a wanke ba.
CDC ta ba da shawarar yin amfani da takalma a gaban hanci da bakin lokacin da kake tari ko kuka. Idan ba ka da takalma, ka rufe hancinka da kusurwar hannunka.
An gaya mana mu wanke hannayenmu bayan mun yi tari ko kuma mun yi tari.
CDC ta ba da shawarar yin amfani da sutura don rufe fuska yayin tafiya a wuraren jama'a don hana kamuwa da cutar daga mutanen da ba su da alamun cutar. Dalilin nisan nesa na zamantakewa shine rage haɗuwa da mutane da yawa da ke kamuwa da cutar.
A cikin batun nesa, an umurci mutane su kasance aƙalla ƙafa 6 daga juna.
Ba a san ko akwai magani da zai iya hana cutar COVID-19 ba, kuma ba a tsammanin za a samu allurar rigakafi ba a farkon shekara ta 2021, saboda haka, a halin yanzu, babban ɓangare na gudanar da COVID-19 shine sarrafa cutar.
Hukumar ta shawarci mutane su yi wanka a kai a kai da sabulu da ruwa na akalla na tsawon dakika 20, musamman idan sun shiga cikin gidan wanka ko kuma idan sun ga hannuwansu sun lalace, kafin su ci abinci da kuma bayan sun taɓa hanci da kuma bayan sun yi tari ko sun yi ta zagi.
CDC ta kuma ba da shawarar cewa a yi amfani da kayan tsabtace hannu da ke dauke da giya, wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya, amma a yi amfani da shi ne kawai idan babu sabulu da ruwa.
A cikin waɗannan maganganun, maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin janyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyanyany
Ana amfani da hydrogen peroxide don hana ƙwayoyin cuta girma a cikin giya; ba shi da "abin da ke kashe hannu".
An haɗa glycerol a matsayin mai riƙe danshi.
Ana kula da marasa lafiya ta hanyar kulawa da taimako, wanda ya haɗa da ba da iskar oxygen, magani da ruwa da kuma tallafawa wasu gabobin da suka shafi cutar.
Hukumar ta ce duk wanda ya yi shakkar cewa shi mai dauke da cutar ya kamata ya saka abin rufe fuska mai sauki.
Ana amfani da maganin oxygen na waje don magance matsalar rashin numfashi, amma har yanzu ana ganin amfanin.
An ba da shawarar tsaftace mutum da kuma ingantaccen salon rayuwa da abinci don haɓaka rigakafi.
Hukumar lafiya ta duniya da Hukumar lafiya ta kasar Sin sun wallafa shawarwari kan kula da marasa lafiya da ke cikin asibiti da ke fama da cutar COVID-19.
Masana cututtuka masu tsanani da likitocin huhu a Amurka sun hada shawarwarin magani daga hukumomi daban-daban a karkashin tushen IBCC guda daya.
Har zuwa watan Afrilu na shekarar 2020, babu takamaiman magani da aka tabbatar don COVID-19.
Wasu likitoci suna ba da shawarar yin amfani da paracetamol a farkon wuri na ibuprofen saboda alamun.
Dole ne a yi hankali sosai don rage haɗarin yaduwar cutar, musamman a lokacin aiwatar da hanyoyin da ke haifar da ruwan jiki a cikin iska, kamar shigar da bututu ko iska ta hannu, dole ne a yi hankali a cikin amfani da wuraren kiwon lafiya.
CDC ta ba da shawarar cewa a lokacin da za a yi amfani da kayan aikin kare lafiyar da ke kula da marasa lafiya da ke fama da COVID-19, a kiyaye su da kuma kula da su a cikin yanayin yanayi, a kula da su da kuma kula da su da kuma kula da su da kuma kula da su da cutar ta iska.
Shawarwarin kayan rigakafi don shiri: PPE gaunt, respirator ko fuska mask, tsaro ga idanu da kuma safofin hannu na likita. Idan akwai, to, ya kamata a fi dacewa da kayan numfashi maimakon fuska mask.
An amince da kayan numfashi na N95 don tsarin masana'antu, amma FDA ta amince da amfani da masks a ƙarƙashin izinin Amfani da Gaggawa (EUA).
An tsara su ne don kare su daga ƙura kamar ƙura a cikin iska, amma ba a iya tabbatar da tasirinsa ga wani takamaiman matsakaiciyar halitta a wasu aikace-aikace ba.
Idan babu masks, ana iya amfani da masks na fuska ko kuma na gida a matsayin ƙarshen, kamar yadda CDC ta ba da shawarar.
Yawancin marasa lafiya da ke fama da COVID-19 ba su da matukar damuwa da bukatar samun iska ko wani zaɓi, amma akwai wasu kashi.
Ana ci gaba da nazarin irin maganin numfashi da marasa lafiya ke samu saboda matsalolin numfashi na COVID-19 ga mutanen da ke asibiti. Ana iya hana tsarin hayewa ta hanyar hangewa ta hanci ko kuma bi-level positive airway pressure.
Ba a san ko ko ɗaya daga cikin waɗannan abubuwa biyu zai amfane marasa lafiya masu ciwo ba.
Wasu likitoci suna son irin wannan maganin iska mai iska idan akwai, saboda yana iyakance yaduwar kwayoyin cutar a cikin iska fiye da yin amfani da iska mai iska.
Yawancin ƙasashe masu tasowa ba su da isasshen gadaje a asibiti, saboda haka, yawan marasa lafiya masu tsanani na COVID-19 da suka tashi ba zato ba tsammani na iya iyakance ikon tsarin kiwon lafiya yayin da ake magance matsalar shigar da su asibiti.
Wani bincike da aka gudanar a kasar Sin ya nuna cewa kashi 5 cikin 100 na dukkan marasa lafiya sun shiga ICU, kashi 2.3 cikin 100 na marasa lafiya sun bukaci taimakon iska daga waje, kuma kashi 1.4 cikin 100 sun mutu.
A China, kusan kashi 30 cikin dari na marasa lafiya da suka kamu da cutar COVID-19 da aka yi musu asibiti sun shiga ICU.
Yayin da marasa lafiya da ke fama da COVID-19 ke fuskantar ciwon huhu mai tsanani (ARDS), ana samun rikitarwa a cikin iska ta fasaha kuma yana da wuyar samar da iskar oxygen.
Ana buƙatar masu iska masu ƙarfin matsi da masu ƙarfin PEEP don samar da iskar oxygen mai yawa don rage haɗarin cutar huhu da cutar huhu.
Tsoffin masu iska na iya zama cewa ba a samun PEEP mai ƙarfi a kan iska.
A watan Janairun shekarar 2020 ne aka fara bincike kan yiwuwar maganin, kuma an fara gwada kwayoyin rigakafi da yawa.
Wannan shi ne abin da ya fi sa mutane farin ciki.
Ko da yake zai ɗauki lokaci har zuwa 2021 kafin a sami sababbin magunguna, yawancin magunguna da aka gwada sun sami amincewa don wasu amfani ko kuma suna ci gaba da gwaji.
Ana iya gwada magungunan rigakafi a kan marasa lafiya masu tsanani.
Masu aikin sa kai sun shiga gwaje-gwaje don nazarin tasirin da amincin waɗannan hanyoyin magani, kamar yadda Hukumar Lafiya ta Duniya ta ba da shawarar. FDA ta ba da izinin wucin gadi don magance convalescent plasma a matsayin gwaji ga marasa lafiya waɗanda rayuwarsu ke cikin haɗari.
Ba a yi nazarin sunadarai ba don tabbatar da cewa suna da tasiri da kuma lafiya a maganin cutar.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani app na wayar hannu don magance cutar.
Ana tambayar masu amfani su saka sunayensu da lambar ID ɗin su a ciki.
Aikace-aikacen zai iya nuna 'ƙusoshi' daga bayanan da aka lura kuma ya ba da damar gano yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka nuna hadarin, app ɗin yana ba da shawarar yin amfani da kai-kai, kuma yana ba da sanarwar ga hukumomin kiwon lafiya na gida. Ana amfani da manyan bayanai a cikin bayanan wayar hannu, analytics, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere-kere don saka idanu kan marasa lafiya da waɗanda suka kamu da cutar da kuma waɗanda suka haɗu da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta bai wa jami'an tsaro damar duba bayanan wayar salula na mutanen da ke da yiwuwar kamuwa da cutar.
An dauki matakan da za su sa a ware mutane da kuma kare wadanda za su iya samun wadanda suka kamu da cutar.
A watan Maris na shekarar 2020, kamfanin sadarwa na Deutsche Telekom ya mika wa kamfanin Robert Koch Institute, wata hukumar gwamnatin tarayya ta Jamus, bayanan da aka tattara na wuraren da ake amfani da wayoyin don hana yaduwar cutar da kuma gudanar da bincike.
Rasha ta kafa fasahar gano fuska don gano mutanen da ke karya keɓewa.
Kwamishinan lafiya na yankin Italiya, Julio Gallari, ya ce yana samun bayanai ta wayar salula.
Gwamnatin Jamus ta shirya hackathon na tsawon sa'o'i 48 a karshen mako tare da mahalarta sama da 42,000.
Shugaban Estonia, Kirsty Karlulid, ya yi kira ga duniya da ta dauki matakan da za su iya hana yaduwar cutar.
Mutane suna iya jin tsoro don yin zaman kansu, hana tafiya, ko kuma tsoron yin maganin da zai iya haifar da cutar.
BBC ta yi magana da Rory O'Connor a kan "ƙaruwar keɓewa ta zamantakewa, kaɗaici, kulawar lafiya, damuwa da kuma raguwar tattalin arziki sune manyan dalilan da ke sa lafiyar mutum da kuma lafiyarta cikin haɗari".
Wannan zai iya zama rashin bayyanar cututtuka ko kuma ba shi da alamun bayyanar cututtuka, kamar yadda yake da sauran cututtukan numfashi kamar sanyi da zazzabi.
A wasu lokatai, ana iya warkar da marasa lafiya cikin makonni biyu, amma a wasu lokatai, ana iya warkar da marasa lafiya cikin makonni uku zuwa shida.
Bayanin wasu irin cututtukan kamar SARS, MERS, ya nuna cewa mata masu ciki da suka kamu da cutar COVID-19 suna iya fuskantar haɗarin cutar, amma babu wani bayani game da COVID-19 a cikin wannan yanayin.
A cikin mutanen da suka sami mummunan tasiri, COVID-19 na iya haifar da cutar ta rikitarwa ta numfashi (ARDS), wanda zai iya haifar da rashin numfashi, saɓo na hanji, ko kuma lalacewar gabobin jiki da yawa.
Rikicin da ya shafi COVID-19 ya hada da cutar sepsis, cututtukan jini marasa kyau da kuma cututtukan zuciya, koda da hanta, da dai sauransu.
Kashi 6 cikin 100 na mutanen da aka kwantar da su asibiti saboda COVID-19 sun sami cututtukan jini, an sami karuwar prothrombin, da kuma cututtukan koda a cikin kashi 4 cikin dari na mutanen da aka kwantar da su.
Kusan kashi 20-30 cikin dari na mutanen da ke da cutar COVID-19 sun kamu da cutar na hanta.
Rahoton ya ce, a lokacin da aka samu bayyanar cututtuka, an yi kwanaki 10 kafin a mutu, daga cikinsu akwai kwanaki 5 da ake bukata a yi masa asibiti.
Amma, a lokacin da aka kai marasa lafiya zuwa sashen kula da marasa lafiya, an kai su asibiti kuma sun mutu a matsakaici na kwanaki bakwai.
Nazarin farko ya nuna cewa matsakaicin lokacin mutuwa daga bayyanar cututtukan farko na cutar ya kasance kwanaki 14.
Wani bincike da hukumar lafiya ta kasar Sin ta gudanar ya nuna cewa mace-mace a maza sun kai kashi 2.8 cikin dari, amma mata sun kai kashi 1.7 cikin dari.
Binciken da aka yi na gano cutar ƙwayoyin cuta a cikin huhu biyu ya nuna lalacewar alviollar da ta taso a cikin huhu biyu tare da fibromyaroxide.
An gano cewa an samu wasu canje-canje a cikin ƙwayar cuta.
Hoto na huhu yana da alaƙa da cutar ta RAS (ARDS).
A cikin mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta bayar, kashi 11.8% na wadanda suka mutu sun nuna cewa suna da matakan troponin da suka fi girma ko kuma suna da bugun zuciya.
Rahoton Maris na Amurka ya nuna cewa kashi 89 cikin 100 na mutanen da aka kwantar da su a asibiti sun riga sun yi wasu korafi.
Saboda bambancin yankuna, an yi hasashen cewa yawan mutuwar a wannan yanayin zai canza, amma kuma saboda matsalolin da ake samu a cikin tsarin.
Idan aka rage yawan cututtukan da suka shafi cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Koyaya, gaskiyar cewa waɗannan mutuwar sun kasance sakamakon wasu lokuta na tuntuɓar a baya, na iya nufin cewa ƙididdigar mutuwar ta yanzu ta ragu.
Masu shan sigari suna da damar samun alamun COVID-19 mai tsanani sau 1.4 fiye da waɗanda ba sa shan sigari, kuma kusan sau 2.4 ne mafi yawan mutane ke buƙatar kulawa da matsananciyar iko ko mutuwa.
Jami'an asibitoci a Hong Kong sun gano cewa a wasu mutane, wanda ya warke daga cutar, akwai raguwar kashi 20 zuwa 30 cikin dari a cikin ƙarfin huhu, kuma a cikin binciken huhu an gano cewa akwai lalacewar gabobin.
Wannan zai iya haifar da ciwon bayan-karfin hankali bayan an warke.
Har zuwa watan Maris na shekarar 2020, ba a san ko mutanen da suka warke daga cutar sun samu tasiri da kuma kare lafiyar su na dogon lokaci ba.
Idan muka duba yadda wasu cututtukan suka shafi cutar, za mu iya cewa akwai yiwuwar samun rigakafi, amma a cikin wasu lokuta, an sami gwajin gwaji na COVID-19 a cikin 'yan kwanaki masu zuwa bayan sun warke daga COVID-19.
An yi imanin cewa a cikin irin waɗannan lokuta, za a iya samun ciwon na dogon lokaci maimakon sake kamuwa da cutar.
Ana ganin cewa wannan kwayar halitta ce kuma ta samo asali ne daga dabba kuma ana yada ta ne ta hanyar kamuwa da cuta.
Ba a san ainihin asalinsa ba, amma har zuwa watan Disamba na shekarar 2019, cutar ta kasance ta hanyar kamuwa da cutar daga mutum zuwa mutum.
Nazarin da aka buga a cikin The Lenset a watan Janairu na mutane 41 da suka kamu da cutar COVID-19 ya nuna cewa ranar 1 ga Disamba, 2019 ita ce farkon ranar bayyanar cututtuka.
Hukumar ta WHO ta bayyana cewa, ranar 8 ga watan Disamba, 2019 ne farkon ranar bayyanar cututtukan.
Ana amfani da hanyoyi daban-daban don lissafin mutuwar.
Wadannan kididdigar sun bambanta daga yanki zuwa yanki da kuma lokaci, kuma suna shafar yawan gwaje-gwaje, ingancin tsarin kula da lafiya, zaɓin magani, tsawon lokacin da ya fara barkewar cutar, da kuma yanayin yawan jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta ba da lambar gaggawa ta ICD-10 mai lamba U07.1 ga mutuwar da aka tabbatar da gwaje-gwaje daga kamuwa da cutar SARS-CoV-2 da lambar cutar COVID-19 mai lamba U07.1 ga mutuwar da aka gano ta hanyar cutar ta SARS-CoV-2 wanda ba a tabbatar da cutar ta hanyar gwaje-gwaje ba. Mutuwa-zuwa-kashi rabo yana nuna yawan mutuwar da aka raba ta yawan shari'o'in da aka gano a cikin wani takamaiman lokaci.
A cewar jami'ar Johns Hopkins, yawan mutuwar mutum-zuwa-kashi a duniya ya kai kashi 6.9 cikin dari.
Sauran matakan sun hada da CFR, wanda ke nuna yawan mutanen da aka gano, wanda ya mutu saboda wani cuta, da kuma Inflammatory Death Rate (IFR), wanda ke nuna yawan mutanen da suka kamu (masu gano da marasa gano) da suka mutu saboda wani cuta.
Wadannan kididdigar ba su da iyaka a lokaci kuma suna amfani da wasu alƙaluma masu kamuwa da cutar ta hanyar cututtukan cututtuka.
Ba duk waɗanda suka kamu da cutar suke samun rigakafi ba, saboda haka, kasancewar rigakafi na iya ba da sanarwa game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar, a Italiya, a wani karamin kauye mai suna Castiglione d'Adda, mutane 4600,80 (1.7%) sun mutu.
A Gangalt, an yi amfani da bikin Carnival don yaɗa cutar, kuma an yi amfani da ita ga matasa, wanda ya haifar da ƙarancin mutuwar da aka kwatanta, kuma wataƙila ba za a iya rarraba duk mutuwar COVID-19 ba ta hanyar da ta dace.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba shi da nauyi.
A cikin Netherlands, kusan kashi 3 cikin 100 na mutane na iya samun rigakafi, kamar yadda aka samu daga masu ba da jini.
An tabbatar da mutuwar mutane 69 (kashi 0.004%) daga COVID-19.
Sakamakon cutar da kuma mutuwar mata da maza sun bambanta.
Bincike da aka yi a kasar Sin da Italiya ya nuna cewa maza sun fi mutuwa.
Maza a cikin shekarun 50 ne suka fi fuskantar haɗari, kuma mafi karancin bambanci tsakanin mace da namiji a cikin mutuwar mutane a shekarun 90s.
A kasar Sin, mace-mace ta kashe mutane da yawa, amma a kasar Sin, mace-mace ta kashe mutane da yawa, kuma yawan mutuwar maza ya kai kashi 2.8 cikin 100 da mace-mace ya kai kashi 1.7 cikin 100.
Ba mu san ainihin dalilin da ya sa ake samun bambancin jinsi ba, amma zai iya kasancewa na halitta ko kuma na aiki.
Rashin karfin rigakafi bisa jinsi, rashin yawan shan taba a cikin mata, da kuma ci gaban cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
A Turai, maza sun kai kashi 57 cikin 100 na mutanen da suka kamu da cutar, kuma maza sun kai kashi 72 cikin 100 na mutanen da suka mutu daga COVID-19.
Har zuwa watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta samun bayanan jinsi tsakanin mutanen da suka kamu da COVID-19 ba.
Bincike ya nuna cewa cututtukan cuta kamar Ebola, HIV, influenza da SARS suna shafar maza da mata a hanyoyi daban-daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma mata masu jinya, suna da haɗarin kamuwa da cutar.
Hukumar ta WHO ta sanar a ranar 11 ga Fabrairu 2020 cewa za a yi amfani da sunan COVID-19 a matsayin sunan da aka sani.
Shugaban WHO, Tendrose Adhanom Ghebreyesus, ya bayyana cewa CO na nufin Corona, VI na nufin Virus, D na nufin cuta, kuma 19 shine shekarar da cutar ta fara barkewa: 31 ga Disamba, 2019.
An ba da sunan ne don kauce wa komawa ga wani yanki na ƙasa (kamar China), nau'in dabba, ko rukuni na mutane, wanda ya bi shawarar bayar da sunaye ta duniya, kuma don kauce wa kowa ya zama mai ƙazanta. An kira cutar da ke haifar da COVID-19 da ake kira Sars-CoV-2 (Covid-19).
WHO ta yi amfani da "COVID-19 Virus" da kuma "Covid-19 Responsible Virus" a cikin sadarwa ta jama'a.
Wannan cuta da kuma cutar ana kiranta "Coronavirus".
A lokacin da cutar ta fara barkewa a birnin Wuhan, China, ana kiran cutar da cutar "Coronavirus" da kuma "Wuhan Coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCoV da 2019-nCoV acute respiratory diseases a matsayin sunayen rikodin don cutar da cutar, daidai da jagorar 2015 kan amfani da wuri a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin jerin abubuwan da ba a cika ba, wasu masana'antun dijital suna buga kayan kula da lafiya a matsayin sassan na'urar motsa jiki da sassan iska.
Alal misali, a wani asibiti a Italiya, lokacin da ake bukatar bawul na iska sosai kuma mai ba da kayayyaki bai iya ba da shi a kan lokaci ba, wani kamfani na gida ya yi aikin da ya dace da shi kuma ya buga bawul 100 a daren.
Bayan barkewar cutar COVID-19, an tattara bayanai marasa inganci da kuskure game da asalin cutar, girmanta, maganin ta da sauran abubuwa, kuma an yada su cikin sauri ta yanar gizo.
Mutane sun gano cewa suna iya yada cutar a wasu dabbobi.
Wannan binciken ya kawo sakamako mai kyau na gano cewa akwai wasu kwayoyin cutar a cikin alade, da kuma kaza.
Babu wani magani ko allurar rigakafi da aka amince da ita don magance cutar.
Gwamnati na ci gaba da bincike na kasa da kasa kan alluran rigakafi da magungunan COVID-19.
A watan Maris, WHO ta kaddamar da "Taraitaccen Gwajin" don tantance tasirin maganin abubuwa huɗu na riga-kafi masu inganci.
Duk da cewa babu allurar rigakafi a halin yanzu, hukumomi daban-daban suna aiki sosai wajen samar da 'yan takarar rigakafi'.
Ana amfani da binciken da aka yi a baya akan SARS-CoV-2, saboda SARS-CoV da SARS-CoV-2 duka suna amfani da ƙwayoyin cuta na ACE2 don shiga cikin ƙwayoyin mutum.
Har zuwa yanzu an gano dabarun rigakafi guda uku.
Na farko, masu bincike suna da burin samar da cikakken rigakafin cutar.
Ana amfani da irin wannan kwayar cutar, ko dai ita ce mai guba ko kuma mai mutuwa, don samar da sabon kamuwa da cutar COVID-19 a cikin gaggawa na jikin mutum.
Dabarar ta biyu ita ce allurar rigakafi ta subunit, wanda ke nufin samar da allurar rigakafi da ke sa tsarin rigakafi ya zama mai saurin kamuwa da cutar zuwa wani takamaiman subunit.
Game da SARS-CoV-2, binciken ya mai da hankali ne kan furotin S-spike wanda ke taimakawa kwayar cutar ta rarrabe ƙwayoyin cuta na ACE2 enzyme.
Dabarar ta uku ita ce rigakafin nucleic acid (DNA ko RNA, sabuwar fasaha don samar da allurar rigakafi).
Ana buƙatar gwaji don aminci da tasiri na kowane ɗayan waɗannan dabarun gwaji. An fara gwajin asibiti na allurar rigakafi tare da masu sa kai huɗu a Seattle a ranar 16 ga Maris, 2020.
Wannan rigakafin yana da lambar kwayoyin halitta mara haɗari, wanda aka yi kwafinta daga kwayar cutar da ke haifar da cutar. An ba da shawarar adana tushen antibody a matsayin ƙalubale mai yuwuwa don haɓaka rigakafi don SARS-CoV-2, amma wannan abu ne mai rikitarwa.
Rahotanni sun nuna cewa, a cikin watan Afrilu na shekarar 2020, an gudanar da gwajin asibiti sama da 300.
Ana tantance gwaje-gwaje guda bakwai daga cikin magungunan da aka riga aka amince da su don cutar zazzabi, ciki har da bincike guda hudu akan hydroxychloroquine ko chloroquine.
Yawancin binciken da aka yi na kasar Sin sun hada da maganin kashe kwayoyin cutar da aka yi amfani da su a wurare da dama, kuma a cikin rahoton da aka gabatar a karshen watan Afrilu, an samu gwaje-gwaje tara a kan mataki na III na Remediciver a kasashe da dama.
A cewar rahoton na watan Afrilu 2020, akwai nazarin ci gaban kiwon lafiya na COVID-19 don allurar rigakafi da kuma masu neman magani. An tantance wasu magungunan riga-kafi na yanzu don magance COVID-19, gami da Remedicivir, Chloroquine da Hydroxychloroquine, Lopinavir/Rythonvir da Interferon Beta.
A cewar wani rahoto na Maris 2020, akwai shaidar wucin gadi na yin amfani da Remedicivir.
A cikin marasa lafiya da aka yi wa magani da Remediciver, an samu ci gaba a fannin kiwon lafiya.
Ana gudanar da gwaji na asibiti na Phase III a Amurka, China da Italiya. An yi nazarin chloroquine, wanda a baya aka yi amfani da shi don maganin malaria a China a watan Fabrairun 2020, wanda ya ba da sakamako na farko.
Duk da haka, wannan bincike yana bukatar nazari na gaba daya.
Hukumomin kiwon lafiya na kasar Sin da na kasar Korea sun bada shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayar cutar Wuhan ta ba da shawarar yin amfani da gram 1 a kowace rana, ta lura cewa sau biyu yana da haɗari sosai kuma yana iya haifar da mutuwa.
FDA ta ba da izinin gaggawa na Hydroxychloroquine da Chloroquine a ranar 28 ga Maris, 2020, bisa ga sanin likitocin da ke kula da marasa lafiya da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban sashi na raibovirine don hana SARS-CoV-2 a cikin gwaji.
Nazarin ya nuna cewa an fara bukatar yin amfani da spike protein priming ta hanyar transmembrane protease serine 2 (TMPRSS2) don samun damar shiga SARS-CoV-2 ta hanyar hulɗa da ACE-2 na'ura mai aiki.
Akwai manyan matsaloli a cikin nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba wanda ya hana al'umma ta likitanci yin amfani da waɗannan magunguna ba tare da ƙarin bincike ba. Oseltamivir bai hana SARS-CoV-2 a cikin gwaji ba kuma ba a gano wani sanannen aiki a cikin maganin COVID-19 ba.
Taurari na cytokine na iya zama rikitarwa a cikin matakai na gaba na COVID-19 mai tsanani.
Wannan ya nuna cewa hydroxychloroquine na iya samun tasirin anti-cytokine. Bayan wani karamin bincike, Hukumar Lafiya ta kasar Sin ta hada da Tocilizumab a cikin jagorar magani.
A Italiya, ana gudanar da gwaje -gwaje marasa daidaituwa na mataki na biyu a matakin ƙasa, yayin da aka sami sakamako mai kyau a cikin mutane masu rashin lafiya.
Idan aka haɗa serum ferritin tare da gwajin jini don gano hadari na cytokine, yana nufin hana ci gaban da aka ɗauka ya haifar da mutuwa a cikin wasu mutane masu kamuwa da cutar.
A shekara ta 2017, FDA ta amince da maganin interleukin-6 wanda ke da ƙwayoyin cuta, bisa ga wani bincike na farko da aka yi don magance cutar cytokine release syndrome, wanda ya haifar da wani abu daban mai suna CAR T cell treatment.
Babu wata hujja ta bazuwar da ta tabbata cewa tosilezumab magani ne mai tasiri ga CRS.
Ana gudanar da bincike kan hanyar yin allurar rigakafi ta hanyar rigakafin mutum da aka yi amfani da shi don yin amfani da shi a cikin mutanen da ke bukatarsa.
An yi amfani da wannan dabarar don cutar SARS, amma ba ta da sakamako na musamman.
Ana tsammanin aikin neutralization na kwayar cutar zai iya zama hanyar da za a iya magance maganin antibody mai hana aiki da SARS-CoV-2.
Duk da haka, wasu dabaru, kamar su antibody-dependent cellular cytotoxicity da/ko phagocytes, na iya yiwuwa.
Ana ci gaba da yin amfani da wasu nau'ikan maganin rigakafi na rashin aiki, misali, amfani da kwayoyin rigakafi na monoclonal.
Ana iya ƙara samar da maganin ƙwayoyin cuta, wanda ya ƙunshi furotin na jini na marasa lafiya da suka warke kuma ya ƙunshi rigakafin da ke da alaƙa da wannan kwayar cutar, don saurin ci gaba.
Cutar Coronavirus, wata cuta da ta shafi cututtukan da ke kusa da juna
Likita Li Wenliang, daga asibitin Wuhan na tsakiya, ya kamu da COVID-19 kuma ya mutu bayan ya sanar da jama'a game da yaduwar cutar.
